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INTRODUCTION 
Superoxide Dismutase 
Superoxide dismutases (SODs) are key enzymes in the cellular defense against free 
radical oxidation (Geslin, el a/., 2001).Although free radicals are a normal 
byproduct of metabolism, their generation results in damage to biological 
macromolecules, thus contributing to such adverse conditions as aging, cancer, and 
a variety of degenerative diseases (Bonnefoy, et al.^ 2002), SODs are present 
virtually in all known cells and, by catalyzing the degradation of the superoxide 
free radicals to water and hydrogen peroxide, play an important role in reducing 
the damage associated with, for example, ischemic injury, inflammatory disorders, 
cardiovascular diseases, immune system decline, brain dysfunction, cataracts and 
other aspects of aging and degenerative disease. Superoxide itself is a free radical 
sink as most reactive oxygen species are scavenged by dioxygen to superoxide. 
Since superoxide is scavenged in turn by superoxide dismutase, SOD is a master 
eukaryotic regulator of intracellular reactive oxygen species. 
Superoxide dismutase (SOD) was first isolated by Mann and Keilin (1939) 
and thought to be a copper storage protein. The study of superoxide dismutase 
(SOD) (E.G. 1.15 1.1) started almost half a century ago when the copper known to 
be present in blood was found to be associated with a protein. This copper protein 
was isolated from red blood corpuscles and ox liver and named hemocuprein and 
hepatocuprein respectively. Purified preparations of hemocuprein and 
hepatocuprein were found not to combine with oxygen as does hemocyanin, which 
is a copper-containing respiratory protein of invertebrates. Also, both proteins were 
found not to promote phosphorylation reactions and not to have 
polyphenoloxidase, cytochrome oxidase, peroxidase, catalase, or carbonic 
anhydrase activity. The fianction of the protein remained unknown until the work 
of Mc Cord and Fridovich in (1969), when, as a result of various obser\'ations 
carried out at Duke University on the reduction of cytochrome C by the superoxide 
radical O2' generated from xanthine/ xanthine oxidase reaction, hemocuprein 
(erythrocuprein) was identified as SOD. This copper protein of previously 
unknown function was found to catalyze the dismutation of superoxide radicals 
O2 + O2" + 2H" > H2O2 + O2 
In the intervening period between the first isolation of hemocuprein and the 
discovery of its function, it was realized that a whole family of cupreins was 
present in the various organs Porter and Folch (1957), isolated a copper protein 
from bovine brain and called it cerebrocuprein A similar protein was isolated from 
normal human bram (Porter and Ainsworth, 1959) All the cupreins isolated from 
the various organs in a single species were suggested to be identical (Porter, et al, 
1964) Antibodies raised against the human hemocuprein were found not to cross 
react with beef hemocuprein, (Markowitz, et al, 1959) indicating a species 
difference Human hepatocuprein, cerebrocuprein and erythrocuprein were 
confirmed to be identical (Carrico and Deutsch, 1969) These proteins were 
observed to have a similar isoelectric point, sedimentation velocity, molecular 
weight, electron paramagnetic resonance and visible absorption spectra, 
immunological cross reactivity and amino acid composition and gave similar 
peptide maps following trypsin digestion Besides coppei, the cupreins were also 
found to contain zinc (Carrico and Deutsch, 1970) 
The activity of this enzyme determines the relative propoitions of the two 
constituents of the Haber-Weiss reaction that generates hydroxy! radicals Since 
SOD is present m all aerobic organisms and most (if not all) subcellular 
compartments that generate activated oxygen, it has been assumed that SOD has a 
central role m the defense against oxidative stress (Beyer, et a/, 1991) The 
discovery of SOD opened a whole new area of research not only on the structure 
and function of the enzymes, but also concerning the roles of free radicals in 
biology and medicine A number of texts have been published on the subject 
(Halhwell, et al, 1985, Halliwell and Gutteridge, 1985, Rotilio, 1986, 
Greenwald,1985) This field of research has today come to be of interest to 
physicists, biochemists, molecular biologists and clinicians 
Types of Superoxide Dismutase 
There are four distinct types of SOD classified on the basis of metal cofactor. 
Manganese containing Superoxide Dismutase (Mn-SOD) - Manganese 
containing superoxide dismutase (MnSOD) is the SOD isoform found in the 
mitochondrial matrix of eukaryotes and variety of prokaryotes. Mn-SODs from 
different organisms are homologous and have manganese ion in the active site. The 
human mitochondrial enzyme is a homotetramer and in E.coli it is a dimer. Mn-
SOD is a homotetramer (96Kda) containing one manganese atom per subunit that 
cycles from Mn(lII) to Mn(ll) and back to Mn(III) during the two step dismutation 
of superoxide (Singh, et al, 1999; Regelsberger, et a!., 2002, Li, et al, 2002). 
Iron containing Superoxide Dismutase (Fe-SOD) - Fe-SODs and Mn-SODs show 
homology and have the same metal chelating residues at the active site, sharing 
considerable sequence and three dimensional structural homology, however, the 
other superoxide dismutases are structurally unrelated. Fe and Mn-SODs are 
unequally distributed throughout the kingdoms of living organisms and are located 
in different cellular compartments. In particular, Fe-SOD is found in obligate 
anaerobes and aerobic diazotrophs, facultative aerobes (exclusively or together 
with MnSOD), in the cytosol of cyanobacteria, in the chloroplast stroma of higher 
plants and in protozoa (Regelsberger, et a/., 2002, Li, et a/., 2002). 
Nickel Superoxide Dismutase (Ni-SOD) - Ni-SOD has been purified from the 
cytosoiic fraction of various streptomyces species. The amino acid composition, N-
terminal amino acid sequences and immunological properties show that Ni SODs 
are distinct from the M.n, Fe or CuZn enzymes; and thus characterize a new class 
of SOD. This enzyme has Ni atom at its active site. 
Copper Zinc Superoxide Dismutase (Cu,Zn SOD) - Cu,Zn SOD are another class 
of enzyme conserved throughout evolution, which usually have two identical 
subunits of about 32 KDa, each containing a metal cluster, the active site, 
constituted by a copper and a zinc atom bridged by a common iigand: Histidine. 
Cu,Zn SOD is a prototypical dinuclear metalloprotein,as shown in Figure 1, 
has been subjected to extensive mechanistic and spectroscopic studies. The 
structure of the enzyme from bovine erythrocytes ( dimer with MW = 32,000 Da ) 
has been determined at 2.0A resolution by the use of x-ray crystallography which 
revealed a distorted square pyramidal Cu" '^ and a distorted tetrahedral Zn^' in the 
active site ( Banci, et ai, 1998; Tainer, el al, 1982). The Cu^" site is responsible of 
catalysis and is coordinated by four Histidine residues (His-44, His 46, His 61 and 
His 118) and a water molecule, and the Zn"" site is bound to the protem through 
His 61, His 69, His 78 and Asp 81 (Figure 2 ). The two metal ions are 6.3 A away 
from eacli other and bridged by the iniidazolate of the His 61 residue The 
positively charged Arg 141 located in the active site channel about 5 A away from 
the copper has been proposed to play a key role in the catalysis hy providing an 
electric gradient to attract the negatively charged 02" substrate (Figure 3 ). 
The complete primary structure of reduced and s-carboxymethylated 
bovine erythrocyte superoxide dismutase has been derived through analysis of 
peptides from the peptic, plasmin and hydroxylamine digests of the intact 
polypeptide chain, and from the chymotryptic, subtilisin and dilute acid digests of 
derived peptide (Steinmann, et ai, 1974). From these data the unique amino acid 
sequence of 151 residues was deduced corresponding to the Mol, Wt, of 1 5,600 Da 
in each of the two apparantly identical subunits of the protein molecule. The amino 
acid sequence reported, (Figure 4) excluded the possibility that the metal ions are 
bound via the a amino nitrogen atoms, for the a amino groups are acetylaled 
However, a histidine rich sequence located within peptide T4 (His-Gly-F^he-His-
Val-His, residues 41-46) was an obvious candidate for one or more of the metal 
binding ligands in this enzyme. In fact, His 44 and His 46 (as well as His 61 and 
His 118) are observed to be ligands of the copper atom in 3 A resolution electron 
density map of bovine dismutase. The most outstanding feature of the amino acid 
composition of bovine erythrocyte dismutase and of other copper zinc dismutases 
Figure 1 Structure of Bovine Cu,Zn Superoxide disniutase. 

Figure! Three dimensional structure of Bovine Cu,Zn Superoxide dismutase 

Figure 3 Structure of Bovine Cu,Zn Superoxide disniutase. 
Illustration of the electrostatic field (yellow ) around an active site (red ) 
of the enzyme SOD which controls oxygen toxicity by converting the 
superoxide radical to less dangerous forms. 

Figure4 Amino acid sequence of Bovine Cu,Zn Superoxide dismutase. 
Ac-Ala-Thr-Lys-Ala-Val-Cmc -Val 
Gly -Pro-Val-Gln-Gly-Thr-lle -His 
Gly -Asp-Thr 
30 
Leu -Thr-Glu' 
50 
Phe -Gly-Asp-
60 
Pro -His-Phe-
Pro -Lys-Asp-
Asn -Val-Thr 
Asp -lie -Val 
MO 
Tyr -Ser-Ile 
120 
Lys -Pro-Asp 
Ser -Thr-Lys 
Cmc -Gly-Val 
•Val-Val-Val-Thr -Gly 
40 
Gly-Asp-His-Gly -Phe 
Asn-Thr-GIn-Gly -Cmc 
Asn-Pro-Leu-Ser -Lys 
-Glu-Glu-Arg-His -Val 
90 
-Ala-Asp-Lys-Asn -Gly 
100 
-Asp-Pro-Leu-Ile -Ser 
-He -Gly-Arg-Thr -Met 
•Asp-Leu-Gly-Arg -Gly 
•Thr-Gly-Asn-Ala -Gly 
150 
•He -Gly-He -Ala -Lys 
10 
-Leu-Lys-Gly -Asp-
20 
-Phe-Glu-Ala -Lys-
-Ser-He -Thr -Gly-
-His-Val-His -Gln-
-Thr-Ser-Ala -Gly-
70 
-Lys-His-Gly -Gly-
80 
-Gly-Asp-Leu -Gly-
-Val-Ala-He -Val-
-Leu-Ser-Gly -Glu-
-Val-Val-His -Glu-
130 
-Gly-Asn-Glu -Glu-
140 
-Ser-Arg-Leu -Ala-
is the predominance of glycine (Table 1). In the bovine enzyme nearly one sixth of 
amino acids are glycine and 25 residues of glycine per subunit are distributed 
relatively evenly throughout the amino acid sequence. This feature could permit 
many bends m polypeptide backbone, allowing multiple contacts between non-
adjacent regions in the primary structure. Such interactions could contribute to the 
remarkable stability of this dismutase. The two identical subunits is formed by a P-
barrel, made of eight antiparallel P-strands connected by seven turns and loops. 
There is also EC-SOD, a secretory, tetrameric, copper and zinc containing 
glycoprotein (with a high affinity for certain glycosaminoglycans such as heparin, 
and heparan sulfate) found in interstitial spaces of tissues and also in extracellular 
fluids, accounting for the majority of SOD activity of plasma, lymph and synovial 
fluid. 
Distribution of Superoxide dismutase 
All living cells are prone to oxygen toxicity. This arises from the production of 
reduction products of oxygen or the excited singlet state. The univalent reduction 
of oxygen leads to the formation of O2', which can react fiarther to produce 
hydrogen peroxide (H2O2) and hydroxyl radicals (OH). Superoxide radicals are 
generated in many biological oxidations. These include the autoxidation of flavins, 
hydroquinones, catecholamines, thiols, tetrahydropterines, hemoproteins and 
reduced ferrodoxin. Subcellular organelles such as chloroplasts and mitochondria 
also produce superoxide radicals. The radical is also formed by several oxidative 
enzymes - xanthine oxidase, aldehyde oxidase, dihydroorotic acid dehydrogenase 
and by several flavin dehydrogenases. The radical may occur as an intermediate in 
the reaction catalyzed by galactose oxidase, indoleamine dioxygenase, and 2-
nitropropane dioxygenase and other flavin cotaining oxidases Finally superoxide 
radicals are formed by neutrophils and macrophages during phagocytosis. The 
toxicity of the superoxide radical has been considered in terms of the possible 
indirect reactions it can undergo with other cellular constituents, with the most 
important being hydrogen peroxide. This reaction in the presence of trace 
Tablel Amino acid composition of Bovine Cu,Zn Superoxide dismutases. 
Amino acid Bovine Cu,Zn Superoxide 
dismutases 
Half-cystine 
Aspartic acid 
3 
17 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Argenine 
Tryptophan 
12 
8 
11 
6 
25 
9 
15 
1 
9 
8 
1 
4 
10 
8 
4 
0 
metal ions leads to the formation of hydroxyl radicals Clearly, therefore, the 
presence of SOD is to be considered as the first line of defense against the toxicity 
of oxygen-centered radicals This implies that the enzyme is essential to aerobic 
organisms and is not required by anaerobic organisms Mc Cord ct ul (1981) 
proposed an enzyme-based theory of obligate anaerobiosis, whereby the aerobic 
existence of an organism depend upon its ability to produce SOD, followmg their 
finding that obligately anaerobic bacteria, i e species which exhibit sensitivity to 
oxygen at 0 2 atm or less, did not possess any SOD activity The distribution of the 
three forms of SOD in the cell of a prokaryotes and eukaryotes has extensively 
been studied (Table 2 and 3) 
The combination of sensitivities and insensitivities of the three enzymes to 
cyanide, h\drogen peroxide and azide has allowed the determination ot which 
form of the enzyme is present in a crude extract In general, such investigations 
have been confirmed by the isolation and characterization of the enzyme from the 
organism The first detailed investigation on the presence of SOD in obligate 
anaerobes was carried out by Hewitt and Morris (1975) who reported the presence 
of the enzyme in anaerobic photosynthetic bacteria, sulfate-reducing bacteria and 
Clostridia Activity was also detected in Clostridium acetohutyliciirn and C 
pastuenamim, which Mc Cord et al (1981) had reported to be devoid of the 
enzyme It appears that the level of the enzyme in anaerobic species is low and that 
It can avoid detection Preliminary characterization indicated that the enzyme in C 
perfnngens was not inhibited by 10 M cyanide, implying that it is either the iron 
or manganese form of the enzyme SOD activity was also demonstrated in other 
anaerobic species Lumsden and Hall (1975) and Asada ct al (1976, 1977) 
demonstrated the occurrence of a cyanide-msensitive activity in the anaerobic 
green and purple sulphur bacteria Chlorohnim thiosulfatophilum and Choniatium 
Vmosiim Cyanide insensitive activity was also found in various species of the 
anaerobe bacteroides (Gregory, et a!, 1977, Carlsson, et al, 1977) Tally, et al 
(1977) and Gregory, et al ^ (1978 ) reviewed the presence of SOD in various 
anaerobic bacteria of clinical importance, and in all the organisms in\estigated the 
activity was detected Various strains of halophilic vibrios, (Daily, et al, 1978) 
Table 2 Distribution of SOD in Prokaryotic Cells. 
FeSOD 
MnSOD 
Prokaryotic Cells - SOD 
MW/Da 
40,000 
40,000 
80,000 
Subunits 
Two (Dimer) 
Two (Dimer) 
Four (Tetramer) 
Intracellular Location 
Outermembrane 
Matrix (Inner) 
12 
Table-3 Distribution of SOD in Eukaryotic Cells. 
MnSOD 
CuZnSOD 
EC(Cu,Zn)SOD 
EC MnSOD 
Eukaryotic Cells - SOD 
MW/Da 
88,000 
32,000 
135,000 
150,000 
Subunits 
Four 
Two 
Four 
Two, Four 
Intracellular Location 
Mitochondrial matrix 
Cytoplasm, nucleus, 
lysosomes 
Plasma membrane, 
extracellular 
Plasmamembrane 
EC-Extracellular 
13 
and ruminal bacteria (Fulghum and Worthington, 1984) were also found to possess 
SOD activity The insensitivity to cyanide indicates that the form of the enzyme 
present m anaerobic bacteria is either the manganese or the iron isozyme An iron 
form of the enzyme has also been purified from the anaerobes Desiilfovihrio 
desulfuricans (Norway, 4), (Hatchikan and Henry, 1977), ChromaUum vmosum 
(Kanematsu and Asada, 1978), Chlorohium thiosulfatophiliini (Kanematsu and 
Asada, 1978), Piopionihactenum shermanii (Meiei and Schwartz, 1980) and the 
methanogen Methanohactenum htyantii (Kirby, et al, 198!) Therefore, the most 
primitive foim of SOD appears to be the iron enzyme, ahhough a manganese SOD 
has also been isolated from the anaerobes P shermanii (Meier, ct al, 1982) and B 
fragilis- (Gregory, 1985) 
In contrast to anaerobic bacteria, aerobic and facultative anaerobic species 
contain either the iron or the manganese enzyme or both Facultative anaerobic 
bactena such as L toll contain only the iron enzyme when grown anaeiobically 
but,in the presence of oxygen, the manganese enzyme is also present (Dougherty, 
et al, 1978) Aeiobic diazotrophs possess both forms of the enzyme An iron SOD 
was isolated from the free living Rhizohium japonicum (Stowers and Flkan, 1981) 
and from Azospinlhtm hrasiheme (Clara and Knowles, 1984) However, in R 
phaseoh both forms of the enzyme were present, with the manganese enzyme 
being the piedominant form (Dimitroijovic, e( al, 1984) A manganese SOD was 
also isolated from Azotohacler chroococcum (Buchanan and Lees, 1980) 
However, a recent survey of various Azotobacter species indicated they can 
possess either form of the enzyme (Moore, et al, 1984) The presence of SOD in 
nitrogen fixing bacteria was proposed to be a defense mechanism against oxygen 
mactivation of the nitrogenase (Eady and Smith, 1979, Yates, 1977) 
Algae have also been found to possess iron and manganese SODs (Asada 
and Kanematsu, 1978) Although the form of the enzyme purified from the blue 
green algae (Cyanobacteria), which are considered to be among the most advanced 
prokaryotes, is the iron isozyme (Lumsden, et al, 1976, Misra and Keele, 1975, 
Asada, c1 a/., 1975, Cseke, et a/., 1979), the manganese enzyme has been isolated 
from the cytosol of the unicellular alga Porphyridium cruetUum, which is 
considered to be most primitive eukaryotic species (Misra and Fridovich, 1977), 
Both forms of the enzyme have been isolated from the eukaryotic Euglena gracilis 
(Kanematsu and Asada, 1979). The enzyme isolated from the protozoan Crithidia 
fasciculata contains iron (Trant, et ai, 1983).While a copper, zinc SOD is still 
lacking in protozoa, its presence in fungi and slime molds and the rest of the 
animal and plant kingdom has been definitely established, as has the presence of 
the manganese SOD. Asada and Kanematsu, (1978), have reported the SOD 
activity in two species of Mycomyceta (slime molds) and 43 species of ICiimyceta 
(fungi). In all the species, the presence of the cyanide sensitive copper/zinc SOD 
could be demonstrated, as could cyanide-insensitive activity. This is probably the 
manganese SOD since this form of the enzyme has been isolated from 
Saccharomyces cerevisisae (Ravindranath and Fridovich, 1975) and the 
luminescent fungus Pleiirotiis oleanus (Lavelle and Michelson, 1975). The 
copper/zinc SOD has been isolated from S. cerevisisae (Goscin and Fridovich, 
1972; Weser, et al., 1972), Neurospora crassa (Misra and Fridovich, 1972) and 
Dactylium dendroides (Shatzman and Kosman, 1979). Bryophytes (mosses) 
Pteridophytes (ferns), and gymnosperms and angiosperms (both seed plants) have 
been demonstrated to contain copper/zinc enzyme in addition to a cyanide-
insensitive form, which is probably the manganese enzyme (Asada and 
Kanematsu, 1978). The copper/zinc enzyme has been purified from green peas 
,wheat germ (Beauchamp and Fridovich, 1973), spinach leaves , kidney beans 
,tomato frmt (Marino, et al., 1995) and maize .In plant kingdom, a manganese 
SOD has only been purified from green peas (Sevilla, et ai, 1980, Seviila, et al., 
1982) and maize (Baum and Scandalios, 1981). Cyanide insensitive activity has, 
however, been detected in extracts from wheat germ (Beauchamp and Fridovich, 
1973), kidney beans (Kono, et a!, 1979), corn (Giannopolitis and Ries, 1977), tea 
(Hakamada, et al., 1978), spinach (Jackson, et al., 1978) and in several mosses and 
ferns (Asada, et al., 1976, Asada and Kanematsu, 1978). 
In invertebrate species, the distribution of SOD has been poorly 
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investigated. SOD activity has been demonstrated in a limited number of helminth 
tissues (Gerasimov, et al, 1979; Paul and Barret, 1980), in the sea anemone and in 
the cephatochordate Amphioxus lanceolatus (Bannister, unpublished observation). 
The presence of copper/zinc and manganese SODs have been reported in the fruit 
flies Ceratitis oepitata (Fernandez-Sousa and Michelson, 1976) and Drosophila 
melauogester (Massie, et al, 1980; Massie, et a/., 1981). The copper/zinc enzyme 
has been isolated and characterized from the nematode Trichifiella spiralis 
(Rhoads, 1983) and from/), melauogester (Lee, etai, 1981; Lee, et al., 1981). No 
manganese enzyme has been characterized from invertebrates or from lower 
vertebrates, where the copper/zinc enzyme has been isolated and characterized 
from the liver of swordfish Xiphias gladius (Bannister, et al., 1977) and from 
various teleost fish (Martin and Fridovich, 1981). In other vertebrates, copper/zinc 
and manganese SODs appear to be present in all the tissues investigated The 
copper/zinc SOD has been purified from bovine erythrocytes (Kumagai, 
etal.,]994) human erythrocytes ( Dubinina,c/a/.,1992;Arai,f/a/., 1994 ),horse ,pig 
livers and erythrocytes The manganese enzyme has been purified from the livers 
of chickens (Ozturk-Urek and Tarhan, 2001), humans ,and rats (Salin,c/ al., 1978) . 
Structure Based Mechanism of Cu,Zn Superoxide Dismutase 
The reaction catalyzed by Cu,Zn SOD -
O2" + Cu(II) Zn SOD > O2 + Cu(I) ZnSOD (i) 
O2 + Cu(I) Zn SOD + 2H" > H2O2 + Cu(ll) ZnSOD (ii) 
Figure 5, shows the reaction mechanism of Cu,Zn SOD. The reaction starts when 
superoxide is electrostatically guided into the active site channel. It then associates 
with Arg 143 and displaces Wat 266. Superoxide binds directly to Cu(II) and 
delivers its electron via an inner sphere mechanism. Dioxygen, no longer charged 
and electrostatically attracted to Arg 143, diffuses out of the active site channel and 
it is replaced by Wat 226, which is hydrogen bonded to Wat 227 at a distance of 
2.7A. In the second half of the reaction cycle, superoxide is electrostatically drawn 
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Figure 5 Schematic diagram of the catalytic cycle for Cu,Zn SOD. 
(A) SOD Cu(II) resting state Copper is in distorted square planar 
conformation characterstic of Cu (II) (B) SOD inner sphere electron -
transfer state Superoxide enters the active site cavity, displaces Wat 
226, and binds directly to the copper ion and gives up its electron (C) 
Cu (I) resting state The histidine bridge breaks , oxygen diffuses out of 
the active site channel,and Wat 226 enters The NE2 atom of His63 may 
get Its proton from bulk solvent The copper is in a trigonal planar 
conformation characterstic of Cu(I) (D) SOD outer sphere electron -
transfer Superoxide enters the active site cavity, displaces Wat226, and 
hydrogen donds with Wat227 and protonated NE2atom of His63 (E) 
Completion of the cycle Superoxide can accept an electron from copper 
and protons from Wat227 and His63 to form hydrogen peroxide 
Peroxide diffuses out of the active site and is replaced by Wat226 The 
imidazolate bridge re-forms as copper becomes square planar Waters 
227, 229,and 225 form a hydrogen- bonded chain that is postulated to act 
as a proton shuttle in this step of the mechanism 
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into the active site channel displaces Wat 226, and forms hydrogen bond vvith Arg 
143 and Wat 227 As the electron is accepted from the Cu(I) via an outer sphere 
electron transfer mechanism, superoxide takes a proton simultaneously from Wat 
227 and the NE2 atom of the bridging imidazolate His 63 The Cu(ll) ion can now 
move to reform the (deprotonated) Histidine bridge Electrically neutral hydrogen 
peroxide difflises out of the active site channel and is replaced b\ Wat 226 A 
chain of water molecules including Wat 229 and Wat 22S can relay piotons to the 
active site, replenishing those delivered to form peroxide (Hart, ei al, ] 999) 
Modulation of Cu,Zn Superoxide Dismutase 
Oxidative modification of cellular constituents, including lipids, proteins and 
nucleic acids, has been implicated in the etiology of different pathological 
conditions and in aging (Halliwell, 1987) Oxidative modification of total cellular 
proteins has been described under pathological conditions Oxygen radical-
mediated reactions have been implicated in the accumulation of damaged enz}'mes 
during aging (Stadtman, 1990) The damage brought about by oxidative stress is 
expected to be exacerbated if the antioxidant enzymes themselves are damaged and 
inactivated by such events (Tabatabaie and Floyd, 1994) 
Superoxide dismutase (SOD, EC 1 15 1 1) is one of the ke> antioxidant 
enzymes which provide an essential defense against oxygen toxicity to the cell 
(McCord and Fridovich, 1969) It has been known that copper, zinc SOD (Cu,Zn 
SOD), a homodimeric metalloenzyme which catalyzes the dismutation of the toxic 
superoxide anion to O2 and H2O2 (Fridovich, 1989), undergoes free radical damage 
by its own reaction product H2O2 (Hodgson and Fridovich, 1975) It is suspected 
that H2O2 reacts with enzyme bound transition metal ions, producing a powerful 
oxidant, hydroxyl free radicals (OH), which presumably then mediates the 
inactivation of SOD (Yim et al, 1990, Yim, el al 1993) In this regard 
peroxidase activity of Cu,Zn SOD, an essential antioxidant enzyme in vivo, may 
have deleterious effects on living cells Furthermore, duiing exposure to oxidative 
stress, It has been implicated that substantial Cu,Zn SOD inactivation may occur 
and that free copper ions could be released (Sato, et al, 1992, Ookawara, el al, 
1992) Therefore, the damaged Cu,Zn SOD may cause the augmentation of free 
radical mediated damage to other proteins upon exposure to oxidative stress 
Although thiols are important agents responsible for helping to maintain 
aerobic cells in a reducing state, despite an oxidizing environment, a growing body 
of evidence suggests that thiols, as electron donors o'l a non-enzymatic metal 
catalyzed oxidation (MCO) system, can paradoxically be responsible for the 
generation of reactive oxygen species (Giannessi, el al, 1993) MCO systems 
compiised o'i Fe ', O2, and thiol compounds as election donois catalyze the 
inactivation of many enzymes such as rhodanese from bo\ine liver (Costa, el a/, 
1977, Horowitz and Bowman, 1987), glutamine synthetase from Lschef ichia call 
and yeast (Kim, et al, 1985), pyruvate kinase from rabbit muscle (Kim, el al, 
1985) and aldolase reductase from bovine lens (Giannessi, et al, 1993) Thiol-
MCO systems are especially effective in damaging metallo-enzymes The 
discovery of a protein in yeast and mammals which protects against a thiol 
containing oxidation system (Kim, et al, 1988, Kim, et al, 1989) has now become 
strongly suggestive of the relevance of thiol MCO systems in protein damage /// 
Mvo These damaging effects are thought to be the result of the generation and 
reaction of oxygen species It is known that the auto-oxidation of mercaptans in the 
presence of iron generates reactive oxygen species such as superoxide anion, 
hydrogen peroxide and hydroxy! radical, as well as reactive sulfur centered free 
radical species (Misra, 1974, Rowley and Halliwell, 1982) The ability of Cu,Zn 
SOD to catal\ze autoxidation of cysteine and other thiols was investigated by 
measuring thiol loss and oxygen consumption The leaction occurred equally well 
with bovine and human enzymes and produced hydrogen peroxide and the 
corresponding disulfide These studies characterizes a novel pro-oxidant thiol 
oxidase activity of Cu,Zn SOD It is a potential source of reactive oxidants and 
may contribute to the cytotoxicity of reactive thiols such as cysteine and 
cysteamine (Winterbourn el al, 2002) It has also been shown that Cu,Zn SOD can 
enhance MCO-mediated DNA damage and that copper released from damaged 
SOD was responsible for mediating the damage (Park and Floyd , 1997). In 
addition to the direct attack of hydroxy! radicals produced by the thiol-MCO 
system, it can be implicated that Cu,Zn SOD is susceptible to damage due to its 
peroxidase activity as well as by Fenton-type reaction caused by the reaction of 
H2O2, produced by thiol-MCO system, with the released copper. Kwon, el a!. 
(1998) have shown that Cu,Zn superoxide dismutase, when exposed to a metal 
catalyzed oxidation (MCO) system composed of Fe ', O2, and thiol as an electron 
donor was susceptible to oxidative modification and damage as indicated by the 
loss of activity. 
Kwon, et al (2000) have investigated the oxidative modification of human 
Cu,Zn superoxide dismutase (SOD) by alkylperoxyl radicals and alkylperoxides. 
To generate free radicals, the hydrophilic azo-compound, 2,2'-azobis (2-
amidinopropane) dihydrochloride (AAPH) was used when Cu,Zn SOD was 
incubated with AAPH, the enzyme activity was decreased gradually in a time 
dependent manner. The oxidative damage to Cu,Zn SOD by AAPFl derived 
radicals led to protein fragmentation which is associated with the inactivation of 
enzyme. Incubation with AAPH resulted in the release of copper ions from Cu,Zn 
SOD and the generation of protein carbonyl derivatives. Catalase did not protect 
the fragmentation of Cu,Zn SOD whereas azide, glutathione and a metal chelator, 
diethylenetriamine penta acetic acid inhibited the protein fragmentation. When 
Cu,Zn SOD that has been exposed to AAPH was subsequently analysed by amino 
acid analysis, lysine, histidine, proline and valine residues were particularly 
sensitive. It is suggested that oxidative damage of Cu,Zn SOD by AAPH-derived 
radicals may induce perturbation of cellular antioxidant defense systems and 
subsequently lead to the deleterious conditions in cells. Carnosine homocarnosine 
and anserine inhibited the release of copper ions from the enzyme and the 
formation of carbonyl compounds in AAPH-treated Cu,Zn SOD (Kang et aJ., 
2002). Ozmen et al., (2002) have shown that oxidative damage of lens protein is 
involved in the genesis of senile cataract and the development of diabetes-related 
pathologic changes such as the formation of cataracts. They observed a decrease in 
Cu,Zn SOD activity suggesting the oxidative modification of the enzyme. 
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Sharonov and Churilova (1992) have investigated that bovine superoxide 
dismutase (SOD) was inactivated during incubation with phorbol myristate acetate 
stimulated neutrophils. Stimulated neutrophils were able to disrupt the SOD 
structure. Inactivation and structural damage were dependent on the action of 
hypochlorous acid, an oxidant generated by the myeloperoxidase-hydrogen 
peroxide-chloride system of neutrophils. Incubation of SOD with stimulated 
neutrophils lead to long-wavelength fluorescence (ex, 350 nm; em, 450 nm) and 
the appearance of new structural forms with other isoelectric points. These 
additional forms possess catalytic activity. Generation of catalytically active new 
forms of SOD demonstrates the inaccessibility of the active centre of SOD to 
hypochlorite and may be a reason for the successful application of SOD durmg 
anti-inflammatory therapy. The inactivating effect of hypochlorite on Cu,Zn 
superoxide dismutase (SOD) from bovine erythrocytes has been studied by 
Sharonov and Churilova (1992). According to SDS gel electrophoresis and 
isoelectric focussing data, oxidation is associated with the degradation of the 
polypeptide chain, formation of aggregates, and appearance of new isoforms. 
These protein fractions differ from native SOD by the electric charge and 
molecular mass but possess a catalytic activity. Modified SOD isoforms occur as a 
result of intramolecular crosslinking of amino groups and aldehydes which is 
confirmed by the appearance of fluorescence maxima in the long wave region 
characteristic of such links. It is assumed that the mechanism of SOD inactivation 
is coupled to the oxidation of amino acids located outside the active center of the 
enzymes. 
Oxidative damage of Cu, Zn SOD caused by H2O2 has been examined and 
is suggested that the fragmentation of Cu,Zn SOD induced by H2O2 is due to the 
oxidative damage resulting from OH radicals generated by a combination of the 
free radical generating function of Cu,Zn SOD and the Fenton like reaction of free 
copper released from oxidatively damaged SOD (Choi et al., 1999). Inactivation of 
Cu,Zn superoxide dismutase (Cu,Zn SOD) by its own reaction product H2O2 is a 
well known phenomenon. Generation of the hydroxyl radical has been a matter of 
great concern, and the target molecule has been regarded as its own active site 
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histidine residues (Uchida and Kawakishi, 1994) and that histidine 118 is 
converted selectively to 2-oxo histidine. The reaction of H2O2 with various SODs 
has been extensively studied (Yamakura, 1984; Dooley el ai, 1986; Sampson and 
Beckman, 2001; Lee et al., 2001, Midorikawa and Kawanishi, 2001). Both copper, 
zinc SOD (Cu,Zn SOD) and iron SOD (Fe-SOD) are inactivated by H2O2 whereas 
manganese SOD (Mn SOD) is unaffected. The inactivation of Cu,Zn SOD appears 
to be caused by the modification of one histidine at the active site of the enzyme 
(Bray et a/., 1974; Blech and Borders, 1983). 
Diseases Associated with Cu, Zn Superoxide Dismutase 
Cu,Zn SOD has great physiological significance and therapeutic potential. The role 
of this enzyme has been investigated in various specific red blood cell (RBC) 
disorders, such as iron deficiency anemia, oxidative hemolytic anemia, 
thalassemia, sickle cell anemia, molecular dystrophy and cystic fibrosis 
(Panchenko et al., 1979; Mavelli et al., 1984; Concetti et al., 1976 and Mizuno, 
1984). Zelman et al. (1989) have monitored the activity of Cu,Zn SOD in 
fibroblast cell lines derived from familial Alzheimer's patients and normal 
controls. Cu,Zn SOD activity was found to be significantly elevated in the patients, 
supporting the earlier theory that paired helical filaments are synthesized in 
Alzheimer's disease by free radical hydroxylation of proline residues in paired 
helical filament precursor protein. In addition to these findings, one remarkable 
study has described the localization of Cu,Zn SOD in the brain tissues of patients 
with Alzheimer's disease (Delacourte etal., 1988). Immunostaining experiments 
showed that large pyramidal neurons, which are potentially susceptible to 
degenerative processes in Alzheimer's Disease, contain higher amounts of Cu,Zn 
SOD than other brain cells. 
Recently, extensive work has been carried out on the link between 
amyotrophic lateral sclerosis (ALS) and SOD. ALS is a devastating neurological 
disease that rapidly progresses from mild motor symptoms to severe motor 
paralysis and premature death. Kruman et al., (1999) have employed a mouse 
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model of ALS in order to test the excito-toxicity hypothesis of ALS. In this model 
over expression of a mutant familial ALS-linked Cu,Zn SOD leads to progressive 
motor neuron (MN) loss and a clinical phenotype remarkably similar to that of 
human ALS patients^ Vukosavic, et al (1999) proposed that a mutation in the gene 
for Cu,Zn SOD, the only proven cause of ALS, induces the disease by a toxic 
property that promotes apoptosis. Further studies have been carried out m 
polypeptides of mutant Cu,Zn SOD in relation to ALS (Ratovitski et ciL, 1999). 
Other studies related to ALS have confirmed that AI.S is caused by a mutation in 
the gene for Cu,Zn SOD (Pedersen and Mattson, 1999). In a recent study related to 
SOD and ALS (Stieber et a!., 2000), the aggregation of ubiquitin and mutant ALS-
linked Cu,Zn SOD protein correlates with disease progression and fragmentation 
of the Golgi apparatus (GA). In these studies the transgenic mice that express the G 
93A mutation of human Cu,Zn SOD found in FALS showed the clinical symptoms 
and histopathological changes of sporadic ALS, including fragmentation of the 
neuronal G A 
The role of Cu,Zn SOD in several other diseases has also been thoroughly 
studied. Plasma and total antioxidant status in patients with benign and malignant 
breast disease has been studied by Afrasyap ei al. (1998). The study was earned 
out on 25 women with breast cancer, 25 with fibrocystic breast disease and 19 
healthy subjects. Antioxidant enzyme activities and total antioxidant status were 
measured in the erythrocytes and plasma of patients and healthy individuals. A 
positive correlation was found between erythrocytes and plasma Cu,Zn SOD 
activity in al! groups indicating that enzymatic and non-enzymatic antioxidants are 
differentially altered in human breast tumors. Superoxide dismutase activity has 
been determined by Gonzales el al (1984) in RBC isolated from patients with acute 
myelogenous leukemia, chronic lymphocytic leukemia, Hodgkin's disease, 
lymphosarcoma and various visceral cancers. SOD activity was found to be 
significantly elevated in RBC from patients with acute myelogenous leukemia and 
lymphoproliferative syndromes. 
The role of free radicals and Cu,Zn SOD has also been investigated in 
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neuronal injury (Facchinetti, ei al, 1998) Free radicals may play an important role 
in several pathological conditions of the central nervous system (CNS), where they 
directly injure tissue, and where their formation may also be a consequence of 
tissue injupy Free radicals produce tissue damage through multiple mechanisms 
and can worsen acute neurodegenerative disorders including Parkinson's disease 
These diseases are linked to a missence mutation of Cu Zn SOD \ coireldtion 
between OH radicals and Cu,Zn SOD activity m Parkinson's disease (PD) has also 
been suggested by the studies of Ihara e) al, (1999) The higher OH level and 
lower Cu,Zn SOD activity may play a role in the onset of progression of PD and 
pergolite may act neuroprotectively by including Cu,Zn SOD In general, 
therapeutic approaches, which limit oxidative stress, may be potentially beneficial 
m several neurological diseases Grasbon Frodl et al (1999) have identified two 
polymorphism of the Mn SOD gene associated with Parkinson's disease The 
Nobel Prize for physiology and medicine in 2000 was awarded for findings 
showing that Parkinson patients have abnormally low concentration of dopamine 
in basal ganglia (Carlsson, et al, 2000) As a consequence L-Dopa was developed, 
as a dnig agamst Parkinson s disease, and it remains to this day the most important 
treatment method for this disease Recent findings on the etioiog\ ot cataiact and 
age related muscular degeneration (AMD) suggest the role of an oxidative 
mechanism in these diseases (Pitkanan and Robinson, 1996) In these studies high 
levels of erythrocyte SOD activity was associated with a two fold increase in 
nuclear cataract The diseases associated with dengue fever include the classical 
dengue (DEN), dengue hemorrhagic fever (DHF) and dengue shock syndrome 
(DSS) SOD and other antioxidant proteins have been found to be abnormal in 
these diseases (Ray, et a/ , 1999) The preliminary report of dengue confirms the 
assumption of free radical generation and alteration in antioxidant status during 
acute illness However, fijrther studies are required to understand their complex 
interaction in disease progression and the possible therapeutic utility of the 
findings Changes in Cu, Zn SOD activity have also been found in children with 
steroid sensitive nephrotic syndiome (NS), implicating the role office ladicals in 
the development of this syndrome (Fydryk, e/ al, 1998) Er}'thiocUe antioxidant 
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activity and trace element levels are also the best markers in Behcet's disease 
(Tuzun, et al., 1998). Selenium (Se), Zinc (Zn), copper (Cu) and antioxidant 
enzymes, including SOD levels in sera, have been detected in Behcet patients. In 
this study, the SOD level was low in the serum of Behcet's disease patients. It has 
been suggested that decreased SOD activity and increased production of free 
oxygen radicals may play a role in the etiopathogenesis of this disease. 
Antioxidant enzyme activity, especially Cu,Zn and Mn SOD has also been 
studied in human abdominal aortic aneurysmal and occlusive diseases (Dubick, et 
al., 1999). The activity of these enzymes was lowered in the tissue of these 
patients, which points to the involvement of free radicals. The plasma extracellular 
SOD levels in an Australian population with coronary artery disease were 
measured (Wang, et al., 1998). The results of these studies show an association 
between extracellular SOD (EC-SOD) and coronary artery disease. EC-SOD is 
considered to be more protective, contributing to reduce coronary risk. Down's 
syndrome (DS), which is characterized by premature aging, has also been related 
to oxidative stress, resulting from the aberrant expression of Cu,Zn SOD 
(Druzhyna, et al., 1998). SOD activity has also been measured in the blood of 
different individuals between 50-93 years of age and the level of this important 
enzyme was found to decrease with age (Casado, et al., 1998), In diabetes, the 
persistence of hyperglycemia has been reported to cause increased production of 
oxygen free radicals through glucose auto-oxidation and non enzymatic glycation. 
The highest erythrocyte SOD activity has been found in diabetic children at the 
onset of clinical diabetes. In diabetic adolescents, SOD activity is also significantly 
higher than in control subjects. 
Flavonoids 
Numerous epidemiological studies show a protective effects of vegetables and 
fruits against cancer and cardiovascular disease (Ness and Powles, 1997). An 
attractive hypothesis is that vegetables and fruits contain so called bioactive 
compounds such as flavonoids, that might have a protective effect independent of 
that of known nutrients and micronutnents Flavonoids are widely distributed plant 
secondary' metabolite that belong to a vast group of antioxidant polyphenolic 
compounds (HoUman and Arts, 2000, Lu and Foo, 2002, Cotelle, 2001) The term 
flavonoid (Latin Flavonoid= Yellow) was first used for the family of yellow 
coloured compounds with a flavone moiety It was later extended to various plant 
polyphenols to include less intensively colored flavonones, colourless flavon-3-ols 
and even more coloured red and blue anthocyanidins Over 8,000 varieties of 
flavonoids have been identified so far Flavonoids are found in the edible portions 
of a majority of food plants such as citrus fruits, leafy vegetables,loots,tubers and 
bulbs, herbs and spices, legumes and cereal grains Beverages such as tea,coffee, 
cocoa, red wine and beer which accounts for about 2S% of intake by humans Plant 
cells have a relatively high concentration of flavonoids usually exceeding 
lmM,with reports of concentrations of 3 to lOmM in epidermal cells of Vicia faha 
(Viersta,(^/a/, 1982 ) The estimated average intake of flavonoids by humans as a 
part of the normal diet can be as high as 1 g/day 
Flavonoids possess fifteen carbon atoms , two benzene rings joined by a 
lineai three carbon atom 
This skeleton can be represented as 
Ce —C3 —Cfi 
Individual differences within each group result from the variation in number and 
arrangement of hydroxyl groups as well as from the nature and extent of alkylation 
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and/or glycosylation of these groups. The flavonoids are formed in plants, but not 
in animals, from the amino acids phenylalanine and tyrosine by combination with 
acetate units. Flavonoids are benzo-y-pyrone derivatives and consists of benzene 
ring (commonly known as A-ring) attached to a six-membered heterocycle (named 
C-ring) which at C2 carries a phenyl group (named B-ring) as a substituent. The C-
ring is either a y-pyrone (flavones and flavonols) or its 2,3-dihydroderivative 
(flavanones and flavanols). The most commonly occurring flavones and flavonols 
are those with dihydroxylation in position 5 and 7 ( A-ring) and in position 3' and 
4' (B-ring). 
CHEMICAL STRUCTURE OF FLAVONOID 
Based on the degree of oxidation of the C ring , flavonoids are divided into various 
subclasses. Both the oxidation state of the ring C and the position of ring B are 
important in the classification.These classes of flavonoids can undergo further 
substitutions such as hydrogenation, hydroxylation, mcthylation, sulfation and 
glycosylation 
Examples of the 6 major subgroups are: 
1. Chalcones 
2, Flavone (generally in herbaceous families, e.g. Labiatae, Umbelliferae, 
Compositae), 
Apigenin (Apium graveolens, Petroselinum crispum). 
Luteolin (Equisetum arvense) 
-OH 
3, Flavonol (generally in woody angiosperms) 
Quercitol (Ruta graveolens, Fagopyrum esculentum, Sambucus nigra) 
Kaempferol (Sambucus nigra, Cassia senna, Equisetum arvense, Lamium album, 
Polygonum bistorta).Myricetin 
., OH 
4. Flavanone 
HO O 
28 
5. Anthocyanins 
HO 
6 Isoflavonoids 
HO 
-OH 
Most of these (flavanones, flavones, flavonols, and anthocyanins) bear ring B in 
position 2 of the heterocyclic ring. In isoflavonoids, ring B occupies position 3. 
Intestinal Absorption of Fiavonoids 
Table-4 shows the major sources of different fiavonoids. It is estimated that the 
human intake of all tiavonoids is a few hundereds of miligram per day Fiavonoids 
present in foods used to be considered non absorbable because they are bound to 
sugars as P- glycosides. However, it was found that human absorption of the 
quercetin glycosides from onions (52%) is far better than that of the pure aglycone 
(24%).The sugar moiety is an important determmant of their absorption and 
bioavailability, Flavonol glycosides might contribute to the antioxidant defenses of 
blood. Amongst the most common and thoroughly studied of these fiavonoids are 
the flavonols, quercetm, myricetm and kaempferol. It has been estunated that even 
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Table 4 Sources of flavonoids 
FOOD 
Apples 
Broccoli 
Celery 
Eseplant skin 
Endive 
Grapes 
Grapefruit 
Leek 
Onions 
Orange iuice 
Parsley 
Raspberries 
Red wine 
Soybeans 
Strawberries 
Tangerine peel 
Tea 
FLAVONOIDS 
catechins, quercetin 
kaempferol 
apigenin 
delphinidin 
kaempferol 
cyaniding 
kaempferol, naringin 
kaempferol 
quercetin 
hesperidin 
apigenin 
cyanidin 
oenin 
isoflavones 
cyanidin 
tangeretin 
catechins 
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in industrialized societies, intakes of flavonoids could be as high as 1 gram per day 
(Kuhnau, 1976), but this is probably an over estimate based on inadequate 
analytical data (Hertog and Hollman, 1996). The more conservative estimates of 23 
mg per day in the Netherlands, 64 mg per day in Japan and 6 mg per day in Finland 
are probably much more realistic (Hollman and Arts, 2000; Hertog et al, 1995). In 
Western Europe, flavonols and flavones are consumed predominantly in the form 
of water soluble glycosides in apples and onions, or as free solutes in black tea and 
wine (Hertog et al, 1993).The absorption and subsequent distribution, metabolism 
and excretion of flavonoids in humans have been little studied. Absorption of 
flavonoids from the diet was long considered to be negligible, as most flavonoids 
are present in foods bound to sugars. Only free flavonoids without sugar molecule, 
the so called aglycone, were considered to be able to pass the gut wall, and no 
enzymes that can split these predominantly (3 -glycosidic bonds are secreted into 
the gut or present in the intestinal wall ( Hollman ,e/a/., 1995),It was argued that 
only a marginal absorption of dietary flavonoids was expected because micro-
organisms in the colon are indispensible for hydrolysis of P-glycosidic bonds but 
additionally degrade the liberated aglycones (Kuhnan, 1976).In the human study 
with ileostomy subjects, it was found that absorption of orally administered 
quercetin aglycone was 24%, where as the absorption of quercetin glycosides from 
onions was much higher,viz 52%,and the absorption of pure quercetin rutinoside 
was 17%)( Hollman,^/ a/., 1995).From these data it was concluded that humans 
absorption of quercetin -P -glycosides was higher than the absorption of quercetin 
without its sugar moiety,the so called aglycone and of quercetin- P-
rutinoside(Hollman et a/., 1995)..In subsequent studies it was found that the 
bioavailability of quercetin glucosides from onions was superior to that of various 
quercetin glycosides from apples and to that of pure quercetin rutinoside (Hollman 
et al.,1997). These data suggested that the sugar moiety of quercetin glycosides is 
an important determinant of their absorption..Hollman,e/ al ( 1999) found that 
glucoside of quercetin was absorbed much more efficiently than rutinoside. The 
position of sugar moieties differ between the two molecules. However, in the 
preliminary studies it was found that 3-glucosides was absorbed as efficiently as 
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the 4'-glucosides.Thus it is tiie nature and not the position of the sugar moiety 
which controls the absorption,It was suggested that flavonoids conjugated with 
glucose are carried as such into the small-gut enterocyte,and this involved active 
transport for instance via the intestinal Na^-glucose cotransporter.Thus the active 
transport of p -D-glycosides would explain why quercetin is extensively absorbed 
from onions in which it occurs as glucosides and free quercetin is not 
absorbed.Quercetin-3-rutinoside is probably absorbed because rutinose cannot be 
transported by the putative transporter. Flavonol glycosides must be hydrolyzed 
prior to absorption and the low solubility of the liberated aglycones was regarded 
as a major rate-limiting factor for uptake into the circulation (Manach et al, 1996). 
Hollman el al (1996) have obtained direct evidence to show that they are readily 
absorbed in the human small bowel. Subjects were fed a meal of cooked onions 
containing quercetin aglycone. The level of quercetin in plasma, determined after 
deconjugation, rose rapidly within 1 hour of ingestion, peaked at approximately 
200 ng/ml after 2.9 hour, and fell slowly to around 10 ng/ml after 48 hour. Several 
other studies have also shown that average concentration of querecetin in plasma 
after the meal is quite high and elimination of quercetin from the plasma is 
relatively slow, so that accumulation can occur if repeated oral doses of quercetin 
are taken over a prolonged period (Manach et al, 1996; Hollman and Arts, 2000, 
Hollman and Katan, 1997, Hollman el al, 1997). 
Flavonoids as Antioxidants 
Many studies have suggested that flavonoids exhibit biological acivities, including 
antiallergenic, antiviral, anti-inflammatory and vasodilating actions. These 
pharmacological effects are generally linked to the antioxidant properties of these 
molecules. Flavonoids can express these properties by (i) suppressing ROS 
formation by inhibiting some enzymes or chelating trace elements involved in free 
radical production, (ii) Scavenging radical species and more specially the ROS. 
(iii) Up-regulating or protecting antioxidant defence. Flavonoids have been 
identified as fulfilling most of the criteria described above. Thus their protective 
effects are multiple. In a study performed by Roig et al (2002), it has been shown 
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that flavonoids such as catechin, epicatechin, quercetin and procyanidins protect 
the Fao cells against hydrogen peroxide induced oxidative stress. Cardoon (Cynara 
cardunculus L.) is a species containing considerable amounts of poiyphenolic 
compounds, namely flavonoids and phenolic acids, which shows its antioxidant 
activiy against superoxide radical, hydroxy! radical, and hypochlorous acid 
(Valentao e/ al, 2002). There are numerous evidences to show the beneficial , 
antioxidant, anti-inflammatory and anticancer etfects of various naturally occurring 
flavonoids ( Perez et al, 2002; Ficarra et a/, 2002, Shahat e/ cil, 2002, Salucci ei a/, 
2002, Rezk el al, 2002; Aviram and Fuhrman, 2002 ).The data obtained by these 
different findings confirm that the radical scavenging activity depends on the 
structure and the substituents of the heterocyclic and B-ring, as suggested by Bors 
et al (1990). The major determinants for radical scavenging capability are (i) the 
ortho-dihydroxy structure on the B-ring which has the best electron-donating 
properties, confers higher stability to the radical form and participates in electron 
delocalization. (ii) The 2,3-double bond in conjugation with a 4-oxofunction in the 
C-ring is responsible for electron delocalization from the B-ring. The antioxidant 
potency is related o the structure in terms of electron delocalization of the aromatic 
nucleus, (iii) The 3- and 5- hydroxyl group with a 4-oxofunction in the A and C-
ring for maximum radical scavenging potential. The maximum effectiveness for 
radical scavenging apparently requires a 3-OH group attached to the 2,3 double 
bond and adjacent to he carbonyi in the C-ring. The 3-hydroxyl group interacts 
with the B-ring through a hydrogen bond between the 3-OH and the 2' or 6' proton 
which conformationally maintain the B-ring in the same plane as the A- and C-
rings favoring the conjugation between the B- and C-ring. This might well explains 
the excellent antioxidant activity of flavonols. In flavones the B-ring is slightly 
twisted in relation to the plane of the A- and C-rings (Cody and Luft, 1994). The 
glycosylation of this position (as in rutin ) reduces greatly the radical scavenging 
capacity. 
Pro-oxidant Activity of flavonoids 
The scavenging properties of antioxidant compounds are often associated with 
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their ability to form stable radicals after being effective. In fact, those flavonoids 
containing hydroxyl groups, especially those having ortho, di- or trihydroxy-
fUncions on the A-ring (Gao et al, 1999) or B-ring (Cotelle et a/, 1996), which can 
scavenge radicals effectively usually give rise o semiquinonic radicals in alkaline 
solution stable enough to be detected by EPR spectroscopy. Nevertheless, this 
molecular oxidative process ( or auto-oxidation which can also take place in the 
presence of transition metal catalysis) can be accompanied by production of pro-
oxidant molecules such as reactive oxygen species (Hodnick e/ al, 1988) or 
secondary flavonoids radicals ( Roginsky et al, 1996), which are more reactive 
than the primary aroxyl radicals. Consequently these species are able to propagate 
chain reactions. The proposed mechanism generally accepted for antioxidant 
activity or for auto-oxidation involves the formation of an intermediate aroxyl 
radical of flavonoids. This aroxyl radical can interact with oxygen or glutathione, 
generating an oxidized flavonoid and superoxide anion (Metodiewa et al, 1999). 
Galati et al (2002) have observed that dietary polyphenolics with phenol rings 
were metabolized by peroxidase to form pro-oxidant phenoxyl radicals which, in 
some cases were sufficiently reactive to co-oxidize GSH or NADH accompanied 
by extensive oxygen uptake and reactive oxygen species formation. The order of 
catalytic effectiveness found for oxygen activation when polyphenolics were 
metabolized by peroxidase in the presence of GSH was phloretin>phloridzin>4,2'-
dihydroxychalcone>p-coumaric acid >narigenin >apigenin > curcumin 
>resveratrol>isoliquiritigenin>capsaicin>kaempferol. Ueda et al (2002) have 
reported that baicalin induces apoptosis via mitochondrial pathway as pro-oxidant. 
Induction of apoptosis by baicalin was accompanied with the marginal generation 
of intracellular reactive oxygen species (ROS), the increase of the cytosolic 
fractions of cytochrome c, and the disruption of mitochondrial transmembrane 
potential prior to the activation of caspase-3. Ferguson (2001) has demonstrated 
that not all polyphenols and not all actions of individual polyphenols arc 
necessarily beneficial. Some have mutagenic and/or pro-oxidant effects, as well as 
interfering with essential biochemical pathways including topoisomerase enzyme 
activities, prostanoid biosynthesis and signal transduction. A small number of 
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adequately controlled human intervention studies suggest that some, but not ail 
polyphenol extracts or high polyphenol diets may lead to transitory changes in the 
anti-oxidative capacity of plasma in humans. 
Interaction of Flavonoids with Various Enzymes 
In several studies, it has been demonstrated that certain flavonoids interact with 
many enzymes causing their inactivation involving different mechanisms and 
mode of interaction. To elucidate possible mechanisms of activity in medicinal 
plants containing flavonoids, the inhibitory potency of twenty flavones, flavonols, 
flavonones, phenylacrylic acids and various hydroxylated phenyl acetic acids on 
the activity of neutral endopeptidase (NEP), angiotensin converting enzyme (ACE) 
and aminopeptidase N (APN) was investigated in vitro by Melzig and Bormann 
(2000). Their studies clearly indicate that flavonoids have different inhibitory 
potency on these enzymes depending upon their chemical structure. 
Pycnogenol, an extract from French maritime pine bark (PBE), is a 
complex mixture of bioflavonoids with reported protective effects against disease. 
PBE is an effective scavenger of reactive oxygen species, and its main constituents 
are procyanidins of various chain lengths. PBE dose-dependently inhibited the 
activities of xanthine oxidase, xanthine dehydrogenase, horse radish peroxidase 
and lipoxygenase, but did not affect the activities of glucose oxidase, ascorbate 
oxidase or elastase (Moini, et ol., 2000). In vitro studies were conducted in which 
various dietan,' flavonoids were evaluated for their inhibitory effect on xanthine 
oxidase, which produces hydrogen peroxide and superoxide anion during the 
oxidation of hypoxanthine to xanthine and then to uric acid. These active oxygen 
species produced by xathine oxidase have been proposed to cause oxidative injun,' 
to tissues by ischemia-reperfusion. Therefore, flavonoids with an inhibitory effect 
on xanthine oxidase might suppress oxidative lesions by ischemia reperfusion and 
could be used for preventing gout. The structure activity relationship revealed that 
the planar flavones and flavonols with a 7-hydroxy group such as chrysin, luteolin, 
kaempferol, quercetin, myncetin and isorhamnetin inhibited xanthine oxidase 
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activity at low concentrations in a mixed type mode while the nonplanar 
flavonoids, isoflavones and anthocyanidins were less inhibitory (Nagao, et al., 
1999). Thirty seven naturally occurring flavonoids were investigated for their 
inhibitory activities on the mouse brain monoamine oxidase (MAO) (Lee, et al., 
2000). Three flavonoids, apigenin, liquiritigenin and genistein were judged to be 
very active, four flavonoids quercetin luteolin and eupatilin were moderately 
active. 6-Methoxy flavonoids showed considerable activities, while most 
isoflavones except genistein and daidzein showed weak activities. According to the 
results of structure activity relationship of flavonoids as inhibitors of MAO, three 
hydroxyl groups at C-5 and C-7 on A ring and C-4' on B-ring of flavone/flavanone 
seems to be essential for inhibitory activity, and ortho catechol moiety at B-ring 
showed somewhat weaker activity. Flavone/flavonone glycosides, showed weaker 
inhibitory activity than their corresponding flavone/ flavonone, and double bonds 
between C-2 and C-3 were not critical for the mhibitory activity on MAO enzyme. 
As for polymethoxylated flavones, 6-methoxyl group was assumed to be important 
for moderate inhibitory activity. A structure activity study of fourteen chemically 
related flavonoids was conducted to evaluate their abilities to inhibit glutathione 
reductase (GR). By comparing the 150 values of flavonoids from different classes 
possessing an identical hydroxyl configuration, the following order of potency for 
inhibition of GR was determined: Anthocyanidin > dihydroflavonol = chalcone -• 
flavonol > catechin (Elliott, etai, 1992). 
Flavonoids containing phenol B rings, eg narigenin, naringin, hesperetin 
and apigenin formed prooxidant metabolites that oxidised N/\DH upon oxidation 
by peroxidase/H202. Extensive oxygen uptake occurred which was proportional to 
the NADH oxidized and was increased upto two fold by superoxide dismutase 
(Chan, et al., 1999). Flavonoids including baicalin have been reported to not only 
fianction as antioxidants but also cause cytotoxic effects (Ueda,t^/ c//., 2001). A 
series of polymethoxylated flavonoids has been isolated from orange peel and their 
inhibitory activity towards soybean 15-lipoxygenase was determined. The 
strongest inhibition was shown by 3,5,6,7,3',4'-hexamethoxyflavone. Sinensetin, 
nobiletin, tangeretin, tetramethylscutellarein. It has been suggested that orange peel 
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constituents may counteract enzymatic lipid peroxidation processes catalyzed by 
15-lipoxygenase in vitro. The radical scavenging activity of orange peel extracts 
was only modest (Malterud and Rydland, 2000). A series of structurally related 
flavonoids and related compounds were evaluated for their inhibitory effects on 5' 
nucleotidase (5'-ribonucleotide phosphohydrolase) activity (Kavutcu and Melzig, 
1999) Some of the flavonoids such as quercetin, morin, apigenin, chrysin, 
myricetin, luteolin, diosmetm (+/-) naringenin and diosmin, were tested to inhibit 
enzymes. Rutin, naringin, hyperosid, (+/-) catechin, cafYeic acid and rosmarinic 
acid had no effect. The results demonstrate that some flavonoids are strong 
inhibitors of 5'-nucleotidase activity which can be correlated to their 
pharmacological effects. Many workers (Agullo, el a/., 1997) have demonstrated 
that depending on their structure, flavonoids display more or less potent inhibitory 
effects on the growth and proliferation of certain malignant cells in vitro, and these 
effects are due to inhibition of various enzymes. These workers had investigated 
the inhibitory action of fourteen flavonoids of different chemical classes on 
phosphatidylinositol 3 kinase alpha (P13-kmase alpha) activity, an enzyme that 
plays an important role in signal transduction and cell transformation. Of the 
fourteen flavonoids tested, myricetin was most potent PI3-kinase inhibitor while 
luteolin and apigenin were also effective inhibitors. Fisetin and quercetin were also 
found to be significantly inhibit PI-3 kinase activity. The above flavonoids were 
also analysed for inhibition of epidermal growth factor receptor (EFG-R), intrinsic 
tyrosinase kinase and bovine brain protein kinase C (PKC). A structure activity 
study indicated that the position, number and substitution of the hydroxyl group of 
the B ring, and saturation of the C2 and C3 bond are important factors affecting 
tlavonoid inhibition of PI3-kinase, These flavonoids were also studied for their 
relationship between the antitumoral properties and biological activity. The 
commercially available flavone derivatives luteolin, morin, myricetin and 
dimyricetin (an oxidation product of myricetin) inhibited the ATPase and double 
stranded DNA unwinding activities of RepA, Dimyricetin the most effective 
inhibitor for both activities (Xu, et al, 2001). Single stranded DNA-dependent 
RepA ATPase activity is inhibited non-competitively by all four compounds 
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Hence, flavones may provide substructures for the design of molecules helpful for 
unraveling the mechanism of helicase action and of novel pharmacologically 
useful molecules 
Over 80 flavonoids, including flavones, flavanones, isoflavones and 
anthocyanidins have been examined for their m vitro effect on gastric H*, K*-
ATPase and some were found to be inhibitors of this enzyme (Murakami, et al, 
1999) The structure activity analysis revealed that (i) The inhibitory potency of 
flavonoids depends on the number of hydroxyl groups upto four per molecule and 
that above this, no marked enhancement was found, (ii) The hydroxylation pattern 
was an important determinant of inhibitory potency Two adjacent hydroxyl groups 
(catechol type), three adjacent hydroxyl groups (pyrogallol type) oi h}droxyl 
groups at C-3, C-5 and C-7 are a minimum requirement for high potency 
inhibition, (in) Protection of the hydroxyl group(s) by glycosylation or methylation 
decreases potency, (iv) Saturation of C-2/C-3 double bond results in a decrease in 
potency, and (v) A ketone at C-4 is not essential for inhibition 
Kameoka, et al (1999) have investigated the effect of flavonoid treatment 
on the antioxidant protein expression in human intestinal Caco-2 cells The 
antioxidant protein of interest were metallothionein (MT), catalase (CAT), and 
superoxide dismutase (SOD) Treatment of Caco-2 cells with 100 |.iM genistem, 
biocanin A, daidzein or kaempferol significantly increased MT mRNA up to IS 
fold On the contrary CAT mRNA level was not affected by various flavonoids 
CAT and Cu/Zn SOD were found not to be affected by 48 hi treatment of ]00f_iM 
dietary flavonoids (genistein, biocanin A, daidzein, flavone, quercetin or 
kaempferol) Thus the effects of flavonoids on antioxidant protein expression are 
structure and gene specific Oxidative modification of DNA, pioteins and lipids by 
reactive oxygen species (ROS) plays a role in aging and disease, including 
cardiovascular, neurodegenerative and inflammatory diseases and cancer Extracts 
of fresh garlic that are aged over a prolonged period to produce aged garlic extract 
(AGE) contain antioxidant phytochemicals that prevent oxidant damage These 
include unique water soluble organosulfur compounds, lipid soluble organosulphur 
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components and flavonoids, notably allixin and selenium. AGE exerts antioxidant 
action by scavanging reactive oxygen species, enhancing cellular antioxidant 
enzymes superoxide dismutase, catalase and glutathione peroxidase, and increasing 
glutathione in the cells. AGE inhibits lipid peroxidation, reducmg 
ischemic/reperfiasion damage and inhibiting oxidative modification of LDL, thus 
protecting endothelial cells from the injury by the oxidized molecules, which 
contributes to atherosclerosis. AGE protects DNA against free radical damage and 
mutations. There are many evidences that supports the beneficial health effects 
attributed to AGE, i.e. reducing the risk of cardiovascular disease, stroke, cancer 
and aging, including the oxidant-mediated brain cell damage that is implicated in 
Alzheimer's disease (Borek, 2001). 
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EXPERIMENTAL 
MATERIALS 
The chemicals used in the present study were obtained from various sources as 
shown below. Glass distilled water was used m all the experiments. 
Reagents 
1, lOPhenanthroline(OP) 
Acetone 
Acrylamide 
Ammonium per sulphate 
Bisacpy'lamide 
Bovine Serum Albumin 
Bromophenol blue 
Cadmium Chloride (CdCl2.2H20) 
Cooper Chloride (CUCI2) 
Copper, Zinc Superoxide Dismutasc 
Catalase 
Di- Potassium hydrogen-o- phosphate 
Dimethyl Sulfoxide (DMSO) 
Ethanol 
Ethylene Diamine Tetra Acetate 
Ferric Chloride (FeCl.O 
Folia's reagent 
Formaldehyde 
Glacial Acetic Acid 
Glycerol 
Glycine 
LMW-Marker protein 
Sources 
Sisco Research Laboratories 
Qualigens 
Sisco Research Laboratories 
Qualigens 
Sisco Research Laboratories 
Sisco Research Laboratories 
Qualigens 
LOBA-CHEM[E 
INDOAUSTRANAL Co. 
E.Merck 
Sigma Chemical Co , USA 
Himidea Laboratories 
Qualigens 
Qualigens 
Qualigens 
Sisco Research Laboratories 
Qualigens 
Sisco Research Laboratories 
Qualigens 
Qualigens 
Qualigens 
Qualigens 
GENEI 
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Manganese Chloride ( MnCh ) 
Myncetin 
± Naringenin 
Nicotinamide Adenine Dinucleotide 
(Reduced) NADH 
Nitroblue Tetrazolium (NBT) 
Neocuproine Hydrochloride 
Phenazine Methosulphate (PMS) 
Potassium Dihydrogen Phosphate 
Quercetin 
Riboflavin 
Rutin 
Silver Nitrate (AgNOs) 
Sodium Corbonate (Na2C03) 
Sodium Hydroxide (NaOH) 
Sodium Lauryl Sulphate 
Sodium Potassium Tartarate 
Sodium Thiosulphate (Na2S203) 
TEMED 
Tetra-sodium pyrophosphate 
Trichloroacetic Acid 
TRIS 
Uric Acid 
E.Merck. 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sisco Research Laboratories 
Sisco Research Laboratories 
Sigma Chemical Co., USA 
Sisco Research Laboratories 
E. Merck 
Sigma Chemical Co., USA 
Sisco Research Laboratories 
Sigma Chemical Co., USA 
Qualigens 
E. Merck 
E.Merck 
Sisco Research Laboratories 
E Merck 
E.Merck 
Sisco Research Laboratories 
CDH 
Qualigens 
Qualigens 
Sisco Research Laboratories 
METHODS 
Assay of Cu,Zn Superoxide Dismutase (Cu,ZnSOD) 
The Cu,Zn SOD activity was determined on the basis of inhibition of the reduction 
of nitroblue tetrazoHum (NBT) mediated by phenazine methosulphate (PMS) and 
nicotinamide adenine dinucleotide (reduced) NADH (Picker and Fridovicli, 1984) 
In a total assay volume of 2.45 ml containing 193 (.iM NBT, 1.9 |.iM PMS and 8.3 
ITLM pyrophosphate buffer (pH 8.2), 107 |_iM NADH was added and reduction of 
nitroblue tetrazolium was recorded at 560 nm, at regular time inter\'als indicated by 
the formation of blue formazan. These values were considered as control (C). In 
the test sample appropriate volume of Cu,ZnSOD was added in the above reaction 
mixture in order to bring the 50% inhibition in the reduction of nitroblue 
tetrazolium. The values were recorded at 560 nm at regular mterv-'als of time and 
considered as Test (T) values. The Cu, ZnSOD units were calculated by the 
formula -
O.D,(uninhibilod) O.D,(inhibited) 
Activity = 
O . D . (uninhibited) 
Activity 
Units Activity = (defined for 2.45 ml assay mixture) 
T/C 
Units Activity 
Units/ml assay = 
2.45 
Units/ml Assay 
Units/ml sample = 
ml sample 
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One unit of Cu,ZnSOD is defined as the colour intensity corresponding to half 
inhibition of nitroblue tetrazolium indicated by the development of blue formazan 
in 2 45 ml of assay mixture at 25"C. 
Colorimetric Estimation of Protein 
The protein was determined by the method of Lowry, et a/ (1951) suitable aliquots 
of the protein sample was diluted to 1.0 ml with distilled water. To this volume, 5 
ml of freshly prepared alkaline copper reagent was added which was prepared by 
mixing 0.5% (w/v) copper sulphate in 1% (w/v) sodium potassium taitarate and 
2% (w/v) sodium carbonate in O.IN NaOH in 1;50 (v/v) ratio. After incubating for 
10 minutes at room temperature 0.5 m! of IN Folin's reagent was added. The 
reaction mixture was mixed properly and incubated at room temperature for 30 
min. The blue colouration of the sample was read against a blank at 660 nm. A 
standard curve was prepared using BSA (30 mg %) for the calculation of the 
protein concentration. 
Studies on the Stability Properties of Cu,Zn SOD 
Stock Cu,Zn SOD solution (75 |aM) was prepared in 15% glycerol mixed with 15 
mM potassium phosphate buffer pH 6.8. Appropriate dilutions of stock Cu,Zn 
SOD were carried out in 1.5mM potassium phosphate buffer pH 6.8 according to 
the experimental set up. In order to see the effect of temperature and ionic strength 
on Cu,Zn SOD activity, suitable volumes of the diluted sample were used as 
mentioned in the respective experimental details 
Metal Chelation Studies on Cu, Zn SOD with 1,10 Phenanthroline 
1,10 Phenanthroline is a well-known metal chelator and has an ability to bind with 
certain metal ions including copper. The Cu,Zn SOD solution was prepared in 1.5 
mM potassium phosphate buffer, pH 6.8 Different aliquots of enzyme (Cu,Zn 
SOD) at varying concentrations (3|aM, 6f.iM, 9|.iM) were mixed with ImlVl solution 
43 
of 1,10 phenanthroline prepared in DMSO (Dimethyl sulfoxide) and incubated for 
1 hr at room temperature. The enzyme activity was determined by NBT reduction 
method. In a separate reaction mixture Cu(II) in the form of CuCb at a final 
concentration of ImM was also included in the reaction mixture The effect of uric 
acid on the metal chelation was also determined by incubating the reaction 
mixtures in presence of 0.5mM uric acid. The reaction mixtures were incubated for 
16-17 hours in the refrigerator and were used for the enzyme assay. The above 
samples were also analyzed on SDS-Polyacrylamide gel. BSA at a final 
concentration of 58 |j.M was treated with ImM 1,10 phenanthroline in presence 
and absence of ImM CuCb for two hours at room temperature under similar 
conditions as described above. The samples were electrophoresed on 7.5% Native 
Polyacrylamide gel. 
Effect of Flavonoids on Cu,Zn SOD 
Flavonoids are polyphenolic compounds and are known to interfere with several 
enzymes. In these studies, we have carried out the screening of few selected 
flavonoids for their interaction with Cu,Zn SOD. The selected flavonoids are 
Myricetin, Quercetin, Rutin and Naringenin. Stock solutions of these flavonoids 
were prepared in methanol and appropriate amounts were used in different 
experiments. 
Effect of Myricetin 
Different sets of experiments were carried out in order to study the interaction of 
myricetin with Cu,Zn SOD. 
(i) Varying concentrations of myricetin (10 -1000f.iM) indicated in each 
experiment were treated with varying concentrations of Cu,Zn SOD (2 -
7.5f_iM) and incubated for different durations at 37"C. l.SmM potassium 
phosphate bufl^ er pH 6.8 was used for these experiments. After appropriate 
incubation periods, Cu,Zn SOD activity was determined by the NBT reduction 
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method as described earlier. In some experiments, the myricetin - Cu,Zn SOD 
complexes were used for spectral studies and SDS polyacrylamide gel 
electrophoresis. In some experiments, myricetin treated Cu,Zn SOD was 
dialyzed extensively against 1.5mM phosphate buffer, pH 6.8 in order to 
remove the free myricetin. The dialyzed samples were compared with the 
undialyzed one in terms of the inactivation of Cu,Zn SOD activity and SDS-
gel electrophoresis pattern. In each set of experiments, the control Cu,Zn SOD 
was used where volume of myricetin was replaced by l,5mM potassium 
phosphate buffer pH 6.8 
(ii) Based on certain observations, that extra copper concentration under in vivo 
conditions activate Cu,Zn superoxide dismutase (Dameron and Harris, 1987), 
an experiment was performed where 7.5fiM Cu,Zn SOD prepared in 1.5mM 
potassium phosphate buffer pH 6.8 was incubated with myricetin at a final 
concentration of ImM at SVC for 3 hrs. A control set of Cu,Zn SOD without 
myricetin was also incubated under similar conditions. After incubation period 
was over both the sets were extensively dialyzed against 1.5mM potassium 
phosphate buffer pH 6.8. The dialyzed control and myricetin treated samples 
were incubated with 0-100)aM copper chloride solution at 37"C for 3 hrs. 
Appropriate volumes from these samples were used for measuring Cu,Zn 
SOD activity. 
(iii) It is known from the literature that certain tlavonoids in presence of Cu(ll) 
generate free radicals leading to inactivation or fragmentation of enzymes and 
proteins (Ahmed, et a/, 1994). In this set of experiment, 7.5).tM Cu,Zn SOD in 
1.5mM potassium phosphate buffer pH 6.8 was incubated with ImM 
myricetin and varying concentrations of CuCh ranging from (0-2000|_iM) at 
37°C for 3 hours. After the incubation time was over, suitable volume of 
aliquots were used for measuring Cu,Zn SOD activity as well as 
electrophoresed on SDS-polyacrylamide ge!. In order to investigate the 
possibility of production of hydroxyl radical, 7.5 |aM Cu,Zn SOD solution was 
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treated with fixed concentration of myricetin and copper ch!oride(each at a 
final concentration of ImM) along with varying concentrations of catalase.The 
reaction mixtures were incubated at 37 °C for 3 hours and appropriate volume 
was taken from each tube for determining Cu,Zn SOD activity. Interaction of 
myricetin and Cu,Zn SOD was also studied in presence of other metal ions 
like Mn^\ Fe^\ Cd^ \ 
(iv) The possibility of metal chelation by myricetin was studied m this experiment 
where low concentration of myricetin (0.5mM) was incubated with varying 
concentrations ( 0 -1000|iM ) of Cu(ll), Mn(Il) and Fe(ni) separately for 
longer duration (18 hours) in order to allow the proper interaction of myricetin 
with these metal ions. In the control myricetin sample, the volume of metal 
ion used, was replaced by equal volume of 1.5mM potassium phosphate buffer 
pH 6.8 and was incubated under similar conditions. The tubes were 
centrifijged briefly and 13.5|j.l supernatant (~ O.lmM myricetin, as calculated 
in the control sample) from each sample was incubated with 7.5|aM Cu,Zn 
SOD prepared in 1.5mM potassium phosphate buffer pH 6.8 for 3 hours at 
37"C. After the incubation period was over, the suitable volume of aliquots 
were used for determining Cu, Zn SOD activity. 
Effect of Quercetin 
In order to carry out the interaction of Cu,Zn SOD with quercetin alone as well as 
in presence of Cu(II), following sets of experiments were conducted. 
Cu,Zn SOD at a final concentration of 7.5),iM was prepared in !.5mM 
potassium phosphate buffer and incubated with vaiying concentrations of 
quercetin(50-500(iM) in presence and absence of ImM Cu(Il) at 37 "C for 3 hours 
and 18 hours separately. After the incubation period was over, .suitable volume of 
aliquots were withdrawn for measuring Cu,Zn SOD activity as well as gel 
electrophoresis.A control set of Cu,Zn SOD was also incubated under similar 
conditions in the absence of quercetin and Cu(II),was considered for calculating 
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the percent inactivation of Cu,Zn SOD in the treated samples. 
The spectral studies of quercetin treated Cu,Zn SOD were also done after 
extensively diaiyzing the samples against 1.5mM potassium phosphate buffer pH 
6.8 in order to remove the quercetin to minimize its interference while measuring 
the different spectra. 
Effect of Rutin 
Rutin is a polyphenolic compound, generally present in citrus fiuits. Interaction of 
rutin with Cu,Zn SOD and subsequent changes in the enzyme molecule were 
investigated by measuring the activity, gel electrophoretic pattern and various 
spectral analysis. These studies were proceeded according to the experimental 
protocols described in the previous section where quercetin was treated with Cu,Zn 
SOD. 
In this set of experiment, 7.5|iM Cu,Zn SOD prepared in 1.5mM potassium 
phosphate buffer pH 6.8 was incubated with varying concentrations of mtin (50 -
500|j.M) in the presence and absence of ImM CuCb solution at 37"C for different 
time intervals i.e 3 hours and 18 hours. As the incubation period was over, suitable 
volume of aliquots were withdrawn for measuring Cu,Zn SOD activity and SDS 
gel electrophoresis. A control set of Cu,Zn SOD was also incubated under similar 
conditions in absence of rutin and CuCb and was considered to have 100% 
activity 
For the spectral analysis of rutin treated Cu,Zn SOD sample, and the 
control Cu,Zn SOD(without rutin) was dialyzed extensively against 1.5mM 
potassium phosphate buffer pH 6.8 in order to remove the rutin and to minimize its 
interference while recording different spectra. 
Effect of Naringenin 
Citrus fruits are rich sources of Naringenin, which is known for its 
antioxidant/pro-oxidant properties. The concentration and time dependent 
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experiments of Cu,Zn SOD and Naringenin were carried out under similar 
conditions as described for quercetin and rutin. The concentration of Naringenin 
selected in our studies were 50|j,M-1000)j.M and time of incubation was 3 hours 
and 18 hours. 'l"he smiilar etTects on Cu,Zn SOD were also carried out in presence 
of fixed Cu(Il) (ImM) while varying the concentration of Naringenin (50fiM-
lOOOuM). The Cu,Zn SOD activity, SDS-gel electrophoretic pattern and spectral 
analysis were carried out as described in the earlier sections. 
Gel Electrophoresis 
Native-Polyacrylamide Gel Electrophoresis 
PAGE was performed according to the procedure described by Laemmli and Lewis 
(1962) using a slab gel apparatus manufactured by Atto.Co., Japan. A stock 
solution of 30% acrylamide containing 0.8% bisacrylamide, 1.5mM Tris HCl (pH 
8.8) was prepared and mixed and appropriate order to give a desired percentage of 
acrylamide, and was then polymerized after inserting a comb that provided 
template for number of required wells. Bubbles and leaks were avoided. Proteins 
samples prepared in 10%) glycerol, 0.25M Tris HCl. ButTer (pM 6.8), and traces 
bromophenol blue were loaded on polymerized gel. Running buffer was 0 025 M 
Tris, 0.2 M glycine and voltage applied was lOOV. 
SDS-Polyacrylamide Gel Electrophoresis 
SDS-PAGE was essentially performed by the method of Laemmli and Lewis 
(1962) using mini slab gel appratus manufactured by Atto Co., Japan. Stock 
solutions of 30%o acrylamide containing 0.8%) bisacrylamide, l.SmM Tris HCl (pH 
8.8) and 10%o SDS were prepared and mixed in appropriate ratios to give the 
desired percentage of the gel. The cocktail was poured between glass plates and 
comb was inserted for making the wells which was allowed to polymarize within 
30 minutes. Protein samples were prepared to give a final concentration of l%o 
SDS (w7v), 0.5% mercaptoethanol, 0.25M Tris-HCl buffer pH 6,8, 10%o (w/v) 
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glycerol and traces of bromophenol blue as a tracking dye. The samples were 
boiled for 3 minutes and applied to the wells. Electrophoresis was performed at 
lOOV till the tracking dye reached the bottom of the gel. Running buffer used 
during electrophoresis contained 1% SDS in addition to 192mM glycine and 
25mM Tris HCi pH 8.8. The protein bands in both SDS-PAGE and Native PAGE 
were stained either by siler nitrate or Coomassie Brilliant Blue, 
Coomniassic Brilliant Blue Staining 
After the completion of either SDS-PAGE or Native PAGE the gel was stained for 
the protein with Coommassie Brilliant Blue R-250 (4X) in 40% methanol, and 
10% glecial acetic acid for about 4-6 hours. The gel was then destained for several 
hours with 10% glacial acetic acid and methanol solution until the background 
becomes clear. 
Silver Staining 
The silver staining was done according to the protocol described by Nesterenko et 
al (1994) with few modifications. Once the gel (either SDS-PAGE or Native 
PAGE) was run, it is suspended in solution of 50% acetone (v/v), 1% TCA (w/v) 
and 0.015%o formaldehyde (v/v) for 15-20 min. The gel was then washed 
thoroughly with distilled water 4-5 times and again suspended in 50%o acetone 
solution for about 20 minutes. After this the gel was immersed in 0.016% (w/v) 
Na2S20.v5H20 solution for 5 min. Again extensive washing of the gel was done 
with distilled water and gel was transferred in a solution of 0,27% silver nitrate 
(w/v) and 0,37% formaldehyde (v/v) and left for 15 min with continuous shaking. 
After extensive washing with distilled water, finally the gel was suspended in a 
solution containing 0,18M sodium carbonate, 0.015%o (v/v) formaldehyde and 
0.004%) (w/v) Na2S203.5H20 with vigorous shaking for few seconds. When protein 
bands appeared, the gel was immersed in a solution of l%o (v/v) glacial acetic acid 
solution for 5 min and finally washed properly with distilled water 
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Activity Staining of Cu,Zn Superoxide Dismutase 
Native Polyacrylamide gel electrophoresis was done in order to do the Cu,Zn SOD 
activity staining. Staining was done according to the method described by 
Beauchamp ad Fridovich, 1971. Cu,Zn superoxide dismutase was localized by 
soaking the gels in 2.45 x lO'M nitroblue tetrazolium for 20 min followed by an 
immersion, for 15 min in a solution containing 0.028M 
tetramethylethylenediamine, 2.8 x 10' M riboflavin, and 0.036M potassium 
phosphate buffer at pH 7.8. The gels were then illuminated for 5-15 min. During 
illumination the gels became uniformly blue except at positions containing 
superoxide dismutase. Illumination was discontinued when maximum contrast 
between the achromatic zones and the general blue colour had been achieved. 
Finally the gels were photographed. 
Spectral Studies 
The interaction of Cu,Zn SOD with different flavonoids was studied by various 
spectral studies. 7.5|j.M Cu,Zn SOD (prepared in 1.5mM potassium phosphate 
buffer, pH 6.8) was treated with various flavonoids (Quercetin, Rutin, Myricetin 
and Naringenin) at a final concentration of 500|U,M and incubated for 3 hrs at 
37°C. The flavonoids were prepared as SruM stock in methanol. The control sets of 
each flavonoid alone, and of enzyme Cu, Zn SOD alone was also incubated under 
the similar conditions, the volume in both control sets was compensated with 
1.5mM potassium phosphate buffer pH 6.8. After the incubation was over, the 
reaction mixtures were diaiyzed extensively against 1.5mN4 potassium phosphate 
buffer pH 6.8. The diaiyzed samples were used for recording various spectra like, 
Fluorescence spectra. Absorption spectra and C D . 
UV-Visible Spectroscopy 
The UV-visible absorption spectra were recorded with a Cintra 5 UV-visib!e 
spectrophotometer using a matched pair of quartz cuvettes (1 cm optical length) 
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placed in a thermostated cell holder at 25±0.1°C. The spectra were fitted to several 
overlapping Gaussian curves with the help of a Gaussian curve-fitting program that 
provided the amplitude, center, bandwidth, at half the maximum amplitude, and 
area of each Gaussian function. 
Fluorescence Spectroscopy 
Native and various treated Cu, Zn SOD solutions were analyzed by measuring 
intrinsic lluorescence at 20"±0.2"C in Hitachi F2000 spectrofluorimeter (Tokyo, 
Japan). The protein was excited at 280 nm. Corrected emission spectra were 
recorded with excitation and emission hand widths of 280 nm. Appropriate 
controls containing the substances used for the treatment were run and corrections 
were made wherever necessary. 
The time course of the change in intrinsic fluorescence at 20±0.2°C 
followed measuring the fluorescence in Hitachi F-2000 spectrofluorimeter. To 
analyze the cumulative effect of tyrosine, trytophan and phenylalanine, the protein 
was excited at 280 nm. The temperature was maintained at 22"C by thermostating 
the cuvette housing during the measurement. The time of mixing was defined as 
t=0. The fluorescence spectra at known times were recorded and the change in 
relative fluorescence (AF) was calculated at 340 nm. 
Circular dichroism spectroscopy 
Circular dichroism spectra of native and myricetin treated Cu, Zn SOD were 
measured in a Jasco J-720 spectropolarimeter equipped with a temperature 
controlled sample cell holder. Spectra were collected with a scan speed of 
20nm/min and with a response time of 1 sec. Measurements in the far UV (200-
250nm) were taken with a 1mm path length cell whereas cells with 10mm path 
length were used in the near UV (250-300nm) region. The results were expressed 
as CD (mili degrees) 
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Stoichiometric Titration of Cu(I) Production 
The concentration of Cu(I) produced in the Cu,Zn superoxide dismutase (Cu,Zn 
SOD) and myncetin reaction mixture was determined by titration with 
neocuproine. Neocuproine complexes with Cu(I) to form Cu(neocuproine)2 
complex which has an absorption peak at 450nm (Nebesar, 1961). The reaction 
volume contained lOmM Tris-HCl (pH 7.5),22.5)aM myricetin and finally 0.4mM 
neocuproine was added,and the absorbance was recorded at 450nm after adding 
0.168).iM Cu,Zn SOD. 
In Vivo Studies 
In our initial experiments, mice were divided into two groups- treated and controls. 
The mice in the treated groups were given intraperitoneal injection of drugs, 
myricetin,quercetin and methyl viologen etc.(0.3mg in ethanol) while the mice in 
the control groups were given intraperitoneal injection of ethanol.The animals were 
sacrificed after three hours and liver samples after perftjsing with normal salme 
were homogenized in 5ml of 1.5mM potassium phosphate buffer pH 6.8.All 
homogenized samples were centrifijged at 15,000rpm for 30 minutes and clear 
supernatants were used for determining the total protein as well as Cu,Zn SOD 
activity. 
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RESULTS 
Cu,Zn superoxide dismutase (Cu,Zn SOD) obtained from Sigma, Aldrich, U.S.A. 
was used in all the experiments. In order to carry out the studies related to the 
interaction of flavonoids with Cu,Zn SOD it was essential to know certain physical 
properties of Cu, Zn SOD. The following sections describe some properties of 
Cu,Zn SOD 
Effect of Temperature and Ionic Strength 
The purified Cu,Zn SOD exhibited a remarkable thermal stability at higher 
temperatures. When the enzyme was preincubated for one hour at different 
temperatures, the activity remained constant upto 60"C. The enzyme remained 
active upto this temperature and then its activity declined at higher temperatures 
(Figure 6). Similarly in another experiments, the Cu,Zn SOD was incubated at 
VO^ C for different time intervals, and the results are shown in Figure 7. As shown 
in the figure, the inactivation was started after 30 minutes and there was maximum 
inactivation after 2 hours incubation at this temperature. The effect of ionic 
strength on the Cu,Zn SOD is shown in Table 5. The enzyme exhibited the 
resistance to higher ionic strength as indicated by the unchanged enzyme units 
when the buffers of different molarities were used . 
Interaction of Cu,Zn SOD with 1, 10 Phenanthroline 
The aim of present investigations is to study the interaction of certain flavonoids 
with Cu,Zn SOD which is a primary important defensive enzyme to fight with 
certain diseases associated with oxidative stress. As the flavonoids interact with 
metal ions, it can be presumed that Cu(n) of Cu,Zn SOD may be involved in such 
type of interactions. In order to confirm the possibility, of metal chelation of Cu,Zn 
SOD, we have selected a metal chelating agent, 1,10 phenanthroline (OP) for our 
initial studies. The effect of 1,10 phenanthroline on the activity of Cu,Zn SOD is 
shown in Table 6. As evident from the table, ImM concentration of 1,10 
phenanthroline partially inactivated the enzyme. The inactivation of Cu,Zn SOD 
remained constant by increasing the molar concentration of enzyme at a fixed 
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igure 6 Effect of different temperatures on Cu,Zn superoxide dismutase 
(Cu,Zn SOD) activity. 
Appropriate volumes of enzyme prepared in 15% glycerol in ].5mM 
potassium phosphate buffer pH 6.8 were incubated at the indicated 
temperatures for 60 min. After the incubation was over, the aliquots were 
chilled in ice and activity was determined as described in "Methods" 
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Figure 7 Thermal stability of Cu,Zn SOD 
Enzyme solution diluted in 1 5mM potassium phosphate buffer 
contaming 15°o glycerol solution was incubated at 70"C, ^t the 
indicated time intervals appropriate volume of the aliquot was 
withdrawn, chilled quickly and the Cu,Zn SOD activity \vas determined 
bv the standardized procedure 
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Table 5 Effect of ionic strength on Cu,Zn SOD Activity 
Appropriate volume of the enzyme was assayed in the sodium 
pyrophosphate buffer (pH 8.2 ) of the indicated molarities and enzyme 
units were calculated. 
Molarity (mM) 
20 
40 
60 
80 
100 
200 
Enzyme units/ml 
35 
30 
32 
34 
34 
33 
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Table 6 Effect of 1,10 phenanthroline on the activity of Cu,Zn SOD 
In a total reaction mixture of 40 (il containing indicated amounts of 
Cu,Zn SOD, ImM 1,10 phenanthroline was added and the reaction 
mixture was incubated for Ihour at room temperature. After incubation 
period was over, suitable aliquots were withdrawn and enzyme activity 
was determined. The control set was also run without 1,10 
phenanthroline and percent activity was determined. Each value 
represents the average of atleast three experiments performed 
independently. 
Concentration of 
1,10 phenanthroline 
(mM) 
0 
1 
0 
1 
0 
1 
Molar concentration 
ofCu,ZnSOD 
3.0 
3.0 
6.0 
6.0 
9.0 
9.0 
Percent Remaining 
Activity 
100 
73 
100 
73 
100 
70 
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concentration of 1,10 phenanthroline. In order to confirm whether free copper 
affects the binding etTiciency of OP to the Cu(II) of Cu,Zn SOD, the interaction of 
Cu,Zn SOD with OP was also investigated in presence of ImM copper. The results 
are shown in Table 7, As evident from the table, there was no difference m the 
inactivation pattern of Cu,Zn SOD in presence and absence of free copper. The 
results of table 7, indicated that the Cu,Zn SOD activity was almost completely 
recovered in presence of uric acid in a reaction mixture containing Cu,Zn SOD, OP 
and copper chloride. 
The SDS-Polyacrylamide gel electrophoretic pattern of the above reaction 
mixtures is shown in Figure 8, As shown in the figure, the recoveiy of the enzyme 
activity in presence of uric acid was confirmed by the intensity of the band in lane 
d. In order to study the interaction of 1,10 phenanthroline with some other protein , 
we have selected Bovine Serum Albumin (BSA) for our experiment. BSA was 
incubated with 1,10 phenanthroline in presence and absence of Cu(ll) , The results 
are shown in Figure 9, which suggested that there was degradation of protein in 
presence of both 1,10 phenanthroline and Cu(II),while 1,10 phenanthroline and 
Cu(Il) alone were ineffective. 
Interaction of Cu,Zn SOD with flavonoids 
Myricetin - Cu,Zn SOD 
Myricetin is a flavonol commonly found in wine, tea, fruits, berries and 
medicinal plants. It has anti-inflammatory activity and its therapeutic potential 
includes its role as an anticarcinogenic, antiviral and antimicrobial agent. It is not 
known whether myricetin modulates the activity of Cu,Zn SOD during its 
interaction with the enzyme, so we have carried out the studies demonstrating the 
modulation of Cu,Zn SOD activity in the presence of myricetin alone as well as in 
combination with certain metal ions. In the initial experiment, varying 
concentrations of myricetin were incubated with Cu,Zn SOD for 90 minutes and 
results are shown in Table 8. As evident from the table, there was a marginal 
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Table 7 Effect of CuCb and uric acid on the 1,10 phenanthroline-Cu,Zn 
SOD interaction. 
In a total reaction mixture of 60 |il containing 4 \iM Cu,Zn superoxide 
dismutase, ImM 1,10 phenanthroline, IniM CuCl2 and 0 5 mM uiic acid 
were added m different sets of experiment and Cu,Zn SOD activity was 
deteimined The peicent remaining activity was determined by taking 
the control as 100% Each value represents the aveiage of atleast three 
experiments performed independently 
S.No. 
1 
2 
-> 
J 
4 
Cu,Zn 
superoxide 
dismutase 
(4 \iM) 
+ 
+ 
+ 
+ 
1,10 
phenan-
throline 
(ImM) 
-
+ 
+ 
+ 
CuCl2 
(ImM) 
-
-
+ 
+ 
Uric acid 
(0.5 mM) 
-
-
-
+ 
Percent 
Remaining 
Activity 
100 
74 
76 
93 
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Figures SDS Polyacraylamide Gel Electophoresis of Cu,Zn SOD treated 
with 1, 10 Phenanthroline and CuCh in presence of uric acid. 
A total reaction mixtures of 60\il containing 4|aM Cu,Zn SOD was 
incubated with 1 mM 1, 10 phenanthroline and linM CuCb in presence 
of 0 5 mM uric acid for a long duration of 18 hours at 4 °C After the 
incubation was over, samples were withdrawn from the reaction 
mixtures and were analyzed on SDS-Page Staining was done by silver 
nitrate 
a Cu,Zn SOD alone 
b Cu,Zn SOD treated with ImM 1,10 phenanthroline 
c Cu,Zn SOD treated with ImM 1,10 phenanthroline in presence of 
lmMCuCl2 
d Cu,Zn SOD treated with ImM 1,10 phenanthroline and ImM CuCh 
in presence of 0 5mM uric acid 
60 
i 
ifpm p i# 
a, b d dL 
Figure 9 Effect of 1,10 phenanthroline on Bovine Serum Albumin (BSA) in 
presence of CuCh. 
In a reaction volume of 50)j,l, 58|aM BSA (at final concentration) was 
treated with ImM 1,10 phenanthroline in presence and absence of ImM 
CuCh, and incubated for 2 hours at room temperature Proper aliquots 
(=10 pg protein) were withdrawn from the reaction mixtures and loaded 
on 7 5% native polyacrylamide gel Finally the staining was done by 
silver nitiate 
a BSA treated with 1,10 phenanthroline 
b BSA control 
c BSA treated with CuCl2 
d BSA treated with 1,10 phenanthroline in presence of CuC^ 
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Table 8 Effect of Myricetin on Cu,Zn SOD activity. 
A total reaction mixture of 67[il containing 7.5[.LM, Cu,Zn SOD and 
vaiying concentration of myricetin was incubated for 90 inmutes at 
37"C. After the incubation period was over, suitable aliquots were 
withdrawn for measuring Cu,Zn SOD activity as described in the text. 
Each value represents the average of at least three experiments 
performed independently. 
Concentration of myricetin 
(mM) 
0.00 
0.1 
0.5 
1.0 
2.0 
Percent Inactivation 
0.00 
45.3 
51.0 
56.0 
53.0 
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increase in the inactivation of Cu,Zn SOD by increasing myricetin concentrations 
from 0.1 -O.SniM and beyond this concentration, the enzyme inactivation pattern 
remained constant up to a maximum of 2mM concentration of myricetin used in 
this experiment. By lowering the concentration of myricetin and increasing the 
time of incubation, a different inactivation pattern of Cu,Zn SOD was obtained. 
The effect of varying concentration of myricetin 20-lOOO^M (at lower range) on 
Cu,Zn SOD activity are shown in Table 9. As shown in the table, 20).i.M 
concentration of myricetin decreased the Cu,Zn SOD activity upto 36% during 3 
hours incubation and maximum inactivation, close to 80% was achieved at 
maximum concentration of myricetin ie. ImM taken for this expermient. When 
ImM myricetin was incubated with varying concentrations of Cu,Zn SOD 
(2.2-7.5(.iM), at 37"C for 90 minutes, maximum inactivation was observed at 
4.4|.iM concentration of Cu,Zn SOD which remained unchanged at 7.5|iM 
concentration of enzyme (Table 10). For our fijture studies we have considered this 
concentration of Cu,Zn SOD. The data obtained from these experiments, indicated 
that inactivation of Cu,Zn SOD was increased by increasing the time of incubation 
with myricetin. In order to optimize the time of incubation for maximum possible 
inactivation of Cu,Zn SOD, we have carried out an experiment by incubating a 
fixed concentration of myricetin with Cu,Zn SOD for different durations. The 
results are shown in Figure 10. As evident from the figure, at ImM concentration 
of myricetin, there was a gradual decrease in the Cu,Zn SOD activity by increasing 
the time of incubation up to 3 hours as expressed in terms of increase in the percent 
inactivation. After 3 hours incubation, Cu,Zn SOD lost its almost 80% activity 
which remained constant up to 6 hours of incubation witii the same concentration 
of myricetin. SDS-Polyacrylamide gel electrophoresis of myricetin treated Cu,Zn 
SOD and its respective control was carried out in order to monitor the 
fragmentation of the enzyme in association with the loss in enzyme activity. As 
shown in Figure 11, the myricetin treated Cu,Zn SOD activity exihibited an almost 
identical SDS gel electrohoretic pattern with respect to its control 
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Table 9 Effect of myricetin on Cu,Zn SOD activity. 
In a total reaction mixture of 67),il containing 7.5|LIM Cu,Zn SOD in 
1.5mM potassium phosphate buffer pH 6.8 was incubated with varying 
concentrations of myricetin for 3 hrs at 3TC. After the incubation 
period was over, suitable aliquots were withdrawn for measuring Cu,Zn 
SOD activity by the method described in the text. Each value represents 
the average of at least three experiments performed independently 
Concentration of myricetin {\xM) 
0.00 
20 
50 
100 
1000 
Percent Inactivation 
0.00 
34.6 
56.2 
54.2 
78.2 
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Table 10 Effect of myricetin on Cu,Zn SOD activity as a function of enzyme 
concentration. 
In a total reaction mixture of 67|j.l, containing ImM myricetin in 1.5mM 
potassium phosphate buffer pH6.8, increasing concentrations of Cu,Zn 
SOD was added and reaction mixture was incubated at 37"C for 90 min. 
After the reaction period was over, Cu,Zn SOD was determined by the 
procedure described in the text. Each value represents the average of at 
least three experiments performed independently. 
Samples 
Cu,Zn SOD control 
Cu,Zn SOD treated with 
1 luM myricetin 
Cu,Zn SOD control 
Cu,Zn SOD treated with 
1 mM myricetin 
Cu,Zn SOD control 
Cu,Zn SOD treated with 
] niM myricetin 
Percent 
Inactivation 
0.00 
48.8 
0.00 
67.5 
0.00 
67.5 
Concentration of Cu,Zn 
SOD (|iM) 
2.2 
2.2 
4.4 
4.4 
7.5 
7.5 
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Figure lOEffect of time of incubation on Cu,Zn SOD activity in presence of 
myricetin. 
The total reaction mixture of 67|al containing ImM myricetin, 7 5|j,M 
Cu,Zn SOD in 1 5mM potassium phosphate buffer, pH 6 8 was 
incubated at 37°C for different time intervals and Cu,Zn SOD activity 
was determined as described in the text 
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Figure 11 SDS-EIectrophoretic pattern of Cu,Zn SOD treated with myricetin. 
Cu,Zn SOD at a final concentration of 7.5)j,M was incubated with ImM 
myricetin in 1.5mM potassium phosphate buffer pH 6.8 at 37°C for 3 
hrs. A control set containing enzyme alone was also incubated under 
similar conditions. The volume of the control set was compensated with 
the same buffer, and after the incubation period was over, suitable 
aliquots were withdrawn and analyzed by SDS-PAGE. Staining was 
done by silver nitrate method as described in the text. 
a - Marker Protein 
b - Cu,Zn SOD control 
c - Cu,Zn SOD treated with ImM myricetin 
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From the above mentioned experiments, it was not known whether the 
myricetin induced inactivation of Cu,Zn SOD was reversible or irreversible in 
nature and required the presence of myricetin. In order to confirm this, the 
myricetin treated Cu,Zn SOD and its control were dialyzed extensively against 
1.5mM potassium phosphate buffer (pH 6.8) before measuring the enzyme activity. 
The results are shown in Table 11. The results of Table 11 clearly indicated that 
dialyzed and undialyzed untreated/myricetin treated Cu,Zn SOD exhibited almost 
similar activity, maintaining nearly similar inactivation pattern. When these 
samples were also eiectrophoresed on SDS gel, there was no alteration in the 
electrophoretic pattern of dialyzed and undialyzed, myricetin treated as well 
untreated samples of Cu,Zn SOD (Figure 12). 
Spectral studies on Myricetin - Cu,Zn SOD complex 
In order to monitor the structural and conformational changes in the protein, during 
interaction with other molecules, various spectral studies are conducted. We have 
carried out the absorption, fluorescence, circular dichroism (CD) spectroscopy of 
myricetin treated Cu,Zn SOD. Figure 13 shows the UV/visible absorption spectra 
of untreated dialyzed Cu,Zn SOD control as well as myricetin treated Cu,Zn SOD 
samples. A slight shift towards the ultra violet region (hypsochromic shift ), and a 
considerable decrease in the absorbance of myricetin treated Cu,Zn SOD was 
observed. The fluorescence emission spectra of control and myricetin treated 
Cu,Zn SOD exhibited an emission maxima at 295 and 292nm respectively (Figure 
14) when excited at 280nm. Treatment of Cu,Zn SOD with ImM myricetin also 
resulted in 40% decrease in the fluorescence intensity. Circular dichroism 
predominantly monitors secondaiy structures of proteins and polypeptides in the 
far UV spectral region (190-250nm). At these wavelengths the chromophore is the 
peptide bond, and the signal arises when it is located m a regular, folded 
environment. Pure a helices show negative ellipticity at around 222 nm and 
at around 205 nm whereas pure P sheets generally show a shallow 
minima CD (Greenfield and Fasman, 1969). Figure 15, shows the CD spectra 
in the far UV region of dialyzed untreated / myricetin treated Cu,Zn SOD. 
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Table 11 Effect of dialysis on Cu,Zn SOD activity after treating with 
myricetin. 
7,5|j.M solution of Cu, Zn SOD was incubated with ImM myricetin at 
37"C for 3 hours. A control set of enzyme (Cu,Zn SOD) alone in 1.5mM 
potassium phosphate buffer, pH 6.8 was also incubated under similar 
conditions. After the incubation period was over, half of the samples 
(both from the control and treated sets) were dialyzed extensively 
against 1.5mM potassium phosphate buffer, pH 6.8. Suitable aliquots 
from another half was taken for determining the Cu,Zn SOD activity and 
designated as undialyzed sample. After extensive dialysis, suitable 
aliquots were withdrawn for determining Cu,Zn SOD activity and 
samples were designated as dialyzed sample. 
Samples 
Control Cu,Zn SOD 
Cu,Zn SOD treated with ImM 
myricetin 
Percent Remaining Activity 
Dialyzed 
100 
27.8 
Undialyzed 
100 
21 
69 
Figure 12 SDS gel electrophoretic pattern of Cu,Zn SOD treated with 
iiiyricetin before dialysis and after dialysis. 
The reaction mixture containing 7.5(aM Cu,Zn SOD was treated with 
IniM myricetin and incubated for 3 hrs at 37"C. After the incubation 
period, haU' of the reaction mixture was dialyzed extensively against 
1.5mM potassium phosphate buffer, pH 6.8. Proper volume of aliquots 
(~ 20)ag protein) from both dialyzed and undialyzed samples were used 
for SDS-PAGE. Staining was done by silver nitrate method as described 
in the text. 
a - Myricetin treated Cu,Zn SOD (dialyzed) 
b - Cu,Zn SOD control (dialyzed) 
c - Myricetin treated Cu,Zn SOD (undialyzed) 
d - Cu,Zn SOD control (undialyzed) 
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Figure 13 UVA'IS spectral analysis of interaction of Cu,Zn SOD with ImM 
Myricetin. 
The reaction mixture containing ItnM myricetin and 7.5|.tM Cu,Zn SOD 
was incubated for 3 hrs at 37°C. The control sets containing Cu, Zn SOD 
and myricetin alone at similar concentration were also incubated under 
similar conditions. The volume in the control sets was compensated with 
1.5mM potassium phosphate buffer, pH 6.8. After the incubation period, 
the reaction mixtures were extensively dialyzed against 1.5mM potassium 
phosphate butTer pH 6.8. Proper aliquots (~ 56|.ig/ml) were withdrawn from 
the dialyzed samples and diluted in the same buffer. The diluted samples 
were used for recording the spectra. 
Cu,Zn SOD control ( ) 
Cu,Zn SOD treated with myricetin ( 
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Figure 14 Changes in the fluorescence spectra of Cu, Zn SOD after interaction 
with ImM myricetin. 
Reaction mixture containing 7.5|j.M Cu, Zn SOD and ImM myricetin was 
incubated at 37°C for 3hours. The control sets containing Cu,Zn SOD and 
myricetin alone at same concentrations were also incubated under similar 
conditions. The volume in the control sets was compensated by adding 
1.5mM potassium phosphate buffer, pH 6.8. After the incubation period, 
the reaction mixtures were dialyzed extensively against 1.5mM potassium 
phosphate buffer pH 6.8. Proper aliquots were withdrawn from the dialyzed 
samples (~ 56(a,g protein/ml) and diluted in the same phosphate buffer for 
the fluorescence spectra. The excitation wavelength was 280nm and 
scanning wavelength range was 250 nm-400nm. 
1. Cu,Zn SOD control 
2. Cu,Zn SOD treated with myricetin 
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250 300 350 
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FigurelS Far UV Circular Dichroism spectra of Myricetin treated and untreated 
dialyzed Cu,Zn SOD 
In a total reaction volume of 1ml containing 7.5|i.M Cu,Zn SOD was 
incubated with ImM myricetin for 3 hours at 37°C .Untreated Cu,Zn SOD 
at the same concentartion was also incubated under similar conditions. After 
the incubation was over,the samples were dialyzed extensively against 
1.5mM potassium phosphate buffer pH 6.8. Suitable aliquots from the 
dialyzed samples were withdrawn(s;100ng protein) and used for taking the 
spectra using the cells with 0.1 cm path length.The unit of the ordinate is 
given in CD (m deg). 
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The spectra for Cu,Zn SOD is characterized by the presence of minima at 210nm 
and interaction with ImM myricetin resulted in 2nm blue shift, while there was a 
marked decrease in the C. D. (mdeg) value with a change in the shape of the 
spectra. 
A significant decrease in the Cu,Zn SOD activity in presence of ImM 
myricetin clearly indicated the enzyme inactivation by an unknown mechanism. It 
has already been observed that the inactivated Cu,Zn SOD recovered in the 
presence of excess amount of Cu(Il) (Dameron and Harris, 1987). Wc have carried 
out one experiment in which myricetin treated and dialyzed Cu,Zn SOD was 
incubated with varying concentrations of CuCh (10-100|,iM) (Table 12). As 
evident from the table, no recovery in the Cu,Zn SOD activity was achieved at any 
of the concentrations used in our experiment. 
Studies on reduction ofCu(II) ^Cu(I) ofCu,Zn SOD in presence of myricetin 
In order to explore the mechanism of Cu,Zn SOD interaction with myricetin and 
the inactivation of enzyme involving its Cu(II), we have carried out stoichiometric 
titration of Cu(l) production. When 22.5p.M concentration of myricetin was 
incubated with varying concentratons of Cu(II) ,its reduction into Cu(I) exhibited a 
linear range of absorbance in presence of neocuproine. The results are shown in 
Figure 16. When Cu,Zn SOD was added to the reaction mixture containing 
myricetin and neocuproine, the change in absorbance indicated the reduction of 
Cu(ll) of Cu,Zn SOD into Cu(I). The low values of Cu(Il): myrietin ratio in case of 
Cu,Zn SOD determined from the standard plot, was 3.3x10"''. These low values, 
were obtained due to low concentration of enzyme taken for this experiment. 
Interaction ofCu, Zn SOD with myricetin involving Cu(II) 
Since it is known based on certain observations that flavonoids may also act as a 
prooxidant in presence of certain metal ions (Cao, et a/., 1997; Cotelle,2001). In 
order to see the interaction of Cu,Zn SOD with myricetin in presence of Cu (II) as 
2+ Table 12 Effect of Cu on myricetin treated and dialyzed Cu,ZnSOD. 
7 5[j.M Cu,Zn SOD alone and with ImM myricetin samples in a total 
reaction mixture of 1ml were incubated at 37"C for 3 hours After 
incubation period was over, both the samples were dialyzed extensively 
against 1.5mM potassium phosphate buffer pH 6,8 and suitable volume 
of aliquots were withdrawn from control (referred as A) as well as from 
myricetin treated (referred as B) sets. These aliquots were incubated with 
varying concentration of CuClj at 37"C for 3 hrs. The Cu,Zn SOD 
activity was determined in each sample. The value of untreated and 
dialyzed Cu,Zn SOD control was considered as 100% for calculating 
percent remaining activity. Each value represents mean of three different 
experiments performed in duplicates. 
Samples 
A 
B 
A 
B 
A 
B 
A 
B 
Concentration of 
CuClz (l^M) 
0.0 
0.0 
10 
10 
50 
50 
100 
100 
Percent Remaining Activity 
100 
28.7 
105 
23.9 
104 
18 
106 
27 
75 
Figurel6 Stoichiometric titration of reduction of Cu(II) >Cu(I),of Cu,Zn SOD 
in presence of myricetin. 
The total reaction of 3ml containing 0.4mM neocuproine, 22.5|.i,M 
myricetin was prepared in lOmM Tris HCl buffer (pH 7.5) and absorbance 
was recorded at 450nm after adding varying concentrations of CuCh 
(0.0005^M-100^M)/0.]68nM Cu,Zn SOD, 
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well as copper alone, we have carried out the experirnSntin which Cu,Zn SOD was 
incubated with varying concentrations of Cu (II) (0-2000|j,M) alone as well as in 
combination with ImM myricetin. The results are shown in Table 13. As evident 
from the table, there was a drastic increase in the Cu,Zn SOD activity as a fianction 
of increasing concentration of copper alone, when the values were calculated by 
considering the Cu,Zn SOD as a base control (100%). When the same experiment 
was repeated in presence of ImM myricetin along with the increasing 
concentrations of Cu(II), a gradual decrease in the Cu,Zn SOD activity was 
observed when the values of Cu,Zn SOD in presence of the respective 
concentration of Cu(II) was taken as a base control. Based on several reports that 
flavonoids, in presence of Cu(II) generate hydroxyl radical ( Cao,e/ a/, 1997) it 
could be presumed from the above experiment, that gradual decrease in Cu,Zn 
SOD activity was due to some additional factor. In order to confirm whether 
myricetin, a flavonoid, in presence of Cu(II) leads to the formation of hydroxyl 
radical, we have carried out this interaction in presence of a hydroxyl radical 
scavenger, catalase. The results are shown in Figure 17. As evident from the figure, 
myricetin alone exhibited a marked inactivation of Cu,Zn SOD activity which was 
fijrther enhanced in presence of ImM CuCl2 and no restoration of enzyme activity 
has been achieved by adding increasing concentrations of catalase suggesting that 
there was no involvement of hydroxyl radical in presence of CuCl2 and myricetin. 
Since the uric acid is also considered as a radical scavenger (Ames, el al.^ 1981) of 
singlet oxygen, hydroxyl radical and other oxidants, we have further carried out the 
Cu,Zn SOD and myricetin interaction in presence of Cu(II) and uric acid. The 
results are shown in Figure 18. As evident from the figure, there was no restoration 
of Cu,Zn SOD activity in presence of uric acid. 
The SDS-polyacrylamide gel electrophoresis of Cu,Zn SOD was carried 
out in presence of CuCl2 alone as well as in combination with ImM myricetin. The 
results are shown in Figure 19. There was no change in the electrophoretic pattern 
of Cu,Zn SOD either treated with CuCl2 alone or in combination with myricetin 
suggesting that no fragmentation of Cu,Zn SOD has occurred even after its almost 
complete inactivation. 
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Table 13 Effect of varying concentrations of copper on Cu,Zn SOD activity in 
presence and absence of myricetin. 
The reaction mixture containing 7,5JJ.M Cu,Zn SOD was incubated with 
and without ImM myricetin in presence of increasing concentrations of 
Cu(II) at 37"C for 3 hours. After the reaction period was over, the 
eppendorfs were centrifijge briefly and suitable volumes of the aliquots 
were used for measuring Cu,Zn SOD activity. The percent remaining 
activity was based on (A) by considering the value of Cu,Zn SOD 
control as 100% (B) values of individual Cu(n) concentration incubated 
with Cu,Zn SOD were taken as 100 percent. 
Concentration 
of Cu, Zn SOD 
(7.5^M) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Concentration 
of CuCl2 
0 
0 
100 
100 
200 
200 
600 
600 
1000 
1000 
2000 
2000 
Concentration 
of myricetin 
(ImM) 
-
+ 
-
+ 
-
+ 
-
+ 
-
+ 
-
+ 
Percent 
Remaining 
Activity 
A 
10 
20.6 
134 
35.5 
140 
31.7 
144 
16.9 
134 
6 
136 
7.6 
B 
100 
26.4 
100 
19.6 
100 
9.2 
100 
4.4 
100 
5.5 
78 
Figurel? Effect of catalase on the activity of Cu,Zn SOD in presene of 
myricetin/Cn(n). 
Reaction mixtures containing 7.5|aM Cu,Zn SOD, ImM myricetin and 
ImM Cu(n) were incubated with increasing concentrations of catalase for 3 
hours at 37"C. After the incubation period was over, the reaction samples 
were briefly centrifuged and appropriate volumes of the supernatant were 
used for the determination of Cu,Zn SOD activity. 
1. Cu.Zn SOD control 
2. Cu.Zn SOD treated with myricetin 
3. Cu,Zn SOD treated with Cu(II) alone 
4. Cu.Zn SOD treated \vidi myricetin in presence of Cu(n) 
5. Cu,Zn SOD treated with myricetin and Cu(ll) in presence of 0,4f,ig catalase 
6. Cu.Zn SOD treated with myricetin and Cu(II) in presence of ().9|.ig catalase 
7. Cu.Zn SOD treated with myricetin and Cu(II) in presence of 1,5^g catalase 
8. Cu.Zn SOD treated with myricetin and Cu(ri) in presence of I.O^g catalase 
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FigurelS Effect of uric acid on myricetin treated Cu,Zn SOD. 
In a total reaction mixture of 67|j,l, 7.5|j.M Cu,Zn SOD was incubated with 
ImM myricetin and Cu(ll) in presence/absence of uric acid at 37"C for 3 
hours. After incubation period was over, suitable aliquots were withdrawn 
and Cu,Zn SOD activity was determined. 
1. Cu,Zn SOD control 
2. Cu,Zn SOD treated with myricetin 
3. Cu,Zn SOD treated with Cu(II) alone 
4. Cu,Zn SOD treated with myricetin in presence of Cu(II) 
5. Cu,Zn SOD treated with Cu(II) in presence of uric acid 
6. Cu,Zn SOD treated with myricetin and Cu(II) in presence of uric acid 
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Figurel9 SDS-Gel Electrophoretic pattern of Cu,Zn SOD treated with myricetiii 
in presence and absence of CuCIz. 
In a total reaction mixture of 33|.U, 7.5).iM Cu,Zn SOD was treated with 
ImM myricetin in presence and absence of linM CUCI2 and incubated for 3 
hours at 37"C. Cu,Zn SOD alone and in presence of ImM CuClo only was 
also incubated under similar conditions and after the incubation period, 
suitable aliquots (~ 4(j.g protein) were withdrawn and analyzed by SDS gel 
electrophoretic pattern. The gel was stained by silver nitrate as described in 
the text. 
a - Marker protein 
b - Cu,Zn SOD control 
c - Cu,Zn SOD treated with myricetin 
d - Cu,Zn SOD treated with Cu(ll) 
e - Cu,Zn SOD treated with myricetin in presence of Cu(ll) 
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In order to confirm the possibility of the interaction of Cu(II) of Cu,Zn 
SOD with myricetin, an experiment was carried out in which the different 
concentrations of Cu(Il) were incubated with a fixed concentration of myricetin 
prior to the incubation with Cu,Zn SOD. The resuks are shown in Figure 20. As 
shown in the figure, at 0.1 mM myricetin there was 40% inactivation of the 
enzyme. When the Cu(II) was incubated with myricetin for 18 hours, the 
precipitate of Cu(II)-myricefin complex started appearing at a particular 
concentration of Cu(II). When the supernatant from these complexes were 
incubated with Cu,Zn SOD, there was a gradual decrease in the inactivation of 
Cu,Zn SOD suggesting that no free myricetin was available at maximum 
concentration of CuCb used in this experiment resulting in almost complete 
restoration of Cu,Zn SOD activity. 
Interaction of Cu,Zn SOD with myricetin involving different metal ions 
From the studies conducted so far, it has been demonstrated that myricetin alone 
inactivates the Cu,Zn SOD activity, Cu(II) alone activate the Cu,Zn SOD while the 
same metal ion in combination with myricetin increases the percent inactivation of 
the enzyme. The role of other metal ions in such type of interactions is not known. 
We have performed an experiment, in which the Cu,Zn SOD was allowed to 
interact with myricetin in combination with Fe(IIl), Cd(Il) and Mn(ll). The results 
are shown in Figure 21. As shown in the figure, among the metal ions used for this 
study, iron was the one which maximally inactivated the Cu,Zn SOD activity while 
the other metal ions at the same concentration as well as under similar conditions 
partially inactivated the enzyme. The Cu,Zn SOD activity was completely lost in 
presence of myricetin and Fe(lII) while the cadmium and manganese remained 
ineffective in presence of myricetin. The SDS polyacrylamide gel electrophoretic 
pattern of the samples of Cu,Zn SOD treated with myricetin in presence and 
absence of Fe(III) and Mn(II) is shown in Figure 22 and Figure 23 respectively. 
As evident from figure 22 ,lmM Fe (III) alone caused considerable fragmentation 
of Cu,Zn SOD while in presence of ImM myricetin there was a 
complete fragmentation of the enzyme as suggested by the faint band in lane e. 
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FigureZO Formation of Myricetin-Cu (II) complex and their interaction with 
Cu,Zn SOD. 
In a total reaction volume of 300(.ii, O.SmM myricetin was incubated vvitii 
varying concentrations of CuCl2 (0-1000|iM) for 18 hours at 4"C. In the 
control set of myricetin, volume of CuClj was replaced by 1.5mM 
potassium phosphate buffer pH 6.8. The samples were ccntrifuged briefly 
and equal volumes of the supernatant from each sample (~ 0.1 mM 
myricetin in the control set) were incubated with 7.5|aM Cu,Zn SOD for 3 
hours at 37"C and Cu,Zn SOD activity was determined. The value of equal 
concentrations of Cu,Zn SOD without the supernatant was taken as 100% 
for calculating the percent remaining activity in each sample. These values 
represent the average of at least three independent experiments performed 
in duplicates. 
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FigureZl Interaction of Cu,Zn SOD with niyricetin in presence of different metal 
ions. 
The separate reaction mixtures containing 7.5|.tM Cu,Zn SOD were 
incubated with different metal ions at a final concentration of ImM each in 
presence and absence of ImM myricetin. The incubation was carried out at 
37°C for 3 hours. After the incubation period was over, activity of Cu,Zn 
SOD was determined in a suitable volume of aliquots. 
A - 1. Cu.Zn SOD control 2. Cu,Zn SOD + ImM myricetin 
B - 1, Cu,Zn SOD control 2. CiuZn SOD + MnCf 3. Cu,Zn SOD + MnCl., + myricetin 
C - 1. Cu.Zn SOD control 2. Cu,Zn SOD + CdClj 3, Cu,Zn SOD + CdClj + myncctm 
D - 1. Cu,Zn SOD control 2. Cu,Zn SOD + CuCl2 3.Cu,Zn SOD + CuCI. + mynccUn 
E - 1. Cu.Zn SOD control 2. Cu,Zn SOD + FeCl., 3. Cu,Zn SOD + FcCl, + myricetin 
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Figure22 SDS-Gel Electrophoretic pattern of Cu,Zn SOD treated with myricetin 
in presence and absence of Fe(IIJ). 
7.5|.iM Cu,Zn SOD was incubated with ImM Fe(IIl) in absence and 
presence of ImM myricetin for 3 hours at 37°C. After the mcubation 
period, proper aliquots were loaded on 12.5% SDS-PAGE, Staining was 
done by silver nitrate as described in the text. 
a - Marker protem 
b Cu,Zn SOD control 
c - Cu,Zn SOD treated with myricetin 
d - Cu, Zn SOD treated with Fe(III) alone 
e - Cu, Zn SOD treated with myricetin in presence of Fe(III) 
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From the results of Figure 23 it is suggested that there was no change in the 
electrophoretic pattern of Cu,Zn SOD either treated with MnCh alone or in 
combination with myncetin. 
In order to study the possible interaction of myricetin with Fe(lll), an 
experiment was performed in which different concentrations of Fe(ni) were 
incubated with a fixed concentration of myricetin prior to the incubation with 
Cu,Zn SOD. As shown in Figure 24, when Fe(II[) was incubated with myricetin 
for 18 hours, and then supernatant (^ 0.1 mM myricetin in the control set )of each 
sample was incubated with Cu,Zn SOD, there was a gradual decrease in the 
percent inactivation of the enzyme indicating that almost all of the myricetin was 
used up in forming the complex with Fe(III) and free myricetin was not available 
to interact with Cu,Zn SOD and cause inactivation. The same protocol was also 
followed to determine the interaction of myricetin with another metal ion, Mn(n), 
in this experiment, a fixed concentration of myricetin (0.5mM) was incubated with 
vai7ing concentrations of Mn(II) (0-1000|.iM) for 18 hours at 4"C. After the 
incubation period, the supernatants from these samples were incubated with Cu,Zn 
SOD and no restoration of Cu,Zn SOD activity was achieved (Figure 25). This 
suggests that unlike Cu(ll) and Fe(Ill), IVln(Il)-myricetin complex contributes in 
further inactivation of the Cu,Zn SOD. 
Quercetin - Cu,Zn SOD 
Quercetin is a flavonol present in vegetables, fruit skins, onions etc. It works as an 
antioxidant by scavenging the free radicals and hence prevents the damage caused 
by them. Quercetin offers a variety of potential therapeutic uses, primarily in the 
prevention and treatment of allergies, asthma, hayfever and hives. In order to study 
the interaction of Cu,Zn SOD with quercetin, we have carried out certain 
preliminary studies where, the enzyme (Cu,Zn SOD) was incubated with varying 
concentrations of quercetin in presence and absence of Cu(II) for different time 
intervals ( 3 hours and 18 hours) separately at 37°C. As shown in Figure 26, 
with increasing concentrations of quercetin, in the absence of Cu (II) there was an 
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Figure23 SDS-Gel Electrophoretic pattern of Cu,Zn SOD treated with myricetin 
in presence and absence of Mn(II). 
7.5|j.M Cu,Zn SOD was treated with ImM myricetin in absence and 
presence of Mn(ll) at a final concentration of ImM and incubated for 3 
iiours at 37°C. After the incubation period was over, samples were subject 
SDS polyacrylamide gel electrophoresis and staining was done by silver 
nitrate. 
a - Marker protein 
b - Control Cu,Zn SOD control 
c - Cu,Zn SOD treated with myricetin 
d - Cu,Zn SOD treated with Mn(ll) 
e - Cu,Zn SOD treated with myricetin in presence of Mn(Il) 
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Figure24 Formation of myricetin-Fe(III) complex and their interaction with 
Cu,Zn SOD. 
In a total reaction volume of 300|a,l, O.SmM myricetin was incubated with 
varying concentrations of FeCb (0-1000|iM) for 18 hours at 4°C. In the 
control set of myricetin, volume of FeCI:^  was replaced by I.5mlVI 
potassium phosphate buffer pH 6.8. The samples were centrifuged briefly 
and equal volumes (~ 0.1 mM myricetin in the control set) were incubated 
with 7.5(.iM Cu,Zn SOD for 3 hours at 37°C and Cu,Zn SOD activity was 
determined. The value of equal concentrations of Cu,Zn SOD without the 
supernatant was taken as 100% for calculating the percent remaining 
activity in each sample. These values represent the average of at least three 
independent experiments performed in duplicates. 
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Figure25 Formation of Myricetin-Mn(n) complex and their interaction with 
Cu,Zn SOD. 
In a total reaction volume of 300^.1, 0.5mM myricetin was incubated with 
varying concentrations of MnCU (0-1000|j.M) for 18 hours at 4"C. In a 
control set of myricetin, volume of MnCl2 was replaced by 1.5mJVl 
potassium phosphate buffer pH 6.8. The samples were centrifuged briefly 
and equal volumes of the supernatant from each sample (~ 0 ImJVl 
myricetin in the control set) were incubated with 7.5|iM Cu,Zn SOD for 3 
hours at 37"C and Cu,Zn SOD activity was determined. The value of equal 
concentrations of Cu,Zn SOD without supernatant was taken as 100% for 
calculating the percent remaining activity in each sample. These values 
represent the average of at least three independent experiments performed 
in duplicates. 
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Figure26 Interaction of Cu,Zn SOD with quercetin in presence and absence of 
Cu(II). 
In a reaction volume of 33|il, 7.5\iM Cu,Zn SOD was treated with varying 
concentrations of quercetin (50-500|j.M) in presence and absence of ImM 
CuCh for 3 hours at 37°C. After the incubation period, proper ahquots were 
withdrawn for determining Cu,Zn SOD activity. Control Cu,Zn SOD 
(without quercetin and copper) was also incubated under similar conditions 
and considered to have 100% activity . Calculations of treated sets were 
compared with the control set. 
• Cu,Zn SOD treated with quercetin in absence of ImM Cu(II). 
• Cu,Zn SOD treated with quercetin in presence of ImM Cu(ll). 
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activation of Cu,Zn SOD activity. Incubation of enzyme with quercetin in 
presence of Cu(II) resulted in a significant decrease in the activity of Cu,Zn SOD 
and that the decrease was time dependent( Figures 26 and 27). 
SDS-gel electrophoretic pattern of the above samples incubated for 3 hours 
and 18 hours are shown m Figure 28 and Figure 29 respectively. As shown m 
figure 28, when the incubation of Cu,Zn SOD was done with .SOO|.iM quercetin, in 
presence and absence of Cu(II) for 3 hours at 37°C, there was no degradation of the 
protein. Incubation of the above samples for 18 hours under same conditions 
caused complete fragmentation of Cu,Zn SOD treated with 500nM quercetin in 
presence of Cu(II) as depicted by lane d (Figure 29). 
Spectral studies on quercetin- Cu,Zn SOD complex 
Interaction of quercetin with Cu,Zn SOD was also studied by the UV/visible 
absorption spectroscopy and fluorescence spectroscopy. Figure 30 shows an 
absorption spectra of untreated, Cu,Zn SOD and quercetin treated, dialyzed Cu,Zn 
SOD. As depicted from the figure, the untreated Cu,Zn SOD gives a major peak at 
205nm and a minor peak at 270nm. A hypsochroniic and hypochromic shift was 
obsepv'ed in case of Cu,Zn SOD treated with quercetin as compared to that of the 
control untreated Cu,Zn SOD. Intrinsic fluorescence of the dialyzed treated and 
untreated Cu,Zn SOD is shown in Figure 31. As it is clear from the figure, the 
emission spectra obtained for untreated/native Cu,Zn SOD gives emission 
maximum at 292nm, when excited at 280nm. Treatment with quercetin caused a 
Inm blue shift of the emission maximum with a drastic increase in the intensity of 
fluorescence. 
Rutin - Cu,Zn SOD 
Studies on the interaction of rutin and Cu,Zn SOD were also conducted in order to 
find out whether rutin modulates the Cu,Zn SOD activity. The effect of increasing 
concentrations (SO-SOOpM) in presence and absence of copper for different 
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Figure27 Interaction of Quercetin with Cu,Zn SOD in presence and absence of 
Cu(II) 
The reaction mixtures containing T.S i^M Cu,Zn SOD were incubated with 
varying concentrations of quercetin (50-500|iM ) in presence and absence 
of Cu(ll) for 18 hours at 37°C. After the incubation period suitable aliquots 
were withdrawn to determine the activity of Cu,Zn SOD, considering that 
control Cu,Zn SOD has 100 percent activity. 
• Cu,Zn SOD treated with quercetin m absence of ImM Cu(ll). 
• Cu,Zn SOD treated with quercetm m presence of ImM Cu(ll). 
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Figure28 SDS-PoIyaci-ylamide gel electrophoresis of Cu,Zn SOD samples treated 
with quercetin in presence and absence of Cu(II). 
Reaction mixtures of 33(il, containing 7.5(iM Cu,Zn SOD was treated with 
500(j.M quercetin in presence and absence of ImM CuCb and incubated for 
3 hours at 37°C. The aliquots {- 4\xg) were withdrawn from each sample, 
after the incubation period the samples were subjected to 12.5% SDS 
PAGE. The gel was stained by silver staining method as described in the 
text. 
a - Marker protein 
b - Cu,Zn SOD control 
c - Cu,Zn SOD treated with quercetin 
d - Cu,Zn SOD treated with quercetin in presence of Cu(II), 
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Figure29 SDS-Polyaciylamide gel electrophoresis of Cu,Zn SOD treated with 
quercetin in presence and absence of Cu(n). 
A total reaction volume of 33(il, containing 7.5|j,M Cu,Zn SOD was treated 
with 500|iM quercetin in presence and absence of ImM CuCb was 
incubated for 18 hours at 37°C. As the incubation period was over, proper 
volumes from the reaction mixtures were withdrawn (~ 4|j,g protein) and 
loaded on the gel (12.5% SDS-PAGE). Staining was done by silver nitrate. 
a - Marker protein 
b - Cu,Zn SOD control 
c - Cu,Zn SOD treated with quercetin 
d - Cu,Zn SOD treated with quercetin in presence of Cu(II). 
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FigureSO UVA^IS spectroscopy of interaction of Cu,Zn SOD with quercetin 
The reaction mixture containing 7.5|a.M Cu,Zn SOD and 500|j.M quercetin 
was incubated at 37"C for 3 hours. Control sets were also run in which only 
Cu,Zn SOD and quercetin was present at the same concentration and 
incubated under similar conditions. The total volume was compensated with 
1.5mM potassium phosphate buffer, pH 6.8. After the incubation was over 
the reaction mixtures were extensively dialyzed against 1.5mM potassium 
phosphate buffer, pH 6.8. Proper aliquots (~ 56|j.g/ml protein) from each 
reaction mixture was used for spectral analysis. 
Cu,Zn SOD control ( ) 
Cu,Zn SOD treated with Quercetin ( ) 
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Figure31 Changes in the fluorescence spectra of Cu,Zn SOD after interaction 
with quercetin. 
Reaction mixture containing 7.5|.iM Cu,Zn SOD was incubated with 
500(j,M quercetin at 37°C for 3 hours. Control sets containing quercetin and 
Cu,Zn SOD alone at same concentrations were also incubated under similar 
conditions Total volume in the control sets was compensated with LSrnM 
potassium phosphate buffer, pH 6.8. After the incubation period was over, 
the reaction mixtures were extensively dialyzed against I.5mM potassium 
phosphate buffer, pH 6.8. Proper aliquots (~ 56|.ig protein/ml) were 
withdrawn from each sample and used for takmg the spectra The excitation 
wavelength was 280nm and scanning wavelength range was 250nm-400nm. 
1. Cu,Zn SOD control 
2. Cu,Zn SOD treated with quercetin 
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durations at 37°C as shown in figures 32 and 33.There was an activation of Cu,Zn 
SOD activity in presence of rutin. While an insignificant inactivation was observed 
when Cu,7.n SOD was incubated with rutin in presence of Cu(Il) for a period of 3 
hours (Figure 32). The rutin induced inactivation of Cu,Zn SOD activity in 
presence of Cu(ll) was significantly enhanced when incubation period was 18 
hours (Figure 33). 
The SDS polyacrylamide gel electrophoretic patterns of rutin treated Cu,Zn 
SOD under different conditions are shown in figures 34 and 35. No difference was 
found in the electrophoretic pattern of rutin treated Cu,Zn SOD in presence and 
absence of Cu(II) incubated for 3 hours and 1 8 hours at 37°C, 
Spectral studies on rutin- Cu,Zn SOD complex 
The interaction of Cu,Zn SOD and rutin was flirther confirmed by different 
spectral studies. Figure 36, shows the absorption spectra of untreated dialyzed 
Cu,Zn SOD control as well as natin treated Cu,Zn SOD. A major peak at 205nm 
and a minor peak at 270nm was given by control Cu,Zn SOD while the rutin 
treated. Cu,Zn SOD shows a 7nm hypsochromic and hypochromic shift in the 
major peak. 
The intrinsic fluorescence spectra of the above samples is shown in 
Figure37. Control Cu,Zn SOD was chracterized by the emission maximum at 
294nm when excited at 280nin, treatment with 1 mM rutin caused a 2nm blue shift 
in the emission spectrum and 6% decrease in the intensity of the tluorescence. 
Naringenin - Cu,Zn SOD 
Another flavonoid selected for these studies was naringenin abundantly present in 
tomatoes, grapes and citrus fruits. The Cu,Zn SOD was treated with increasing 
concentrations of naringenin in presence and absence of exogenous copper 
When the reaction mixtures were incubated at 37" C for 3 hours, there was a dose 
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Figure32 Interaction of Cu,Zn SOD with rutin in presence and absence of 
Cu(II). 
In a total reaction volume of 33|j.l, 7.5|iM Cu,Zn SOD was treated with 
different concentrations of rutin (50-500i,iM) in presence and absence of 
Cu(ll) for 3 hours at 37"C. Control Cu,Zn SOD (without rutin and copper) 
prepared in 1.5mM potassium phosphate buffer, pH 6.8 was also incubated 
under similar conditions. After the incubation period, suitable volume of the 
aliquots were withdrawn to determine Cu,Zn SOD activity. Activity of 
control Cu,Zn SOD was considered as 100 percent. 
• Cu,Zn SOD treated with rutin in absence of ImM Cu(II). 
• Cu,Zn SOD treated with rutin in presence of ImM Cu(Il) 
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Figure33 Effect of rutin on Cu,Zn SOD activity in presence and absence of 
Cu(II). 
Reaction mixtures, containing 7.5(iM Cu,Zn SOD and varying 
concentrations of rutin (50-500 \iM ) were incubated at 37"C for 18 hours. 
After the incubation was over, suitable volume of the aliquots were 
withdrawn and Cu,Zn SOD activity was determmed. 
• Cu,Zn SOD treated with rutin in absence of ImM Cu(II). 
• Cu,Zn SOD treated with rutin in presence of ImM Cu(II). 
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Figure34 SDS-polyacrylamide gel electrophoresis of Cu,Zn SOD treated with 
rutin in presence and absence of Cu(II) 
7.5nM Cu,Zn SOD was treated with 500|iM mtin in presence and absence 
of ImM CuCb for 3 hours at 37°C. After the incubation period, proper 
volume of the ahquots were withdrawn (~ 4(ig protein) and loaded on the 
SDS-PAGE The staining was done by silver nitrate as described in the text 
a - Marker protein 
b - Cu,Zn SOD control 
c - Cu,Zn SOD treated with rutin alone 
d - Cu,Zn SOD treated with rutin in presence of Cu(ll) 
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Figure35 SDS-polyaciylamide gel electrophoretic pattern of rutin treated Cu,Zn 
SOD in presence and absence of Cu(Il). 
A total reaction volume of 33|j,l, containing 7.5|j.M Cu,Zn SOD was treated 
with rutin (500|aM mtin) in presence and absence of ImM Cu(II) and 
incubated for 18 hours at 37"C. After the incubation period was over 
suitable aliquots were withdrawn (~ 4|j.g protein) and subjected to SDS-
PAGE, finally the gel was stained by silver nitrate as explained in the text, 
a - Marker protein 
b - Cu,Zn SOD control 
c - Cu.Zn SOD treated with rutin alone 
d - Cu,Zn SOD treated with rutin in presence of Cu(II) 
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Figure36 Absorption spectra of Cu,Zn SOD treated with rutin. 
The reaction mixture containing 500|j,M rutin and 7.5|aM Cu,Zn SOD was 
incubated at 37°C for 3 hrs. The control sets containing ImM rutin and 
7.5)j.M Cu,Zn SOD were prepared in 1.5mM potassium phosphate buffer 
pH 6.8 and incubated under similar conditions. After the incubation period 
the reaction mixtures were dialyzed extensively against 1.5mM potassium 
phosphate buffer pH 6.8 and proper aliquots from the dialyzed samples 
equivalent to (56|j.g/ml) protein were used for taking the spectra. 
Cu,Zn SOD control( ) 
Cu,Zn SOD treated with rutin ( ) 
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Figure37 Fluorescence spectral analysis of interaction of Cu,Zn SOD with rutin. 
Total reaction volume of 400fal, containing 7.5|al Cu,Zn SOD and 500|.iM 
rutin was incubated at 37"C tor 3 hours. Control sets containing 7,5JLIM 
Cu,Zn SOD alone and 500(iM rutin alone, prepared in 1.5mM potassium 
phosphate buffer pH 6 8 were also incubated under similar conditions After 
the incubation time was over, the reaction mixtures were dialyzed 
extensively against 1.5mM potassium phosphate buffer, pH 6.8. Suitable 
volumes of dialyzates were withdrawn (~ 56|ig protein/m!) and used for 
spectral analysis. 
1. Cu,Zn SOD control 
2. Cu,Zn SOD treated with rutin 
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dependent decrease in the activity of Cu,Zn SOD in presence of naringenin alone, 
while a fijrther decrease in the activity was observed in presence of naringenin and 
Cu(II) (Figure 38). Almost a similar pattern was observed when the reaction 
mixtures were incubated for a longer durations As shown in Figure 39, when 
Cu,Zn SOD was incubated with naringenin alone for 18 hours at 37"C, a dose 
dependent decrease in the enzyme activity was observed which was further 
decreased when Cu,Zn SOD was treated with naringenin in presence of ImM 
CuCl2 
The reaction mixtures containing Cu,Zn SOD treated with 500|_iM 
naringenin in presence and absence of ImM CuCh were incubated at 37"C for 3 
hours and 18 hours separately and subjected to SDS polyaci^lamide gel 
electrophoresis. Figure 40, shows the electrophoretic pattern of the samples 
incubated at 37°C for 3 hours. A decrease in the band intensity of Cu,Zn SOD 
treated with naringenin in presence of ImM Cu(ll) was observed (lane d). Figure 
41, shows the gel pattern of Cu,Zn SOD samples treated under identical conditions 
for the duration of 18 hours. Almost similar band pattern was observed in all 
samples (lane b-d ). 
Spectral studies on naringenin- Cu,Zn SOD complex 
The absorption spectra of dialyzed samples of untreated and naringenin treated 
Cu,Zn SOD is given in Figure 42. As shown in the figure, the major and minor 
peaks of control Cu,Zn SOD were obsei'ved at 205nm and 270nm respectively. In 
case of naringenin treated Cu,Zn SOD, there was again a hypsochromic shift both 
in major and minor peak while hypochromic shift was seen in major peak only. 
The fluorescence emission spectra of the above samples are given in Figure 43 . 
The emission of control Cu,Zn SOD shows /l„,ax at 295nm when excited at 280nm 
while the naringenin treated Cu,Zn SOD showed a blue shift of 5nm and an 
increase in the fluorescence intensity 
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Figiiie38 Effect of naringeiiin on Cii,Zn SOD activity in presence and absence of 
Cu(II). 
Cu,Zn SOD at a final concentration of 7,5f.iM was incubated with varying 
concentrations of naringenin (50-500(j.M) in presence and absence of ImM 
Cu(II) for 3 hours at 37°C. After the incubation was over, suitable volume 
of the aliquots were withdrawn and Cu,Zn SOD activity was determined. 
Similar concentration of Cu,Zn SOD prepared in buffer only (I.5mM 
potassium phosphate buffer pH 6.8) was also incubated under similar 
conditions. 
(•) Cu,Zn SOD treated with naringenin alone. 
(•) Cu,Zn SOD traeted with naringenin in presence of CuCh 
105 
120 
100 
o 
CD 
Ol 
C 
' c 
'ro 
E 
0) 
'c 
01 
o 
I 
a) 
Q. 
40 
20 
100 200 300 400 
Concentration of Naringenin(pM) 
500 600 
Figure39 EfTect of naringeiiin on Cu,Zn SOD activity in presence and absence of 
Cu(n). 
A total reaction volume of 33|al,containing 7.3|j.M Cu,Zn SOD was treated 
with varying concentrations of naringenin (50-500)aM) in presence and 
absence of ImM CuCh and incubated for 18 hours at 37"C. An enzyme 
control, containing 7.5|j.M Cu,Zn SOD in l.SmM, potassium phosphate 
buffer, pH 6.8 only was also incubated under similar conditions. After the 
incubation period was over, suitable aliquots were withdrawn and Cu,Zn 
SOD activity was determined. 
(•) Cu,Zn SOD treated with naringenin alone 
(•) Cu,Zn SOD traeted with naringenin in presence of Cu(II) 
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Figure40 SDS-Gel electrophoretic pattern of Cu,Zn SOD incubated with 
naringenin in presence and absence of (iu(II). 
7.5|.iM Cu,Zn SOD, treated with 500(.iM naringenin in presence and 
absence of ImM CuCb was incubated for 3 hrs at 37°C. Proper volumes of 
the aliquots were withdrawn (~ 4|ag protein) and analyzed on SDS 
polyacrylamide gel. 
a - Marker protein 
b - Cu,Zn SOD Control 
c - Cu,Zn SOD treated with naringenin 
d - Cu, Zn SOD treated with naringenin in presence of Cu(Il) 
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Figurc41 SDS-Gel electrophoretic pattern of Cu,Zn SOD incubated with 
naringenin in presence and absence of Cu(II). 
In a total reaction volume of 33|J.1, 7.5|J.M Cu,Zn SOD was incubated with 
500|J.M naringenin in presence and absence of ImM CuCl2 for 18 hours at 
37'^ C. Suitable volumes (~ 4|ag protein) from each sample were analyzed on 
SDS Pohacrylamide gel. 
a - Marker protein 
b - Cu,Zn SOD control 
c - Cu,Zn SOD treated with naringenin 
d - Cu.Zn SOD treated with naringenin and Cu(ll) 
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Figure42 UVA^isible spectra of Cu,Zn SOD treated with Naringenin 
Total reaction volume of 400|il, containing 7.5(iM Cu,Zn SOD and 500|j.M 
naringenin was incubated at 37"C for 3 hours. The control set of Cu,Zn 
SOD alone, was also incubated under similar conditions. The reaction 
volume, in the control set was compensated by the 1.5mM potassium 
phosphate buffer, pH 6.8. After the mcubation period was over, the reaction 
mixtures were extensively dialyzed against 1.5mM potassium phosphate 
buffer, pH 6.8. Suitable volumes of the reaction mixtures were withdrawn 
(~ 56|.rg protein per ml) and spectra was recorded. 
Cu,Zn SOD control. ( ) 
Cu,Zn SOD treated with narmgenin ( ) 
109 
200 300 400 
WAVELENGTH(nm) 
500 600 
Figure43 Fluorescence emission spectra of Cu,Zn SOD treated with naringenin. 
Reaction mixtures containing 7.5|iM Cu,Zn SOD was incubated with 
500|j,M naringenin at 37°C for 3 iiours control set of naringenin and Cu,Zn 
SOD alone, were also incubated under similar conditions. The volume of 
the control sets was compensated by 1.5mM potassium phosphate buffer, 
pH 6.8. After the incubation period was over, the reaction sets were 
extensively dialyzed against 1.5mM potassium phosphate buffer, pH 6.8. 
Proper aliquots (~ 56|j,g protein/ml) were withdrawn from each sample and 
used for spectral study. The excitation wavelength was 280nm whereas 
scanning of the spectra was done at 250-400nm. 
1. Cu,Zn SOD control 
2, Cu,Zn SOD treated with naringenin 
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/// Vivo Studies 
The /// vi^-(j studies were also carried out where myricetin and quercetin were 
injected into the mice and the hver homogenates were used for measuring Cu,Zn 
SOD activity. The resuhs are shown in figures 44-47. As evident from the figures 
there was a 40% decrease in Cu,Zn SOD activity in myricetin treated mice (Figure 
44), while slight activation was observed in case of samples obtained from 
quercetin treated mice (Figure 46), when compared with control samples. When 
the Cu,Zn SOD activity staining was done after native polyacrylamide gel 
electrophoresis, the above samples, a corelation with the activity pattern was 
obtained. 
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Figure45 Activity staining of myricetin treated Cu,Zn SOD from mice liver 
homogenate. 
Control and myricetin treated mice liver homogenates were electrophoresed 
on 7.5% native polyacrylamide gel and the activity was stained as described 
in the text. 
a- Control Cu,Zn SOD 
b- Control mice liver homogenate 
c- Control mice liver homogenate 
d- myricetin treated mice liver homogenate 
e- myricetin treated mice liver homogenate 
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Figure46 Effect of quercetin on mice liver Cu,Zn Superoxide dismutase. 
Treated groups of mice were injected intraperitoneally with 0.3 mg 
quercetin dissolved in 0.5ml of ethanol while the control groups were 
injected with equal volume of ethanol. Mice were sacrificed after 3 hours of 
injection ,liver tissues were perftised and its homogenate was used for 
determining Cu,Zn SOD activity. 
!. Control mice liver homogenate 
2. Quercetm treated mice liver homogenate. 
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Figure47 Activity staining of Cu,Zn SOD from mice liver treated with 
quercetin 
Control and quercetin treated mice liver homogenates were 
electrophoresed on native 7,5% polyacrylamide gel and the activity was 
stained by the procedure described in the text. 
a- Control Cu,Zn SOD 
b- Control mice liver homogenate 
c- Control mice liver homogenate 
d- Quercetin treated mice liver homogenate 
e- Quercetin treated mice liver homogenate 
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DISCUSSION 
Oxygen radicals are among the most recognized and widely investigated mediators 
of cell damage (Kehrer 1993). Chemical species such as superoxide (O2'), 
hydrogen peroxide (H2O2), hydroxyl radical (OH'), and nitric oxide (NO) derived 
from incomplete reduction of molecular oxygen are highly reactive toward key 
constituents of living cells, including DNA, proteins and lipids. Genotoxicity, 
protein denaturation, compromised enzymatic activities, and lipid peroxidation all 
represent consequences of cell exposure to excess amounts of ROS, a condition 
usually indicated as oxidative stress. Both exogenous oxygen radicals and oxygen 
species endogenously derived as a byproduct of mitochondrial respiration, daig 
metabolism, or any other intracellular redox reaction can exert deleterious effects 
on cell function and viability, depending on cellular antioxidant defenses and 
capability to repair oxidative damage (Galeotti, el a/., 1990). Accordingly, a role 
for ROS has been postulated in the genesis of a large number of human and 
experimental pathological processes, including chronic inflammation, 
neurodegeneration, tissue aging and cancer (Berlett and Stadtman, 1997; Sun, 
1990). Superoxide dismutase (Mc.Cord and Fridovich, 1969) is widely distributed 
in living organisms from the bacteria to the higher eukaryotes (Beyer cf a/., 1991; 
Gralla and Kosman, 1992), which catalyzes the conversion of single electron 
reduced species of molecular oxygen to hydrogen peroxide and oxygen. The 
widely distributed copper enzyme, Cu,Zn superoxide dismutase (Cu,Zn SOD) 
contributes 90% of the total SOD and has a great physiological significance as well 
as therapeutic potential ( Danel, et al.^ 1998; Koksoy, el a/., 1997; Ma, et a/., 1998) 
Its role has been investigated in various specific disorders of RBC such as 
iron deficiency anemia, oxidative hemolytic anemia, thalassemia, sickle cell 
anemia, molecular dystrophy and cystic fibrosis. In recent studies SOD has also 
been shown to be associated with dengue fever, post cholecystectomy pain 
syndrome, malign breast disease, steroid sensitive nephrotic syndrome and 
amyotrophic lateral sclerosis. In rheumatoid arthintis, ischemic injury and cancer, 
SOD activity shows a considerable increase suggesting the superoxide related 
pathology and great potential of SOD in these diseases (Afrasyap, ef a/., 1998, 
Kruman, et a!., 1999; Ray, et al., 1999). 
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The Cu,Zn SOD is a cytosolic enzyme containing two moles of copper and 
zinc per mole of a holoenzyme and its activity is dependent on the availability of 
copper (Hodgson and Fridovich, 1973; Brown and Besinger, 1998). Earlier studies 
give a clear indication that agents which capture Cu(ll) from the enzyme molecule 
resulted in complete loss of its biological activity suggesting that reduction of 
Cu(II) is necessary for the inactivation of enzyme (Brown and Besinger, 1998). 
There is a strong evidence that prion diseases are characterized by 
neurodegeneration, gliosis and accumulation of extracellular deposits of abnormal 
isoform of prion proteins. These prion proteins bind to Cu(II) and modulate Cu,Zn 
SOD activity and consequendy, cellular resistance to oxidative stress (Brown and 
Besinger, 1998). 
Flavonoids are widely distributed in plants, including many crop species, 
and are anti-oxidants (Bors, et al., 1990), Furthermore, it is well established that, in 
presence of Cu(II) and to a lesser extent Fe(III), and oxygen, the flavonoid 
quercetin generates breaks in DNA and that the reaction involves the transient 
reduction of Cu(II) to Cu(I) (Rahman, et a/., 1989). Of the active oxygen species 
involved in the reaction, the damage to DNA is caused by the OH" radical and an 
intermediate C4' radical of deoxyribose moieties is formed (Fazal, et a)., 1990). In 
the case of the reaction with Cu(II) and quercetin, the OH" radical is generated 
primarily by the Fenton reaction (Fazal, et a/., 1990), a Cu(ll) - quercetin charge 
transfer complex is formed (Rahman et a/., 1990) and DNA, quercetin and Cu(Il) 
form a ternary complex (Fazal, et al., 1990). Similar reactions are found with other 
flavonoids (Rahman, et al., 1989; Said Ahmad, et al., 1992). The quercetin and 
other flavonoids are also able to bind to a protein and Cu(II) mediate the 
fragmentation of the protein (Said Ahmad, et al, 1994). By considering the all 
above mentioned facts, we have aimed to determine whether Cu(II) of Cu,Zn SOD 
can be mobilized by dietary polyphenolic compounds. Such depletion of Cu,Zn 
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SOD activity, may have implications in several diseases where absence of SOD 
has been considered to be a major cause. It is also aimed to determme whether 
such mobilization of Cu(ll) from Cu,Zn SOD by polyphenols/flavonoids itself 
leads to the generation of reactive oxygen species (ROS). 
In order to investigate the interaction of Cu,Zn SOD with flavonoids, we 
have selected the Cu,Zn SOD obtained from bovine liver. In order to get the 
unique properties of Cu,Zn SOD we have carried out some stability experiments. A 
remarkably high thermal stability of Cu,Zn SOD has been achieved as evident by 
the results of Figure 6 and 7. Generally, Cu,Zn SOD is known to have a very stable 
three dimensional structure and to show unusually high thermal stability (Tainer, et 
al., 1982; Roe, et a!., 1988). It is suggested that hydrophobic regions of the protein 
might play especially important role in its thermal stability (Mozhaev, 1993). The 
active site metals, which could easily be displaced by the chelating agents, were 
found to enhance the thermal stability especially in dimeric Cu,Zn superoxide 
dismutases (Battistoni e/ al., 1998), 
The major objective of the present investigations, is to carry out the 
interaction of certain dietary flavonoids with Cu,Zn SOD which have the ability to 
interact with metal ions (Fernandez, et a/., 2002; Kuo, et a/., 1998). It could be 
presumed that Cu(II) of Cu,Zn SOD might mvolved in such type of interactions. In 
order to confirm the possibility of metal chelation of Cu,Zn SOD, a known metal 
chelating agent 1,10 phenanthroline (OP) has been taken into consideration for its 
interaction with Cu.Zn SOD. The partial inactivation of Cu,Zn SOD in the 
presence of OP could be explained on the basis of formation of Cu'(0P)2 complex 
indicating that metal chelating agents are bound not only with free copper but are 
effective in binding with Cu'^ ^ in bound form (Table 6). Wolfe, et al (1994) have 
reported the inhibition of dexamethasone and etoposide-induced apoptosis in the 
presence of OP by a mechanism involving Cu^^. While in another study, Lewis and 
Laemmli (1962) have confirmed the affinity of OP with Cu^' as well as the 
mechanism of DNA fragmentation in presence of OP by involving Cu^' (Wolfe, et 
al, 1994; Lewis and Laemmli, 1962). George, et al. (1987) have demonstrated that 
there is a copper dependent OH' radical formation in the presence of OP which was 
enhanced by adding ascorbate and hydrogen peroxide. In our studies there is no 
direct evidence to confirm the possibiUty of OH' radical generation in presence of 
Cu' ' and OP leading to the inactivation of Cu,Zn SOD. However, the recovery of 
Cu,Zn SOD activity in presence of uric acid, OP and Cu^^ might be either due to 
hydroxy! radical scavenging property of uric acid or prevention of Cu^* chelation 
with 1, 10 phenanthroline. Howell and Wyngaarden (1960) have shown that OH' 
radical generated by H2O2 plus either FeS04 or UV light are scavenged by urate. 
Earlier studies have shown that uric acid inhibits L-DOPA-Cu(Il) mediated DNA 
cleavage and quenches OH' radical production (Singh, el al.^ 1998). 
Myricetin is a natural bioflavonoid, commonly found in medicinal plants, 
fruits, berries, tea and wine. It has anti-inflammatory activity (Hiermann, el aL, 
1998), and its therapeutic potential includes its role as an anticarcinogenic agent 
(Hertog, el al., 1993), antiviral and antimicrobial agent (Ono, el a/., 1990; 
elGammal and Mansour, 1996) and in the prevention of platelet aggregation 
(Landolfi, el al., 1984). It has been demonstrated to possess both antioxidative and 
prooxidative properties (Ong and Khoo, 1997). Myricetin was also reported to 
enhance glucose transport in rat adipocytes without any effect on insulin receptor 
fijnctions and Glut 4 translocation. It is a potent anticacinogen and antimutagen, 
although it has been shown to promote mutagenesis with the use of the Ames Test 
(Ong and Khoo, 1997). In order to achieve our objective, of the present 
investigations, we have carried out the experiments involving the myricetin and an 
important radical scavenging cytosolic enzyme, Cu,Zn SOD. The different 
experimental protocols for interaction of myricetin with Cu, Zn SOD were carried 
out as described in the "Results" section and are shown in Tables 8-13 and Figures 
10-25. A significant decrease in the Cu,Zn SOD activity was observed at various 
concentrations of myricetin used in our experiments. The inactivation was time and 
concentration dependent, which was maximum at ImM concentration of myricetin 
incubated with the enzyme for 3 hours. Different flavonoids, including myricetin 
have been reported to inhibit several enzymes (Nagao, el al., 1999; Xu, ef al., 
2001; Murakami, et al., 1999). The effect of flavonoids on enzyme activity is 
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generally related to their structural properties. deGroot and Rauen (1998) have 
shown that flavonols possessing 7'OH and 3', 4' OH or 3', 4' 5' OH are effective 
inhibitors of certain enzymes which is in close agreement to our results. In order to 
find out the nature of Cu,Zn SOD inhibition by myricetin, the myricetin treated 
enzyme was dialyzed and activity was determined. The similar inactivation pattern 
of Cu,Zn SOD in the dialyzed and undialyzed myricetin treated samples suggested 
for irreversible nature of enzyme inactivation, which could not be recovered even 
after adding the free copper. Soulere, el al (2002) have also shown that catechol 
inhibited the Fe-SOD and Cu,Zn SOD and was irreversible in nature. With these 
findings it could be presumed that myricetin brings about some changes in the 
structure of Cu,Zn SOD either by chelating the copper or distorting its three 
dimensional conformation by the modification of certain essential amino acids. 
Cu,Zn SOD contams a binuclear cluster, with the active copper and zinc bridged 
by a common ligand (His 63). Copper is bound to the ligands, coordinated with His 
63, His 46, His 48 and His]20 in the active site of Cu,Zn SOD (Tainer, et al., 
1983). Thus It is suggested that copper binding sites were modified during the 
reaction of Cu,Zn SOD with myricetin. Auchere and Blandin (2002), have 
investigated the functional and structural effects of bovine Cu,ZnSOD oxidation by 
myeloperoxidase/ hydrogen peroxide and chloride systems. In their studies the 
complete enzyme inactivation was achieved and two arginine and five histidine 
residues per sub unit had disappeared. The conformation integrity of enzyme was 
so destroyed that zinc and copper became accessible from the outside to chelating 
agents. The results suggested that binding sites of Cu^^ and Zn^ * SOD are partly 
destroyed by treatment with HOCl. Indeed, four histidine residues have been 
known to locate at the active site channel and coordinate with Cu^ ^ and three 
histidine residues w ith Zn^" (Tainer, et al., 1982; Tainer et al., 1983; Getzoff e? al., 
1983). Oxidized histidine residues were not generated in the HOCl- oxidized 
Cu,Zn SOD. However, the concomitant decrease in histidine and arginine content 
and the partial liberation of Zn^ ^ and Cu2+ could not be ruled out. Jewett et al 
(1999), have demonstrated the inactivation of Cu,Zn SOD by certain azo 
compounds which was associated with the loss of histidine residues essential for 
Cu,Zn SOD activity. Melzig and Bormann (2000) have reported the inhibition of 
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metallopeptidases by flavonoids including myricetin. In their studies all inhibitory 
activities described were related to polyhydroxylated flavonoids. They have 
explained these interactions in terms of the generation of chelate complexes with 
the metal ions within the active site or by the formation of hydrogen bridges 
between the inhibitor molecule and amino acids near or at the active sites. Many 
other studies have confirmed that polyphenols are the potential compounds in 
chelating the transition metal ions, particularly those of iron and copper 
(Fernandez, et al., 2002; Van Acker, et af., 1996; Paganga, e/ a/., 1996). The above 
mentioned facts are proved by our findings where, Cu(ll) of Cu,Zn SOD is reduced 
to Cu(l) in the presence of myricetin (Fig 16). Other flavonoids such as quercetin 
also reduces Cu(Il) ion to Cu(l) ion and acting as a copper ion chehitor (Valko, 
1987). 
The ability of myricetin to chelate Cu(II) as well as other metal ions, was 
tested by selecting these metal ions in the free form as evident from the results of 
figures 20, 24 and 25 where a fixed concentration of myricetin was incubated with 
varying concentrations of Cu(II), Fe(III) and Mn(II) in order to form myricetin-
metal ion complexes. The supernatants from Cu(ll) and Fe(IIl)-myricetin 
complexes were ineffective for Cu,Zn SOD inactivation suggesting that no free 
myricetin was available which is responsible to chelate Cu(n) of Cu,Zn SOD. 
These results also indicated that myricetin is selective for metal ion binding as 
Mn(II) was unable to form complex with myricetin. The pharmacological effects 
of flavonoids are generally linked to the antioxidant properties either by 
suppressing reactive oxygen species(ROS) formation, by inhibiting some enzymes 
or by chelating trace elements especially copper and iron which are potential 
enhancers of ROS formation by Fenton and Haber Weiss reaction. Neverthless 
these metal ions are essential for many physiological functions as constituents of 
hemoproteins and cofactors of different enzymes such as cataiase (Fe), 
cemloplasmin (Cu), superoxide dismutase (Cu, Zn): enzymes involved in 
antioxidant defense. Such interactions of flavonoids with enzyme bound metal ions 
may produce deleterious effects by suppressing the activities of these enzymes and 
partly by generating the ROS, and these factors together may contribute in 
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propagation of the diseased conditions. On the basis of our findings , it can be 
presumed that Cu(II) of Cu,Zn SOD may be a potential target of myricetin under in 
vivo conditions, leading to the diseases associated with the involvement of Cu,Zn 
SOD. 
There are evidences to support for high plasma concentration of certain 
flavonoids such as quercetin after ingestion.Hollman, et al (1996), have shown that 
plasma level of quercetin was approximately 200ng/inl after 2.9 hours of ftavonoid 
intake. The potential health impacts of excessive ftavonoid intake have also been 
demonstrated by Skibola and Smith (2000). According to Skibola and Smith 
(2000), at higher doses , flanonoids may act as mutagens, prooxidants that generate 
free radicals, and as inhibitors of key enzymes involved in hormone metabolism. 
Thus in high doses, the adverse effects of flavonoids may outweigh their beneficial 
ones, and caution should be exercised in ingesting them at levels above that which 
would be obtained from typical vegetarian diet. The unborn fetus may be 
especially at risk, since flavonoids readily cross the placenta. 
From the studies of Cao, ei al (1997) and others, it has been shown that 
flavonoids acted as prooxidants when a transition metal ion was available. Inorder 
to investigate such possibilities, Cu,Zn SOD was interacted whh myricetin in 
presence of external copper. As evident from the results of table 13, the copper 
alone exihibited a significant activation of Cu,Zn SOD activity while in 
combination with myricetin,there was a gradual decrease in Cu,Zn SOD activity at 
increasing concentrations of Cu(II). The activation of Cu,Zn SOD in presence of 
copper alone has also been shown by Coudray, et al (1993). .After adding zinc or 
copper to the reaction mixture, it was found that zinc had no elTect on native 
Cu,Zn SOD ,it neither activated nor, above all, inhibited at high concentrations in 
contrast to observations with other zinc enzymes, such as alkaline phosphatase or 
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a-mannosidase (Koukay and Rapport, 1985 ).Copper caused an activation effect in 
native Cu,Zn SOD (Coudray, et al, 1993 ).The enhancement in the myricetin 
induced inactivation of Cu,Zn SOD was also supported by the studies of Sahu and 
Gray (1993). They have shown that myricetin induced concentration dependent 
nuclear DNA degradation concurrent with lipid peroxidation and these effects were 
enhanced by Fe(IlI) or Cu(ll). Catalase, superoxide dismutase, mannitol and 
sodium azide did not inhibit myricetin induced nuclear DNA damage in presence 
of Fe(Ill) or Cu(ll).Similar effects of catalase was observed in our studies as 
shown in Figure 17. Since catalase is a well known scavenger of H2O2 and OH' 
radical , the possibility of the generation of these radicals could easily be ruled out 
where myricetin was interacted with Cu,Zn SOD in presence of external copper. As 
uric acid is a proposed natural physiological antioxidant and is a classical radical 
scavenger (Maples and Mason, 1988) we examined the role of uric acid in the 
myricetin / Cu(II) mediated inactivation of Cu,Zn SOD (Figure 18). Reaction 
between uric acid and free radicals, generate a tautomeric urate radical anion with 
the unpaired electron shared between N'' and N ' (Maples and Mason, 1988) and the 
effects of uric acid vary from protein to protein: for example, lactate 
dehydrogenase is protected from inactivation by OH' radicals (from 
y- irradiations), whereas yeast alcohol dehydrogenase inactivation under these 
conditions is enhanced by the presence of uric acid. In our case , uric acid is 
ineffective in protecting Cu,Zn SOD inactivation under the described experimental 
conditions. 
In order to reveal any possible structural modification of the enzyme 
molecule, the SDS-gel electrophoresis of Cu,Zn SOD treated with myricetin alone 
as well as in presence of certain transition metal ions, such as Cu(ll), Fe(Ill) and 
Mn(Il) was also investigated. No change in the intensity and position of the 
electrophoretic bands of Cu,Zn SOD was observed in presence of myricetin ,Cu(Il) 
and Mn(II) alone or in combination of myricetin with these metal ions , when 
compared with native Cu,Zn SOD (Figures 19 and 23). Although these 
combinations resulted in either significant inactivation or activation of Cu,Zn SOD 
activity. However, fragmentation of Cu,Zn SOD was obser\'ed in presence of 
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Fe(III) which was further increased in presence of both Fe(III) and myricetin^ In 
the studies performed by Sahu and Gray (1993), Hpid peroxidation induced by 
myricetin was significantly enhanced in the presence of Fe(lII) which remained 
uneffected by adding catalase. The mechanism of Cu,Zn SOD fragmentation in 
presence of Fe(III) could not be explained simply by generation of hydroxyl 
radical, as catalase was reported to be inetfective in other studies where myricetin 
was used in combination with Fe(III) ( Sahu and Gray, 1993)^ Kwon ,et al (1998), 
have shown that metal catalyzed oxidation (MCO) system resulted in the release of 
copper ions from Cu,Zn SOD exhibiting the fragmentation and aggregation of 
Cu,Zn SOD,whereas the other systems reported in their studies had much less 
effect leading to no fragmentation and aggregation of Cu,Zn SOD with a decrease 
in the enzyme activity. Direct fragmentation of proteins has been observed 
following exposure to certain oxidants. Fragmentation of Cu,Zn SOD was 
observed by glycation reactin ( Ookawara,e/ a/., 1992) and by H2O2 exposure ( 
Salo, et al., 1990). The mechanism implies lateral chain scission or peptide bond 
cleavage at proline residues (Wolff, et al, 1986; Capeillere, et al., 1991, Kato, et 
a!., 1992; Davies, et al., 1999). In our studies, there is a possibility of loss of 
proline residues where iron was involved in the reaction and no proline loss in case 
of other metal ions. 
Unlike myricetin, the other flavonoids tested in our studies such as 
quercetin, rutin, naringenin , behaved differently when interacted with Cu,Zn SOD. 
The activation of Cu,Zn SOD was observed in presence of quercetin (Figure 26), 
while it was inhibitory to other enzymes ( Kyriakidis, et al., 1986; Murakami, et 
al., 1992; Lyckander and Mahemd, 1992). The inactivation of Cu,Zn SOD activity 
occurred only when incubated with quercetin for a longer period of time. It is well 
established that in presence of Cu(n) and to a lesser extent Fe(III) and oxygen, the 
flavonoid quercetin generates breaks in DNA and that the reaction involves the 
transient reduction of Cu(II) to Cu(I) (Rahman, 1989). It has been shown by Ahmed 
,et al (1994), that quercetin binds to bovine serum albumin and that the complex 
does, in the presence of Cu(II), leads to fragmentation of protein. We have also 
observed the fragmentation of Cu,Zn SOD in presence of quercetin and Cu(n) after 
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18 hours of incubation (Figure 29). Quercetin has been reported to be mutagenic 
(Nagao,^/ al., 1981; Ellinger,e/ a/., 1984) and co-carcinogenic (Zhu and Lier, 
1994).These detrimental effects are attributable to the prooxidant activities of 
flavonoids generating free radicals under conditions , for example in presence of 
metal ions (Cao,e/ a/., 1997; Rahman,e/ a/., 1989; Said Ahmed.e/ al., 1992). 
The richest sources of rutin are citrus fruits, (Herrmann, 1976),while 
naringenin is abundantly found in tomatoes, grapes etc.(Bugianesi,e/^ 
a/.,2002;Herrmann, 1976).The interaction of these flavonoids with Cu,Zn SOD 
under the similar conditions described above, partly modulate the Cu,Zn SOD 
activity. The structural differences of flavonoids are responsible for the variation in 
the mode of their action on the enzyme molecule (Elliott,^/ «/., 1992; Agn\\o,et al., 
1997: Murakami,erfl/.. 1999; Matsuda,er a/., 2002). 
The structural changes associated with protein modifications are generally 
assessed by Fluorescence and Circular dichroism (CD) spectroscopy (Raso,fr ai, 
2001). Different spectral studies are carried out inorder to monitor the structural 
changes in Cu,Zn SOD during its interaction with different flavonoids. The results 
of fluorescence and CD spectroscopy, in case of myricetin treated Cu,Zn SOD 
indicated a significant conformational changes in the enzyme molecule. The 
changes in Far-U.V CD spectra (200-250nm) of myricetin treated Cu,Zn SOD 
indicated for the modifications in conformation (Hernandez-Arana and Sorieno-
Garcia, 1988). The CD spectroscopy in in the U.V region of Cu,Zn SOD has also 
been reported by Mei, et al (1992). The structural functional relationship of 
cukayotic cytoplasmic Cu,Zn SOD is well understood from solution studies of 
native and modified enzymes (Getzoff el al., 1992; Fisher, et al., 1994).The 
variations in the fluorescence intensity as well as shifting of bands observed in the 
fluorescence spectra of quercetin,rutin and naringenin treated Cu,Zn SOD 
indicated for some structural changes in the Cu,Zn SOD. 
The results of in vivo studies are in close agreement to our in vitro 
investigations indicating the absorption of these flavonoids as described by 
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Hollinan, et al, (1996). The consumed bioflavonoids have been shown to be 
absorbed through the stomach as well as intestine (Das, et al., 1973; Hacketl, 
1986). The absorbed bioflavonoids are mainly metabolized by the liver with 
intestinal mucosa, renal tubules, lungs, skin and placenta as the secondary sites. 
The metabolites from the metabolism of bioflavonoids are excreted in the urine 
and faeces (Das, and Sothy, 1971).Although , more systematic in vivo studies are 
needed in order to propose a concrete mechanism for the interaction of these 
flavonoids with Cu,Zn SOD. Ong and Khoo,(2000), have proposed that myricetin , 
was able to stimulate glucose transport in rat adipocytes and enhanced insulin 
stimulated lipogenesis. In a different study, Heikkila, et al, (1975), have reported 
the lowering of Cu,Zn SOD activity in the brain, liver and erythrocytes of mice 
after the administration of diethyldithiocarbamate (DDC) which is a known 
powerful metal chelating agent. 
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SUMMARY 
Oxidative modification of cellular constituents, including lipids, proteins and 
nucleic acids has been implicated in the etiology of different pathological 
conditions and aging. Oxidative modification of total cellular proteins has been 
described under pathological conditions. The damage brought about by oxidative 
stress is accelerated if the antioxidant enzymes themselves are damaged and 
inactivated by such or any other events. Superoxide dismutase (SOD) is one of the 
key antioxidant enzymes, which provide an essential defense against oxygen 
toxicity to the cell. It has been known that copper,zinc superoxide dismutase 
(Cu,Zn SOD), a homodimeric metailoenzyme, which catalyzes the dismutation of 
the toxic superoxide anion to O2 and H2O2 and has a great physiological 
significance and therapeutic potential. Cu,Zn SOD contains two moles of copper 
and zinc per mole of holoenzyme and its activity is dependent on the availability of 
copper. The agents, which capture Cu(II) from the enzyme molecule, resulted in 
complete loss of its biological activity suggesting that the reduction of Cu(II) is 
necessary for the inactivation of enzyme. Flavonoids are a class of polyphenolic 
compounds, present in edible plants, vegetable and fruits, and are known for their 
antioxidant as well as prooxidant properties.These flavonoids also have the ability 
to interact with Cu (II) leading to their oxidation and reduction of Cu(II) to Cu(I) 
and generate reactive oxygen species (ROS). It is also very likely that Cu(II) of 
Cu,Zn SOD may interact with these flavonoids leading to its inactivation. With this 
objective, we have tried to determine whether Cu(II) of Cu,Zn SOD can be 
mobilized by dietary polyphenolic compounds, and such depletion of Cu,Zn SOD 
activity may have implications in the diseases where absence of SOD has been 
considered to be a major cause. 
Work described in this thesis involved the physical properties of Cu,Zn 
SOD in terms of its thermal and other stability properties. The enzyme was found 
to be maximally stable under the experimental conditions and retained its three 
dimensional conformation even at higher temperature. The enzyme was also found 
to be stable at higher ionic strength suggesting for stable orientation of Cu(Il) 
responsible for Its activity 
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The interaction of Cu,Zn SOD with a known metal chelating agent, 1,10 
phenanthroline (OP) and different flavonoids has also been investigated in order to 
study the modulation of enzyme activity under the different experimental 
conditions. Partial inactivation of Cu,Zn SOD was observed in presence of OP, 
which remained unaffected in presence of external Cu(II) Uric acid was able to 
recover the enzyme activity, when incubated in presence of OP and Cu(II) 
suggesting its role in the prevention of Cu(II) chelation with OP. The flavonoids 
selected in these studies include myricetin, quercetin, rutin and naringenin. 
Myricetin is a natural bioflavonoid, commonly found in medicinal plants, fruits, 
berries, tea and wine. Different experimental protocols for the interaction of 
myricetin with Cu,Zn SOD were carried out in order to propose a possible 
mechanism of enzyme inactivation. Myricetin was found to be maximally effective 
in modulating the activity of Cu,Zn SOD. Margmal inactivation of Cu,Zn SOD 
was observed at lower concentrations, and was increased by gradually increasing 
the concentrations of myricetin. Almost 80% loss of Cu,Zn SOD was exhibited at 1 
mM concentration of myricetin, when incubated for 3 hours duration. This 
inactivation was irreversible as suggested by the experiment where myricetin 
treated Cu,Zn SOD was extensively dialyzed and activity was determined. Almost 
similar inactivation was achieved as in the undialyzed myricetin treated samples. 
The possibility of Cu (II) chelation with myricetin was also confirmed by forming 
the complex of external Cu(ll) and myricetin and the ineffectiveness of this 
complex for inactivating the Cu,Zn SOD activity. The inactivation of enzyme was 
unrelated to its degradation or fragmentation as evident by identical SDS gel 
electrophoretic pattern of myricetin treated and untreated samples. The myricetin 
treated and dialyzed samples of Cu,Zn SOD were also monitored by UV-Visible, 
Fluorescence and CD spectroscopy and compared with the untreated and dialyzed 
enzyme samples. The intensity and shifts in the band positions indicated for 
conformational changes in the enzyme molecule. These studies confirmed for the 
chelation of Cu(II) of Cu,Zn SOD by myricetin without generating the hydroxyl 
radical, as evident by enzyme inactivation in presence of catalase 
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The interaction of myricetin with Cu,Zn SOD was also carried out in 
presence of external Cu(II) as well as other metal ions. Cu(II) alone activated the 
enzyme while in presence of myricetin, increased inactivation of enzyme was 
observed when compared with myricetin alone suggesting for an additional factor 
responsibe for such inactivation. The possibility of hydroxyl radical formation was 
ruled out by the experiment where catalase was added in the reaction mixture 
containing myricetin, Cu(II) and Cu,Zn SOD and no activity was recovered. Fe(III) 
alone inactivated the enzyme and in presence of myricetin there was a marked 
increase in the inactivation along with the protein degradation as evident by the 
disappearance of band in the SDS-PAGE. There was strong interaction between 
Fe(III) and myricetin while Mn (II) was unable to form the complex with this 
flavonoid suggesting for the specificity of myricetin towards the transition metal 
ions. 
The other flavonoids tested for such interaction were quercetin, rutin and 
naringenin, which behaved differently than the myricetin. The effect of flavonoids 
on enzyme activity is generally related to their structural properties. The flavonoids 
possessing 7 OH and 3' , 4' OH or 3'. 4', 5' OH are effective inhibitors of 
enzymes. The spectral studies of Cu,Zn SOD treated with these flavonoids were 
also compared with the native as well as myricetin treated Cu,Zn SOD. Few /// vivo 
studies carried out which were in close agreement of in vitro studies suggesting for 
absorption of flavonids at high doses. 
With these studies, it can be concluded that the pharmacological effects of 
flavonoids are generally linked to the antioxidant properties either by suppressing 
reactive oxygen species (ROS) formation, by inhibiting some enzymes or by 
chelating trace elements especially copper and iron which are potential enhancer of 
ROS formation by Fenton and Haber Weiss reaction. Nevertheless these metal ions 
are essential for many physiological fijnctions as constituents of hemoproteins and 
cofacors of different enzymes such as catalase (Fe), ceruloplasmin (Cu), 
superoxide dismutase (Cu,Zn), enzymes involved in antioxidant defence. Such 
interactions of flavonoids with enzyme bound metal ions may produce deleterious 
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effects by suppressing the activities of these enzymes and partly by generating the 
ROS, and these factors together may contribute in the propagation of the disease 
conditions On the basis of our findings, )t can be presumed that Cu(II) of Cu,Zn 
SOD may be a potential target of flavonoids under w vivo conditions, leading to 
the diseases associated with the involvement of Cu,Zn SOD as a protective agent 
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Summary 
Rcadivc i)\\t;i 'n species, siuli as superoxide ladiials, are lli()iiu;lil to underlie llie palhoj^eiie-
sis ol 'vaiioiis (lisea.ses .MIDOSI ;i lo 10'i ol liie o.w^eii iilili/ed h) (issues is e()n\eiled lo lis 
le.Klive inleriiiediales, WIIKII iiiip.ur llie huu tiouiiii; ol iclls and lissiu's. Superoxide disniu-
(ase (.SOD) cataK/es (he (Oiiveision ol siiii^le elerddii reduced species ol niolec ulai o\\<_;cn lo 
liv(h()t;eii iKToxide and oxNt^eii. I here are se\cral classes ol SOI) (lia( diller in iheii nielal 
f)iiKliiit; af)ili(\, ciisli ihiKion in difleicnl c ell c oiiip.iKiiienls. and se(isiti\ il\ (o various re.igeiKs 
.Anioii^ these, C.u. 7.\\ superoxide disiiuil.ise (SODI) is widely clisdihnled and comprises '.Hl'i 
ol the total .SOI). 1 his ul)ic|nii()us en/ \ m e , w hic h i c (|nii(s C.u and / n loi its ac (i\ lt\. has ;-;re,il 
plivsiolo^ic al si^iiilic ant c and lheia|)eulic poienlial. Ilic- picsenl icAiew desc i ihcv (he role ol 
SODs, espeeialK C.u, /.n S()l). in several dise.ises, such as laniilial amvolrophic l.iier.il sc leic>sis 
(F.AI.S), Parkinson's disease. .\l/heiiiier's disease, clen^mie lever, eaiieer, Down's seiidi ciine. 
c<it<nacl, and several neiii olonic al disoidei-. Mulalions in (he .SODI gene cause ,i l.iiuili.il 
lorin oh anivotrophic lateral sclerosis, l l ie inechamsiii hv which mutant S ( ) l ) | caiisc-s the 
des^cneration ol tnolor iieinons is not well iiiidei stood. Iianst^enic mice expressiui; multiple 
copies ol j'.M.S-niutanl SODK develop .m AI.S like 1110(01 neuton disease. X'ac iiolai deiicnei-
alioii ok niiloc hondi ia has been ideniilied ,is ihe inani p.ilhologic al leadire .issoi lalecl Willi 
motor neuron death and paiaivsis m seveial lines ol k.\I.S-SODI mice. X'aiious ohsei v.itions 
and conelusions linkin;^ iiiulaiii S( )D I and I ACS .ire disc ussed in this rev iew in detail. 
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BACKGROUND 
Su|)eroxide dismuta.se (SOD) i.s an enzyme catalyziiifr 
tl\e d ispropor t ion ol' superoxide radicals to dioxygen 
and hydrogen peroxide, according to liie fi;)llo\ving for-
mulae; 
M " + ()„- ^ M-* + ()„ 
M-* + ()„- 2H* M'* + 11,().. 
SOD i.s loiind abtmdaiil ly in ttian\ oiganisins, from 
microorganisms to ])lants and animals, since superoxide 
radicals arc toxic to living (ells, oxidizing and degrading 
biologically important molecules, such as lipids and ]5ro-
tein.s 11-4]. Several types ol SOI)^ have been reported, 
based on the requ i rement ol the metal species at the 
a( live site: 
(a) coppe r -and zinc-iontaining superoxide disiiuilase 
(Cu, Zn SOD) 
(b) Iron-containing superoxide dismuta.sc (I'e SOD) 
(c) manganese-conta in ing superoxide dismutase (Mn 
SOD) [,".-7|, 
In acklition, Ni-containing superoxide dismutase has 
recently been loinid in SlreplDiiiyci's i!^ri.sens and S. roelicolor 
[8-101. 
Cat, Zn SODs have been isolated Irom a wide range of 
organisms, including yt'ast, s|)inach, (hit ken liver and 
bovine blood. In all these (ases, ;i homodiiiiei ic enzvme 
is obtained, with a molecular weight o(~:i2,()()() dallons 
and containing one On (II) and one Zn (11) per subunit. 
The subunits are stabilized l)\ an intra(li;iin disuiiide 
bond , bill asso(iate(l bv noncovalent forces. I his 
enzyitie rc(juiies Cu and Zn loi its biological a(t i \ i (s , 
and the loss of Cat lesults in its complete in;ictivation, 
leading in many (a.s('s to the development ol hiitiian dis-
eases I 11]. (AI, Zn SOD has gre.it phvsiologiial signifi-
cance and therapeiuit potential, l i ie role ol this enzvme 
has been investigated in various spe(ilic led blood (ell 
(RIU^) disorders, such as iron delii ieni) ' anemia, oxida-
tive hemolviic anemia, thahissemia, su kle tell anemia, 
molecular dvst rophy and cvstic fibrosis, [12-1.5]. In 
recent studies, this enzyme h;is also been shown lo be 
assodated with dengue fever, posttholecvsiectoni) pain 
syndrome , malign breast disease, steroid sensitive 
nephrot ic sviidorme and amvolropiiii lateral sderosis 
11()-1S], In rheumato id arthrit is, ischemii mjiirv and 
caiuer , SOD activity is (onsideiabK iiu ii-ascd, suggest-
ing a su|)eroxi(le-relate(l pathology and the involvement 
of SOI) in these diseases. The principle aim of this arti-
cle is to highlight the diseases associated with the 
expression of t'.ii, Zn SOD, as well as other sii|K-idxide 
dismiitases. 
DISEASES ASSOCIATED WITH CU, ZN SUPEROXIDE DISMUTASE 
Prion diseases are characterized by neurodegeneration, 
gliosis and accumulation of extracellular de|)osils of the 
abnormal isoform of the pr ion protein (p,I '") , some-
times in tlie form of pla(iues. Hiiinan |)rion diseases 
include Oreutzfeldt-Jakob disease, O e r s t m a n n -
Straussler-Sclieinker Syndrome, and Fatal Familial 
Insomnia [19,20]. It lias been confirmed that prion p io -
tein expiession regulates (ai incorporation into (a i , Zn 
SOD, thereby modulating its activity. This reduces cellu-
lar resistance to oxidative stress and may regulate o ther 
c()|)[)er-dependent aspects ol cell metabolism. There is a 
strong link between Alzheimer's disease and the activity 
of suijeroxide dismutase. A sludv ol several eleinenls of 
the aniioxidative system - On, Zn superoxide dismutase 
(SOD), catala.se (V.KV), the glutathione system (CTAJ), 
cheniiliiniinescence ((^HK), and anl ioxidant capacity 
(AOX) - was conducted in patienis with dementia of the 
Alzheimer type (D.AT) and vascular dementia (VD) |21] . 
A signilicant assotiation was found between the antioxi-
dant variables measured in blood samples laken from 
these ])atients, demons t ra t ing thai VD and DAT dis-
ea.ses are aicompanied by oxidative disordeis. In a dif-
ferent study, the activity of Cu. Zn SOD was de termined 
in red blood cell (RBO) homogena te obtained from 
demen ted ])atients with D.Af , from their first d e g r e e 
relatives, and from heallhy, non-telated controls |22] . A 
statisticall)' signilicant increase in SOD adivi iv was 
found in RIU'. homogenate between the families ol DA T 
patients and (ontrols. This increase probably ie | ) iesents 
a general alteralion of the oxidative prixesses character-
istic of this dementia, which supports the proposal that 
this enzyme could be used as a peri]5heral earh diagnos-
tic marker ol Alzheimer's disease (.'\D). In an animal 
model of Alzheimer-like vascular patliology and inllain-
matory reaction, the possibility has been explored of 
deleterious vascular actions and inflammatorv response 
to tfie cytokine tumor necrosis factor, interleiikin-1, and 
amyloid-beta, as well as the proteclive effects of super-
oxide dismutase [2;-i|. Zemlan el al. (2i] have monitored 
the activity of C'ai, Zn SOD in fibroblast cell lines derived 
from liimilial Alzheimer's patients and noini.tl conlrols. 
(ai, Zn SOD activity was loiind lo be sigmlKantlv elevat-
ed in the patients, suppor t ing the e.irlier ilieorv that 
paired helical filamenls are svnthesized in . \ l /heimer 's 
disease by lice radical hvdroxvlalion of proline residues 
in paired helical filament piecuisor protein. 
In atfdition to all these (indmgs, one iem,iikable study 
has described the localization of On, Zii SOf) in the 
br<un tissues of patients with .Vlzlieimer's disease |2,5|. 
l inmiinostaining experimenis showed that large p>ra-
iiiidal neu rons , which are potenliallv siisce])tible to 
degenerative processes in ;\D, contain higher amounts 
ofOii, Zn SOD than other brain cells. 
Recently, extensive wot k has been carried out on the 
link between amvotrophic hileral sclerosis (.ALS) a n d 
SOD. ALS is a devastat ing neurological disease that 
rapidly progresses from mild motor symptoms to severe 
motor paralysis and p r e m a t u r e death . Kiumai i ei al 
|2()1 have employed a mouse model of ALS in order to 
test llie excitotoxicitv hvpothesis ol .ALS. In this model 
overexpression ol a mutant lamilial .VLS-linked (ai . Zn 
SOD leads lo |)ic)gressive motor neuron (MN) loss and a 
clinical phenotype reniai kablv simihn to that of human 
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ALS [jatients. Under basal culture conditions, MNs in 
mixed spinal cord culture from the Cu, Zn SOI) nuitant 
mice exhibited enhanced oxyradical product ion, lipid 
peroxidat ion , increased intracellular calcium levels, 
decreased intraniitochondrial calciinii levels, and mito-
cliondrial dysliuiclion. In an anotlier stud)' related to 
ALS, Vukosavic et al [27] have proposed that a mutation 
in the gene for (ai , Zn SOD, the only proven cause of 
ALS, induces the disease by a toxic property that pio-
niotes a])(j|)tosis. Kurther studies have been cariied out 
in |)()lypeplides of mutan t On, Zn SOD in relation to 
ALS [2iS]. Ratovitski et al. (2<S] have shown that a muta-
tion in the gene (or Cu, Zn SOI) causes a lorm olfiiniil-
ial amyotrophic lateral sclerosis (FAl.S). In dillerent kin-
dreds , harbor ing different mutations, the chuation of 
illness (ends to be similai /or a given nuilalion. l o r 
example, patients inheriting a substitution of xalme lor 
alanine at position 4 average a L5-year life e \pe( lan( \ 
after the onset ol the s)ni[)toms, whereas patients har-
boring a substitution of arginine for histidine at position 
46 (H4()R) have an average 18-year life ex])ectancv after 
disease onset, i hese studies show that 9 different lv\LS 
variants of SOD pcjfypeptides appear to be soluble, bin 
different nnUant en/ymes show a remarkal)le degree of 
variations with respect lo activity, jiolypeplide hall life, 
and resistance (o proleolvsis. Other studies related in 
.'VLS have confirmed that ALS is caused by a mutation in 
the gene for Cai, Zn SOD [29|. rr;nisgenic mice express-
ing .M.S-linked Cu, Zn SOD nuUalion exhibit a pheno-
l\'pe analogous to that of luunan Af„S patients, fn a 
recent stucfv refated lo SOf) and ALS |f<Sl, tfie aggrega-
tion of uf)i(|uitin anci a inulant .'M.S-finked Cu. Zn SOD 
protein correlates with disease progression and Irag-
meiuation of the Colgi ap|)aratus {CtA). In these studies, 
the transgenic nnce that express Ihe Ci93A nunalion ol 
human Cu, Zn SOD IOIUKI in f'ALS showed the dinical 
svinptonis and hislo|)alhologi( al changes of s|)oradit 
. \LS, inchiding fragmeiUalion of the neuronal C,\. f he 
finding of f ragmenled neuionaf ( ;A in asympiomalu 
mice, nioutiis before tfie ousel ol paralvsis, suggests thai 
(he (i.-V is an earh target of (he pathological |)i()cesses 
causing neurona l degenera t ion . .A subsel o( familial 
cases of .ALS are linked to a misseuse inulation in the 
gene for (a i , Zn SOD |!i()]. Patients with such a missense 
mutation develop n jiaralvlic disease indisdnguishable 
from sporadi i .ALS, caused by the addilioii ol an 
u n k n o u n lunct ion, wluih is toxic. Nitric oxide icaits 
with (he superoxide anion to form the sirong oxidant 
peroxyiiitrile, which is inipliialed in neuronal injin\ in 
a varietv ol model s\ stems. I'eioxynitritt' is an allernate 
substrate for Cu, Zn SOI), c.iusing catal)ti( niualion ol 
its tyrosine residues in some patienls. ,A inulation in the 
gene for Cai, Zn SOI) may disrupt the aitive site ol the 
en/.ynie and perinil greater access of jieroxv iiilrile to 
copper, feacfing to increased nitration h\ |)er<)X\ nitrite 
of critical ceflulai targets. Kato et al \'M] have character-
i/ecl the neu rona l Lewv body-like hyaline inclusions 
(LJUfI) and astrocytic hvalme inclusions, which are the 
nenrotJalliological markers of iniilanf SOI) linked 
LALS. 
The K.ALS mutations in the gene lor Cu. Zn SOI) are 
cloniinaiil, and are ct i r ieniK believed to exetl (heir 
elTects because of a gain of function rather than a loss of 
activity. The most convincing evidence for such a gain 
of toxic function is tiie observation that the expression 
of K.ALS mutant human Cu, Zn SODs in transgenic mice 
causes motor neuron disease, while expression of wild 
l)'|)e (vvt) luunan Cu, Zn SOI) doe.s not f32-;M]. 
Knockout mice that do not express Cu, Zn SOD also do 
not develop motor neuron disease [3.51. The g.iin of 
lunclion hypothesis is also supporled by the obser\'alion 
thai expression of K.ALS mutant human Cu, Zn SOD is 
pro-apoptolic in cul tured neuronal cells, while wi 
human Cai, Zn SOD is antiapoptotic ['M')]. I he expres-
sion of tfie KALS mutant but not wt human Cu, Zn SOD 
in a human neurofjlastoma cell line induced a loss ol 
mitochondri.il membrane |)()tential and an increase in 
(ytosolic (alcimn concentralion |;i7|. It is also X'cry likel)' 
thai oxidative damage occurs as a result ol the perox-
iclalive actixilN of K.ALS niulani Cu, Zn SOI), and can be 
h\ ])C)thesi/.ed lo arise hcim eilliei or both ol (be loUow 
ing two niechanisnis. 1) increased access ol ihe substrate 
lo the active site, leading to increased oxidalion ol the 
substrate 2) increased Icjiination of. O i l i,iclical d u e lo 
ihe presence of (ai ralfiei ifiaii Zn at tfie zinc sile lead-
ing to a subpo|nilal ion of Cu, Cu-SOl) ihat is more 
reactive. .An intriguing third possibilily is ib.il increased 
pidduclioii of. OH radicals could lead lo damaged inac-
tive mutant SOD en/. \ ine, which could slowh release 
free Cu ions ca tah / ing deleterious Kentoii-t\pe oxida-
lion leaclions at en near the sites where they are 
released. In this regard, fiirlher work is neecfecf lo lest 
Ifie abilit\ of a varietv of h)'diox\'l radical scavengers lo 
slow the inaclivation of wl and mutant en / \ ines in their 
Cu, Cu and Cu, Zn forms h\ leaclion with hyclrogen 
peroxide. 
I5ased on (he sdidies b\ [aaisina er al ['.'>S] related lo Cu, 
Zn SOD and K.ALS, ihe ol)ser\.ilion lias bc-en made that 
one of the most pu/./liiig .is|)ecls ol SODI-linked l-.ALS 
is ihe large number of clilferenl miilalioiis ihal \ielcl 
mutants having a marked variabiliu of bioc hemic al'hio-
|)h\sical properties, but all causing a rather simil.u dis-
ease phenc)t)pe |39-42] . Sludies so lai ha\c- failed lo 
ideiuih a critical toxic property that links ihe dillerent 
mutants to ihe disease [4I .42 | . Ibis max mclicale ihat 
this common toxic properly arises eilbei liom :i e i lhei to 
unrecognized Inncticjii or property of the SODI 
Protein, or from mulliple factors ihal contiibule lo the 
deleterious action of inutanl SOI) Is. Since SODI is both 
polenlialh dangerous (because of ils capac in lo bind Cu 
and Zn) and abuncknit, it is higlih likeK that abnormali-
ties related to its synthesis or degiaclation could dis luib 
cell hiiiction. 
I he role of Cai, Zn SOf) in se\er<il other disciscs has 
<tlso been thoroughl) studied. Plasma and lolal antioxi-
cl.uit status in patients with l)eiiign and m.ilignanl lireasl 
disease lias been studied bv .Afrasxap el al | L5|. I he 
sliuh was carried out on 2.5 women with bieasi cancer, 
2.5 with fibrocxslic breast disease, and 19 lieallln siilj 
jects. .Autioxidanl en/.vme aclixities and tolal aiilioxichnit 
slatus weic- measured in ihe eiylhicKVles and plasnui of 
patients and heallln individuals. A positne correlalioii 
was found lielween eiytlirocMes and plasma Cu. Zn 
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SOU activity in ail groups , indicating tliat enzymatic and 
non-en/.ymatic antioxidants arc dincrentialiy altered in 
liunian breast t umors . Siipero.xide disnuitase activity 
has hetn de termined by (ion/ales et a! [17] in RlUl iso-
lated from patients with acute myelogenous leukemia, 
chronic lymphocytic leukemia, Hodgkin's disease, lym-
])hosarc()ma and various visceral cancers. .SOI) activity 
was found to be signifrcanlly elevated in RIUl irorrr 
patients with acirte myelogenous leukemia and lyriipho-
pioliferative syndiornes . .SOI) a(t i \ i ly levels Irrrllier 
decrease with an increase irr the drrraliorr of ireatrrrern. 
These results suggest arr abrrorrrralily irr ihe regrrlatiori 
ol the expressiorr ol the SOI) gene in the |)lrrrip()tent 
stem cells. Hrriit-in celhrlar deferrse mechanisms play a 
nrajor role in trrmor protecliorr against norr-srrrgical 
arrrineoplasric ther^apies. Of these, the oxerexpressiorr of 
a n i i o x r d a n i ' e n / ) r n e s srrc h as SOD may be the irrost 
irirporlarrt [*14j. 
The role of h e e radicals and tar, Zn SOI) lias also been 
irrvestigated in nerrronal injrrry 11.")]. Fiee radicals nray 
play an important role in several |)atlrological conditions 
of the central nervotrs system ((-NS), where thev diiectlv 
injure lissire, and where their lor rnatiorr may also be a 
corrsefiirence of tissire injiriy. Free radicais prodrrce tis-
srre d a m a g e t h r o u g h mrrltiple mechanisms and <air 
worsen acirte rrerrrodegeneraiivi- disorders inchrding 
Parkinson's disease. I'iiese diseases are linked to a 
missence rrurlatiorr of (ki , Zrr SOI). .\ correlation 
between. O i l radicals and On, Zrr SOI) activit\ in 
Parkinson's di.sease (I'D) ii.rs also been sirggested l)\ the 
sirrdit-s of Ilrara et al |-I{)|. The higher. Oi l level arnl 
lower C.ir, Zrr SOD ailivit)' mav ])la\ a role in the onset 
of ])rogression of I't), arrd iiergolile ma\ act rrerrropro-
tecti\el\ in irrdircing (.'u, Zn SOD. In general, iherapeu-
til app roaches wliidr limit oxidatixe stress rna\ be 
poterrtiall) berrelicial irr sexeral ricrrrologiial diseases, 
dr.isborr I'rodl el al | 4 7 | have identilied two polvriror-
phisrirs of the .MrrSOD gene asscxiated with Par kiiisorr's 
disease, l ire Nobel Prize lor ph\srolog\ arrd rnedidrre irr 
2()()(l was awarded lor lindings showirrg that Parkirrson 
patlerrts have abnoranalK low (oiri enliatiorrs of 
dopamine in the basal ganglia [ 18|. .\s ,i (onse(|uerice L-
I)oj)a was deve loped , as a d n i g agairrsi Parkinsorr's 
Disease, arrd it remains to this d.iv the most inrportarrt 
trealrnerrl method fi)r this disease, 
Recerrt l indings orr the etiologv ol catar ai t and age-
related rrurscirlar- degenerat ion (.A.MD) sirggesl the role 
of an oxidalixe mechanism in these drseases |4*)]. Irr 
these studies high levels o l e r \thr o o l e SOD .utivitv was 
associated with a two-fold iru rease in nuclear cataract. 
Pitkarran and RolMnson 1,^ )0] ha \e studied complex I 
(NADH- CloQ reductase) in patieirts with fatal inlaritile 
lactic acidosis (FIL.A), caidioirryopathy with rataract 
(CC), hepatopath) with lirbulopathv (HI ') . Leigh's dis-
ease (l.D), cataracts and developmemal delay (C'.D) and 
lactic acidemia in the neonatal period loffowed bv rniid 
syrnplorrrs (MS). The jjrodrrctiorr of sirperoxide railicals, 
in addition to N.-\DII, was measured. Sujjeroxide (no-
duction rates were highest with 01) and decreased in 
the order C D > > MS > i . l ) >(:()riti()l > III > i'lLA = 
CC. T h e quanti ty of Mn superoxide dismutase 
(MnSOD) was highest in CC and F I IA and lowest in 
CD. Given these observations, they hypothesized that 
oxygen radical prodtrction increases when <:omplex I 
activity is coni])romised. Klaeger et al [51] have also 
conhrmed that ;t higher level ofCir, Zn SOD can redirce 
the severity of oxvgen-induced retinopathv in a morrse 
model. 
'lire (li.seases associalerl with derrgire levei inchrde the 
classical d e n g u e (I)FN), derrgrre herrrorrlragic lever 
(DHF) and dengtre shock syirdrome (DSS). SOD and 
other antioxidant [iroteiris have been loirnd to be 
abrrornial in these di.seases [ Ibj . 1 he prelimirrary report 
of cfengue confn-ms the assumpliorr of free radical gen-
eration and alteration irr arrtioxidant statirs dur ing acirte 
illness. However, lirrther strrdies are rerjrrired to rrnder-
starid their" complex interaction in disea.se progression 
and lire possible thera | )eut ic irtility of tfie findiirgs. 
Changes in (ar, Zn SOI) activity have also been founcf in 
children with steroid-serrsitive rrephrotic syndrome 
(NS), implicating the role ol Tree radicals in the develop-
meirt of this syndroirre \^2\. F.rvtirrocyle antioxidarU 
activity and trace elerrrent levels are also the besi mark-
ers in Behcet's disease [.'i3]. Selerrium (Se), Zlrrc (Zrr), 
(>)pper ((JU) and aniioxidant enzvmes, irrchrdirrg SOI) 
levels in sera, have beerr detected in Behcet patients. In 
this study, the SOD lexel was low irr the serirnr of 
Behcet's disease patierrts. It has beerr sirggested that 
decreased SOI) activitv and incic-ased producl ion of 
free oxygen radicals may play a role in the elic)j)ailro-
genesis of this disease. 
.•Vittioxidaru eiizNrne aclivil\', esijcciallv Cir, Zn and Mrr 
SOD, has also been stridiecf in iuiman abdomirral aorlic 
aireiiiysmal and occhrsive diseases |.")1]. I he aclivit\ ol 
these enz)'mes was lowered in the tissue ol these 
patients, whic h points to the i i uohemen t ol lice radi-
cals, lire plasma extracelhrlai SOD levels rn arr 
.\irslialian population with cororrai} a i te i \ disease were 
measured |o.")]. The results ol these studies show an 
associatiorr between extracellular SOD (FC-SOD) and 
coronary ar tery disease. F.C-SOD is consrdered to be 
more protective, conti ibirting to reduced coionai \ risk. 
Down's syndrome (DS). which is characterized b\ prc--
matirre aging, has also been related to oxidative stress, 
resulting from the aberrant expression of (ai . Zn SOI) 
[.")()]. SOD activity has also been me.isuied in the blood 
of differerit individuals between fit) to '.)!? \ ea i s of age 
and the lexel of this iiripor l<rnt eirz\ nie was lound to 
decrease with age (''"I. In diabetes, the persistence of 
hyperglycemia has been r epor t ed to cairse increased 
prculuclion of ox\'gen free r.idicals th rough glucose 
autooxidalion and nonerrz\malic glvcatiou. I he highest 
erythrocyte SOD ac tivit\ has been loimd in diabetic chil-
dren at the orrset of clinical diabetes. In diabetic: adoles-
cents, SOD activitv is also sigiirlicanth higher than irr 
control subjects. Decreased aniioxidant delenses nra\ 
increase the sirsceptibilit\ of diabetic patients to oxida-
tive injtrr\'. .Approprrale sup])c)i t lor enhaiic iiig antioxi-
dant supply in these \oirng diabelic patients mav help 
in preventing clinical iom|)licatrorrs during the course of 
the disease |58]. 
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Tl ie ie a ie othei diseases tliat liave close associaiion with 
SOD, but our goal in this aiticle is to focus on the most 
lecent iileiatiiie availahle lelated to those diseases dis-
cussed 111 the preMous section Studies on SOD in bio-
logical systems and tlie delete nous ellect ol the O, gen-
ei.itiiig system on biological inacionioletiilcs, subcellu 
lai com|)onents cells and tissues suggest that ()^ can be 
an initialing oi ronl i ihut ing factoi in most of these dis-
eases Siipcioxide-relaled path()log\ ma\ lesult cithei 
fiom incieased pioducl ion of O due to ln|)eioxia, acti 
vatioii of gianuloc)les and maciophages con\ersion of 
xanthine dchydiogenase to xanthine oxidase exjiosiiie 
to loni/ing ladiation and ledox cyrling of xenobiotics, 
Ol (loni dec I eased actnity of SOD 
THERAPEUTIC POTENTIAL 
various diseases T h e functional status of SOD 1 could be 
considered a reliable index of the ability of the oiganism 
to Withstand vaiious pathological conditions 1 he full 
significance of SOD in the diagnosis and piophylaxis of 
various disease condit ions is a m o n g the itiost ciucial 
a ieas in inode in biomedical and c i n i i o n m e i u a l 
leseaich 
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Keeping in mind the •issoeiation of SOD wilh so m.iii) 
diseases U is ecjually impoi t an t to highlight its ihcia 
pciilic potential SOD tan be used m miistaid gas (MS) 
b u m s [59] MS has been used m chtmical wailaic smec 
Woild Wai I I he bhs te i ing skin lesions aie slow lo 
heal Secondary in l lanimat ion, as well as daiiMgc to 
organs distant fiom the oiiginal wound c m occur due 
to these b u m s I'lcsenlly llieie is no antidote foi bums 
and j)oisoning b\ MS A study b \ 1 Idad ct al (')4) has 
shown that t ieatnient modalities v\ith fiee oxygen latfi 
cal sca\ciigcis ( u, / n and Mn SOD aic cHcctive loi MS 
skin b u m s m an expeimienial guinea pig model I acli 
of the SOD compounds cIramaticalU icdiKcd the b u m 
l< sion a ica when admin i s l c i ed intiape iiIoiK all) / 
mlialesionalh (i p/i 1) beloic wound inlliclion Studies 
coiiduelcd b\ Danel ct al [bO] lia\c eonliimed th<il gene 
t l u i a p \ foi oxidant in)ui \-ie laled diseases can be used 
to o \ e i ( o m e oxidant in|vii\ In augmenting intcieellul.u 
ant ioxidant cn/Miies When adult lats wcie in|e(te(l 
intialiaebcalK with an adeno \ i iu s (\(l) \e(t()i e iuodmg 
hum m Cii / n SOD oi c.ualasc cDNA ,i mixtuie ol 
both Ad \cc(ois oi a (on t io l \cl \e( loi eonlainmg no 
exogenous gene the exjjiession ol huni.in catalase <iiid 
C u, / n SOD was d c m o n s t i a t e d i d<i)s latci in distal 
lung cpilhcli.il cells and aheo la i iii.iciopliagcs A(l< i 
exposuie lo lOO'/i O loi t>2 his sui \i\,il was giealei m 
lals m)ectcd with cat.ilasc and/oi SOD \d \e( tois than 
in (onl iol lais \ < linical ti lal has been pei loi i i i td loi 
siiccesslul t icatmcnt ol ladiation induced libiosis using 
liposomal ( u 7n SOD [()l | 
Kokso\ el al [b'i] t i led to eompaic the p i o p l n l i e t u 
c l i e d s o l SOI) SOD + cilalase dcsleiiioxamine \ei<i 
jiamil and disul lnam ,ill lice o w g c n ladical s(a\eiigeis 
in an animal model ol ex])c luiic ntal acetic acid colitis 
I he posilivc clUcl ol SOD on the i c ( o \ e i \ ol hum iii 
hemopoietic stem cells li<is been suecessliilly shown b) 
M i e t a l |()-i| Iheii study demonstial t d tli.it the addi 
tioii ol SOD lo Inpotliciniic stoi.ige inedi.i ina\ incieasc 
the i e r o \ e i ) of hem()]:K)ic tie s tcmielU 
CONCLUSION 
I 10111 the liteiatiiie a\ailal)le to date it is e\ident lli il 
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1 l l u i o \ l ( l i l Supt lOVKit T l(ll( tl UH! Sli[)( T(l\l It (llMIIUl ISl \llll 
R o l i io t lun i I ' l ' h ()1 i|7 1 \> 
2 M t C o i d J M SupcioMcit 1 KIK il (nn l i ( i \ t iMts (ont i u lu l ions iiul 
]) i l l<ln\es I 'KK S(x 1 s p lliol Mid I'l 'J) Jll'l 112 117 
) l< |bi l ) C l d d i l l ! l l n s M \ ( l ll I iiiloldxm i m i i ists liiiif; ( II / i i 
Mipt iosuU disinul 1st [TiRN \ ()2 i iis( s n i / \ i m s \ n d n s i s Viii ] 
I 'tnsiol 1 iiiiK ( ell Mi)l Biol l')S') 2 >7 Id fit 
1 H iss M \ l ( | h i l | ( I t u h l l W l ll Ril liMigt 11 / l l s i ip iKis id t (lis 
mill is< isdlilinii IIKI se(]UtiK( oi lull ienj^lli 11)X \ iiid snulu s ol 
c i i / ) n n i i idi iuion | ( l i i i l i n t s l IMS') Hi I ' l l l i l t ) 
) I i i d o M i h l Supt los ide disiiiul 1st \ d \ t n / \ inol Kt 111 \ i t i s M o l 
Hiol l<)S(, 11 i> 17 
(i S i t i i i i n i n U SuiKios id i disinuI ist I ' lou iii th t i i i isd \ u i t i s l i iu 
luit tuiu lion It 1 ilioiiship ill OiitiltN I W jttl) SiiptioxitU tiis 
iliullsi Mil I 1 1 1)9 e R( p u s s lloi 1 R lion II 
7 l i tnn i s l t i | \ It innisK I W H Rol i l i o l . \sfKt (s ot flit sli nt [ittt 
tuiKlion iiid ipjilit ilions ot supt l o s i d t disniiit 1st ( R( ( iil \li\ 
B K K I K I I I 1'»S7 2> 111 ISO 
s \ o u i i l l l ) Klin I I R o t ) l l t l ll \ i io\t 1 iiitktl ( oiil iiiiinj; si ipti 
o\i(it disinul 1st l ioni Stit ploi iui t s spp BiiHiitin [ IM'Hi U s 
SH'l S<1(> 
'I Kmi 1 I kini H r H i h M Rot 111 Dillt i t i in il t \ p u s s i o i i ol 
s i ip t loxid t disimil ls( tout lining \ i lild 1 t / l l in Slu p lo i i n t t s 
( o d u o l o i I III J l l io t lu in l<l'll> Ml 1 ^ IN') 
ID 'l oiiii HI) 'l oiii) 11 i 11 | \ \ 11 11 t niijiit t ii/wni ( I siipt loxidi 
disinul is{ 111 Sli ( p l o i i u t t s gi 1st us \ i t ll liiiKiit III Bi ip lns !')')! 
i i l t i l !1S 
II Bio\Mi OR Btsnit^ti \ PI ion j i iott ill txiHtssion iiitl siipt loxiilt 
disiiiuMst KdMH B i n l m n l I'I'IS H I -I ' i I ' I 
! ' 1 i n t h t n U o l l I iilli liin^uii 1 ( . i i i lsi i i io\ W I t l il \ ( [ i \ i l \ o l 
siipt 1 osidt disinul 1st 111 lilt blood oi t liijtlu II u id i noil (it ill It 111 \ 
iiKiiiii \ o p i Mill kliiiii l')7') J ) ISi IS) 
i i \ l i \ t i l i l C u i o i o M R R( 1 1 t l ll 1 iMsiii 1 iuiiiolMu dist 1st 
issoi I lit li u ilii lilt It istd sllpi loMtit d Ism 111 1st tiiii d t t it 1st tl _,iii 
I iliii IK p t loMi i i s t It li\ lilt s III It ti iiiood t t i ls 1 III j B i o t i i t m 
i ' ls4 i t ' ) I t IS 
i l ( o n i t l l i \ M i s s t i R Rol i l ioCi i l il Siipiioxitii tiisiiiiii isi i i i i i d 
l i l i o d t t l i s nil ihotl ol issii iiui t i i / \ iiK (oiik Ml 111 itoi Ml ll siilijti Is 
II ti 111 p lilt Ills i nil B lii li isst nil 1 I 1 li ( iiii \ l t t i I') ll s~ 
II) " m i l l 
I \ i i / u i i o ^ Siipt II \ u i t tiisniui 1st It ii\ ii\ 111II i\ si m s ) i i i t \ t i i p 
m t u M i i n li iiid t i \ s l iopi iu l i u t k t n s I lit Sii i ' l s l i l ')() I 
l i t 
il R i\ I Kiiin ll \ iMpooi \ \ 11 li S lu i i so t mil i\iti mis m i i o i i i t i 
iiiot ill mil ll liiiioi 111 liiut s III I liiidi 111 iMiii dt i m i t it \ t 1 [ h o p 
I I til HI i'l'l') -4 1 -I ~ 
i~ ( m / i i t s R \ n t i i i i ( \ oisiii 1 t l li SiiptlOMtit disiiinl 1st i n i 
i 1st iiid i^iiii niiiont p t io s i t i 1st 111 l t d tiiotitl tt lis iioiii J) UK Ills 
\ nil III iiii,ii lilt tiist 1st ( i i i t t i Rts I')S) 11 H i " 111') 
IS S u t l t i \ \ ( on ll IS j o ( on It IS \ K \ ^ ^ u ^ lUou t i t iiiqiniin nui 
i unit lilt \ l S liiiktii se>ll I plot till t o u t lift u nil (list 1st jito-^its 
s 11 1 iti il n,mt 111 11 11 ( i C oli,i ipp 11 11 us I \ i I 1 St I 'I I tl i~ 
RA214 
MedSciMonit 2002 8(9) RA210 215 Noor R et al - Superoxide dismutase - applications and relevance 
19 F rusmt i SB Molecular biology of prion diseases S t i tncc 19')1 
252 r . I 5 1522 
20 Hsi lo K I ' l u s m e r S B I n h t u t e d human prion disc ists ^curolog^ 
1990 40 1820 ]827 
21 l a i n u l u i A I Ma i s tho f l l -R I k s u y SI et al I IK nuioxid uit t n / \ 
malic !)loo(l piofilc in Al /hcnnci s and vasculai diseases I hcii asso 
ciation m d possible ass is to diHcicnti tte dctiu n t t d subjects ind 
conliols J N c u i o l S c i 199() 141 09 78 
22 S c i ] i J \ I u i u i l i n A l K o h a n S t l a l Copp t i / i i u supcioxidf dis 
mut ist ic(i\it) in i cd l)loo<i cells in p iobabk Al/iieuiu i s j) iiieiUs 
ind tlKii h i s t d e g i e e lelal ivts | N e i i i o l S c i 1994 122 179 188 
2 i RIHKIIII [ I b o n u s 1 l i n m t M Sullon F 1 Aninul iii<Kle! ol 
\ l /h t i i i ie i likt \ i sculM pi tbo logy ind mil mini iloi \ u ul ion \ n n 
\ ^ V id SLI 2900 9 0 i iT) r , 2 
21 / e i n l i n l P l i i i c n b u i s O ) B o s m n i n H B Supeioxidt (bsniut ist 
leliMlv in Al/beiniei s disc isc Possible meehmisni loi p uied lieli 
( ilfiliMicnl foiniHion B r i m Res 1989 47b 100 1()2 
25 D e l i e o u i t e A Dc los se /A ( abiUos I el al I 'K li u nti il Kx il i /uiou 
of ( o p p t I /me s u p c i o \ i d e disinul isc in the vulnt i il)le coilu il IK u 
ions in \ l / b e i m e i s disc ise Ni. uiosei Ixtt 198S 92 217 2 )^ 
2b K n n n u i l l T t d e i s i n W A S p n n g t i |1 M u t s o n M I ' M S l n i k u i 
( u / n null it ion i iu ic ists vuliiei ibililv ol moioi neu ions lo iv t i to 
loMcit) b) I n i e tb uiisiii i i n o U m g inei iased o \ id iii\e stiess md 
pei iu i l )ed ( ik iuni lioincosl ISIS t x | ) N e u i o l 1999 !()() 2S V) 
27 \ u k o s i \ K S Dubois [)\f k o m c i o N iV/cdboisLiS B i \ md fK I 2 
intei Ktion 111 i ti insgenie mouse model o( fmuli il imvotiopliu 
l i t i i i lsclciosis ) NeuKKbcm 1999 7^ 2160 21(»S 
28 RiiovMsLi 1 ( o i s o n l B Strain ) c l a i Variation m the l)ioclunH 
{ i l l j jopln sit il p i o p e K J t s oj nujt inl sufjcioxidt disintil nc t n / \ n u •> 
ind the i Uc ol disc isc piogression m limilii l mnot iopl iK Iitti il 
s e l e i o s i s k i n d u d s H u m M o K - e n d 1999 8 1151 14<>0 
29 IVdt I sen W \ M HI son MP No bt. ne tit ot diet n ) lesti itiioii on dis 
e ise onset oi p iog iess ion in a n n o t i o p i n e 1 ui i il st U losis ( u / n 
sup( loxide disinul isc mut uu mi t t Bi im Rts 1999 S U 117 120 
U) I u t h m e t l 1 S i s i k i M C u t l i n g l B e t il 1-itk ol i i n o b t i i R n l ol 
n t u i o n il niti It oxide s>nlbast in ihe p ithogt lu sis ol i li msjM mi 
mouse inodt 1 oi 1 unili d im\ol io])hie 1 lit i il s( I tn sis 
N t n i o s t K i u t s 199') 90 1 I S i 1492 
\\ k i t o S S uto M Mil m o \ Oh im \ 1 Rett nt itK nu t s in u s t irtli 
oil n e u i o p ilhoiogu il i sp t t t s ol f unili it i in^otiopliu I ilt i il st lei 
SIS v\ith supt loxidt <lisinut ist, 1 ^t n(_ inul Uion nt lU m l I eu \ 
bo(I\ likt h\ lime nit lusious m d isdotvtu In duu iiulusi »ns Hist( ! 
H i s i o p u h o l 1999 n 97 i 9S0 
i2 C m nt \ Ml I'u H ( bin X'l 11 il Moioi i i t u iou d t g t n t i uion m 
uiK t Ih i[ t \ p u ss i hum m ( u / n supt lovidt disiuul ise in u! it ion 
V i t n t t 190} _()} ] / / J 1/7 ) 
i i t . u i n e \ MI I i i i i s ^en i t mini d niodt ls ol I unili il ini\<)lio])lni I it 
t i il s t i uos i s I \ e u i o l 1997 211 )l > )20 
U I) lit uiio M( (.111 nt> Ml \ lou exjjitssoi line ol ti uisgt nit mut 
( ii Min/^ 1 mut uu hufJMii ( u / n supt loxidt disnuK ist (S( J1>1) 
^eiit d( \ t 1 )ps p i[h()!oL,it li t h uigt s th it niosi 11 )st U i t s t mblt 
thost in b u m in un \oI i opine I itei il sdi losis \et i Nt u iop itliol 
40 
()<)- 91 •\7 >0 
Re mint \( I Ihoi JI 1 l o i b i u u 1 K 11 il Mon)i nen ions m ( ii / i i 
supt loxidt disiuui 1st debt lent imc e tit \ t lop noi in ill\ but txhibil 
tn l i m t t d ( t i l (It iih i t l t i ixon il m j u n N it! ( . eu t t 1990 H 4 I 
17 
R i b i / i d e h S ( . i i l h l B B o i t b e i t D R c t il Nbilitions iss ( lUtd 
uitli u ino i l opine 1 ilt i il s( k io s i s t o i n e r l supt loxitlt (lisiniu ist 
t iom m mti i[K)i)totic gene lo i pi o ipoptotie gent studu s in \e isi 
m d neui il tells R) oe \ ul Vt id St i LS \ 1995 9 ' M)'\ WIS 
C i i u M l l e i i i A B itlisioui \ e t il 1 x p u s s i o n ol ( u / n supeiox 
Kit disumt ise C\pR (i of I iiiiili il misot iophie i itei i( sd t ios i s 
i n d u i t s initoeluintb i il du i nit)n md in t i t ist ol (\tosf)lit ( a^ + 
(oiKt nil ilion in ti msiected nt u iobi istom i SI ! S\ 5 \ tells 1 1-BS 
I t i t 1997 I M 3()> IdS 
J1 nsni 1 0 Hi isdijk t D ( . n s h o m fA( t i il i i nn i m ( u /n supt i 
oxidt disimit ist (SODl ) o \ e i e \ p i e s s i o n m m u t t nisi s rniUuiK n 
di i il \ u u o h / It ion ixttnil dcgene i Uion ind prciii itnie inoi nicu 
ion tit lib mtl u t t t e i lies i no loncu ion diseist in mid i_x[)iessin^ i 
I unili i! \ i u \ o l i o p I n c I.<uei il Selciosis mut mi SO! ) ! \ ( i u o b i o l 
Dist ists 2000 7 02^ O H 
M u L i u n d S I \ n t l t i ; , t n P M l o r s g i e n l i i li \ o i m il biiulmg md 
le ieti\it\ oi topi»ei in mut mt supcioxide tlismul ise isol iied lioni 
m u o t i o p h i t I ilei il stlt losis p itients N e n u K h t m 199" (») (,7 , 
(>S1 
()1 
O g a u a \ Kosaka H Nakanishi I et al Stability of m u t a n t s u p e r -
oxide dismutase 1 associated n i th familial a m ) o t r o p h i c lateral scle 
losis tiete i mines the manner of copper release and induc t ion of 
thioredoxin m ciytlirocytes BitKhem Biopbys Res C o m m u n , 1997, 
Ml ^)1 2>" 
Ratoviski \ l ^ igh PN ( u/Zn SU[KIox ide dismutase g e n e m u i a 
lions in i i inot ioj jhi t I iteral sckiosis ( o n e l ition be tween gcno 
i>pes ind tliiiit il fe Uuies Neui il Neu iobu ig Psytliol 199() Gi 
"iO) J 72 
SiddKiui I \ I S Moiecul ir tliies to the )igs i\\ puzzle ol n e u r o n il 
t l tgcnei ilioii ( olti Spiing H uboi Svnip Q n ml Biol 1990 01 
()<)<) 708 
\fi i s )ap I ( - luene i iC . I m k n u n S PI ism i md ei ) i h i o t > t e tot li 
uuioxid ml St uus m p ititnis uiili bcm^n tntl in ilign ml bicasi dis 
eise C m e e i Bioehem Bioph>s 1998 l b 129 I J8 
Kong Q I i l l e b t i K O Antioxid mt mhibi tois lor cancel tiiei ipy 
Med Hypothesis 1998 5J 4 0 » 4 0 9 
I l e t l n n t t t i l DiwsonVl D i u s o n I M l i e t r id ie iU t s m e t h i t o i b 
o f n t u i o n i l i n j u i ) ( cll Mf>l Ntuiol ) io! I99H 18 ()07 082 
! h i i i \ ( hud I M K u i o d a S H i ) i b n i l I i \ d r o x \ l i idit il m d 
supt 1 oxide disiunl ise in bIcMKi oi p i t i tnts with P n kiuson s dist ist 
Rtlilionsln|> t o d m i t d d m I N t u i o l S t i 1999 170 90 95 
( .Msbon I lodl I M Rose I S R u s s O e t il \nal \s is t)f n n l o t h o n d i i d 
I irgt tmg s t ( | u t i u c md ttKhng i t g i o n pol )moi j)hisms ol the n u n 
g me St sii|)t iox id t disnml jst gt ne in C.ei m in P irkinson dise ise 
p i u t n t ^ Bio them Bioph)s Res ( o in inuu 1999 255 749 752 
( II Issoii V ( i t e n g utl P k mdt I 1 Sign \\ ti msduet ion in tlit IK i 
\ o u s s ) s t t m Nobel Pri/e m Phjsiolog) m d Mtd i t i ne 2000 
Del toui i ( ( i n to ! | P l ^ ) e j ( ) e( d \ssof / itjon of inlit>xid nu 
e n / \ m c s with c It II itt md ige i t l ited mus tu l ii tit gent i ilion 
Oph th i lmo logv 1999 106 215 >2Z 
Pitk m m S Robinson BM Miiot l iondi i i! ( oniplex 1 tie lieu n t ) 
le itls to n u i t isttl juofhit t ion oi siij>eioxitit i idu lis m d mt lu t t i on 
oi suj)eioxid( dismutase J d m l i n t s t 1990 98 Ut ^51 
K! i tgei ( dt s I ! k l leger Vj et d \ n ele\ itetl le\el ol ct)ppei znu 
supt loxidt <iisnuit i>(, f Ills lo p i t \ e I I I t)x)ge n m d u t t t l l e t i n o p i th\ 
in mite Bi | {)i)litlulmol I99f) 80 129 4 U 
I \tli \k I I i tobson I k n r / lusk 1 O 11 il XiUioxitt mt it ilus ol t hi! 
d i t n with sit I Old st nsiti\e nepli ioti t svutl iome Ptdi u i Nepl i io l 
1998 12 7 .1 751 
I u / u n \ \ \ d n i \ I ui in M F i ) l l i ioe \ l e i iuu.xuiui t itlivitv mti 
II itt e lement levels in Bt ht t t s dist ist Biol 11 ue I- lem Res 199S 
01 1(.9 171 
l ) u I m k M \ k u n C I Disihestio R \ et i! \nl ioxid mi e n / \ mt 
i(iiMi\ Ml luiin Ml tlxlomin il loitie mei i ivsmi l m d o t t lusi \e (lis 
t ist Pi< ( S K I xp B.ol Med 1999 220 ^9 4 > 
\\ mg \ ! Vditlii I Sim VS WiltktnDC PI ism i txii u t ilul u supt i 
oxidt tiiMiiuI ise le\t ls m m \usli i!i m popu! it ion with tint)!! n \ 
i i t t i \ dist ist A i u i i o s d t i honi i ) \ isc iiio! I')<»S IS 1915 1 9 ' ! 
Diu/ l iMU N N HI R( U H o u x S P Wilson ( ! D t h t t i v e i t p m ol 
oxid l in t d un igt in mitoeliondi u l DN V in Doun s S \ n d i o m e 
Mut u Rts 199S 109 81 80 
( is ido \ d t ! i I oM I R I opt / 111 n mtli / I 11 il Supt i oxide dis 
mut ISC inti ( It il ist Icicis in thst ii< s ol (ht ig td (. ic Med Mix 
I99S 111 19 )14 
D o m i i m i c / ( Rui/ I (-ussni) i M ( ai i is tosi \ Oxid i l i \ t stiess 
it onset md in e 111\ st igts oi t \pe I th iljclts in d n l t l i t i i nu! ido 
kst f j i t s D i i l x i t s t n t 1998 21 1710 1 7 4 ' 
1 Ifi id \ B t i i M t n 1) B u m 1 m m S CI il Supeioxidc tiisnnit is( 
(SOI)) loi must i i d g i s b m n s B u m s 199S 24 H I 119 
1) mt 1 C I- i /n i um S( Pia \ss i t P t t il (Ttnt th t i ip\ ioi oxit! mt 
inju) \ It ] Itt (I (bse is< s (d tuo i n us n i td i i t td (i uisfei of s u p e i o x 
ide disnuii 1st ind t it il ist tON \ piotet is ig nnst In jjt i o \ i i but 
not i^ iinsi isdiemi I icpei lus ion lung m]u i ) H u m in O e n e I hci 
199S 9 1 1S7 1 19f) 
D t h i u in S B nlltt 1 Hu ut J tt il Sn t t t ssiiil tie ttinenl oi i idi i 
ti )n indu t t d bill osis using lipos un il ( u/Zii supt i oxidt ehsimii ist 
( I m i t i l t i i i l s R id io i l u i Oiitol 12 12 20 
Kokso\ i N kost H So\bii t R t l il 1 ht p iop ln l i< tit elleels oi 
Mipt loxidt disniut tst t U il l^ e dt sit 11 lox iiiiine \ei ip mill mti tlisul 
ill im in txp t Hint nl il colitis | R ( ol! Snig I tiimb 1997 12 27 10 
Ml 1 1' 1 lu \ / I 111 \ i n et il I he t tlett ol supt i ox it! t d ismui ise 
on tilt i t ( o\ t I \ ol hum in l)ont m u lou hemojKntiH stem tells 
t i i t d It 1°( ( n o b i o l . , \ 19)S 17 r i T i 
RA215 
on 
\W. 
<S^-\/.Qr 
i i 
< | ] | ! | i | \ 
Mi erence 
Vbemetics 
July 14-18,2002 
Orlando, Florida, USA 
in 11 
LV^^^ I '^l*! T"** 
Volume XVII 
Industrial Systems and 
Engineering III 
Organized by HIS 
International 
Institute of 
Informatics and 
Systemics 
Member of the 
International Federation of 
Systems Research IFSR 
EDITED BY 
Nagib Cal laos 
Yigang He 
Jorge A. Perez-Peraza 
Metal Chelation studies on Cu, Zn Superoxide dismutase 
Sonali MHTAL 
Biochemistry Department, F/0 Life Sciences 
Aligarh Muslim University, Aligarh 202002 (U.P) INDIA 
and 
Jawaid IQBAL 
Biochemistry Department, F/0 Life Sciences 
AUgarh Muslim Universtiy, Aligarh 202002 (U.P) INDIA 
ABSTRACT 
Tlic rcdox-active metal ions Fe"* and Cu"' are believed lo 
play a central role in the promotion of hydroxyl radical 
formation from the partially reduced oxygen species, 
superoxide and hydrogen peroxide, which are themselves 
generated in all mammalian cells. The Cu, Zn Superoxide 
dismutase is a cytosolic enzyme containing 2 moles of Cu 
and Zn per mole of holoenzyme and its activity is 
dependent on the availability of copper. From the studies 
conducted so far, it has been shown that agents which 
capture Cu(Il) from the enzyme molecule resulted in 
complete loss of its biological activity suggesting that the 
reduction of Cu(II) mediate the inactivation of enzyme. 
There are certain dietary polypheonlic compond which are 
widely distributed in various foods and beverages of plant 
origin. Some flavonoids are well known for their 
interaction with metal ions generating free radicals and 
strand scission in DNA. It is ver)' well known whether 
bound Cu'' of Cu, Zn SOD may involve in such type of 
interaction either resulting in loss of enzyme activity or 
generating certain free radicals. We have carried out 
studies in this direction by selecting one metal-ion-
complexing agent. 1,10 phenanthroline (OP) which can 
chelate several metal ions, the most relevant being Cu'* , 
Fe" and Zn '. These studies are aimed to investigate the 
possibel interaction of 1,10 phenanthroline with Cu, Zn 
SOD involving its Cu(ii). The role of bound Cu^' of Cu, 
Zn SOD in the modulation of enzyme activity as well as 
the conditions for inactivation of enzyme in the presence 
and absence of free copper and other agents have been 
discussed 
Keywords: Copper, zinc superoxide dismutase 
(Cu,ZnSOD), 1,10 phenanthroline (OP), flavonoids, metal 
chelating agents, uric acid. 
INTRODUCTION 
The Cu, Zn superoxide dismutase (Cu, Zn SOD) is a 
cytosolic enzyme and is of prime importance because it is 
considered to be the first defensive enzyme in catalyzing 
the dismutation of O2" to H2O2 and O2 [1-3]. This enzyme 
has two identical subunits which are associated by non 
covalent interaction and each subunit contains Igm atom 
each of copper and Zinc [4,5]. The role of Cu(Il) and 
Zn([|) and their bridging imidazole in the catalytic 
mechanism has been well studied. It has also been proved 
that the activity of this enzyme is dependant on the 
availability of copper and reduction of Cu(II) is essential 
for the inactivation of the enzyme [6]. The key feature of 
the generally accepted catalytic mechanism of Cu, Zn 
superoxide dismutase really accepted catalytic 
mechanism.of Cu, Zn superoxide dismutase is the breakage 
of the imidazolate bridge between copper and zinc and the 
loss of a coordinated water molecule from copper on 
reduction from Cu(ll) to Cu(l) [7]. This enzyme has a close 
affiliation with several diseases such as amyotrophic lateral 
sclerosis, breast cancer, dengue fever, Alzheimer's disease, 
Parkinson's disease and several other disorders [8-11 ]. 
It has been demonstrated that flavonoids cause strand 
scission in DNA in the presence of Cu(n) and that this 
reaction is associated with the transient reduction of Cu(II) 
to Cu(l) and the generation of reactive oxygen species 
which may interact with other macromolecules [12,13]. It 
can well be predicted based on the earlier observations that 
Cu, Zn superoxide dismutase may interact with these 
flavonoids by involving its Cu(II) and bring about certain 
physiological changes which are linked to certain 
pathological conditions. 1,10 phenanthroline is a metal 
chelating agent which bind Cu^* in a preferential manner. 
Earlier it has been demonstrated that 1,10 
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phenanthroline, in the presence of a reducing agent, a 
copper salt and molecular oxygen, degrades double 
stranded DNA to acid soluble fragments [14]. So far 
there is no report regarding the interaction of Cu.Zn SOD 
Mvith this metal chelating agent by involving its Cu(f!).In 
the present paper, we have demonstrated the interaction 
of 1.10 phenanthroline with Cu,Zn SOD in the presence 
and absence of free Cu(II)/Uric acid. With these studies, 
it will be possible to explore the mechanism of 
interaction of certain dietary flavonoids with Cu.Zn SOD 
and its inactivation under certain specified conditions. 
RESULTS AND DISCUSSIONS 
As the flavonoids interact with metal ions.it can be 
presumed that Cu(n) of Cu,Zn SOD may be involved in 
such type of interaction.In order to confirm the 
possibility of metal chelating agent 1,10 phenanthroline 
(OP) for our initial studies.The effect of 1,10 
phenanthroline on the activity of Cu.Zn SOD shown in 
Table 1. 
Table I 
Effect of 1,10 phenanthroline on the activity of Cu,Zn SOD 
MATERIALS AND METHODS 
1,10 Phenanthroline and uric acid were purchased from 
Sisco Research Laboratories (SRL).Mumbai, India. 
Copper chloride was obtained from Qualigens Fine 
Chemicals, Mumbai, India, and Cu.Zn SOD ( fi-om 
Bovine Liver) was the product of Sigma (St. Louis, MO, 
USA). All other reagents were of analytical grade. 
Metal chelation studies with 1,10 phenanthroline 
1,10 Phenanthroline is a well known metal chelator and 
h ^ an ability to bind with certain metal ions including 
copper.the Cu,Zn SOD solution was prepared in 1.5mM 
phosphate buffer,pH 6.8. Different aliquots of SOD at 
var\'ing concentrations (1.19x 10"''|aM-3.56xlO'^ HM) was 
mixed with 1 mM solution of 1,10 phenanthroline 
prepared in DMSO( Dimethyl sulfoxide) and incubated 
for 1 hour at room temperature.The enzyme activity was 
determined by NBT reduction method[15]. In a separate 
reaction mixture Cu(n) in the form of CUCI2 at a final 
concentration of ImM was also included in the reaction 
mixture.The effect of uric acid on the metal chelation 
was also determined by incubating the reaction mixture 
in presence of 0.5 mM uric acid. The reaction mixtures 
were incubated for 16-17 hours in the refrigerator and 
were used for the enzyme assay. 
Fluorescence Spectra 
.Fluorescence spectra of 1,10 phenanthroline ,Cu,Zn SOD 
alone as well as in the complex form were recorded on 
specirofluorometer. Spectra of this complex were also 
recorded in the presence of CUCI2 and also in presence 
of CUCI2 + uric acid.The excitation wavelength was 
280nm. 
SDS-PolyacrylamideGelElectrophorcsis(SDS-PAGE) 
Cu,Zn SOD was treated with ImM 1,10 phenanthroline 
in the presence and absence of CUCI2/ uric acid and was 
incubated in the refrigerator for 16-17 hours.The reaction 
mixtures were diluted with the sample buffer containing 
SDS,p mercaptoethanol and bromophenol blue and then 
were boiled for 2 minutes . An aliquot of each sample 
was subjected to 10% SDS-PAGE as described by 
Laemmli [17]. The gel was stained by using silver nitrate 
[16] 
Concentration of 
1,10 
phenanthroline 
(mM) 
Molar 
concentration of 
Cu,ZnSOD( X 
10-^  HM) 
% 
Activity 
1.19 100 
1.19 
2.39 
2.39 
3.56 
3.56 
73 
100 
73 
100 
70 
In a total reaction mixture of 40 [il containing indicated 
amounts of SOD, ImM 1,10 phenanthroline was added and the 
reaction mixture was incubated for Ihour at room temperature. 
After incubation period was over, suitable aliquots were 
withdrawn and enzyme activity was determined. The control 
set was also run without 1,10 phenanthroline and percent 
activity was determined. 
As evident from the Table, 1 mM concentration of 1,10 
phenanthroline partially inactivates the enzyme.The 
inactivation of Cu,Zn SOD remains constant by 
increasing the molar concentration of enzyme at a fixed 
concentration of 1,10 phenanthroline. 1,10 
Phenanthroline is rep orted to inhibit dexamcthasone and 
etoposide -induced apoptosis in the rat thymocytes by a 
mechanism involving Cu^*[18].OP has a highest affinity 
with Cu^^  and its addition to nuclei, which contain 
copper ions result in DNA fi-agmentation with the 
mechanism involving copper [19] 
The inactivation of Cu,Zn SOD in the presence of OP 
can be explained on the basis of formation of Cu*(OP)2 
complex indicating that the metal chelating agents are 
not only bound to the free copper but also effective in 
binding with Cu^ "^  in bound form. Although no clear cut 
mechanism can be predicted based on these results. It is 
very likely that copper and OP complex might involve in 
the generation of hydroxyl radical which damages other 
macromolecules including the strand scission in DNA. 
Inorder to confirm, whether ft-ee copper can influence the 
binding efficiency of OP to the Cu(ll) of Cu.Zn SOD.thc 
interaction of Cu.ZnSOD with OP was also investigated 
in the presence of ImM copper chloride. The results are 
shown in Tablc-IL 
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Tabic II 
Effect of CuCli and uric acid on the 1,10 phcnantlirolinc-
Cu,Zn SOD interaction : -
s. No 
1 
2 
3 
4 
Cu.Zn 
superoxid 
c 
dismutasc 
(2.87 X 
lO'^M) 
+ 
+ 
+ 
1. 10 
phcnanili 
rolinc 
(1 
+ 
+ 
+ 
mM) 
CuCl2 
(ImM) 
-
+ 
+ 
Uric 
acid 
(0.5 
mM 
) 
. 
-
-
+ 
% 
Aclivily 
100 
74 
76 
93 
From these findings, it can be concluded that mcial 
chelating agents such as 1,10 phenanthroiine not only 
interact with free 
Fig 2 : SDS-Polyacrylamidc Gel Electrophoresis of Cu,Zn 
SOD in presence of 1,10 Plienanfhrolinc SDS-
Polyacrylamide gel electrophoresis (10%) was performed 
By the standard procedure and staining was done by silver 
nitrate. 
1 
in a total reaction mixture of 60 nl containing 2.87 x 
10'" n M Cu.Zn superoxide dismutase, ImM 1,10 
phenanthroiine, ImM CuCla and 0.5 mM uric acid were added 
in different sets of experiment and Cu,Zn SOD activity was 
determined. The percent remaining activity was determined by 
taking the control as 100%. 
As evident from the table,there was no difference in the 
inactivation behaviour of Cu.Zn SOD in the presence and 
absence of free copper suggesting that 1,10 
phenanthroiine is able to bind to Cu^* in free as well as 
bound states. 
It has been demonstrated earlier.that there is a 
Cu^^dependent OH radical formation in the presence of 
OP which was enhanced by adding the ascorbate and 
hydrogen peroxide[20].The possibility of OH radical 
generation cannot be ruled out in our experiment where 
free copper was added in the reaction mixture. The 
results of Table-II indicate that the Cu,Zn SOD activity 
was almost completely recovered in the presence of uric 
acid in the reaction mixture containing 
enzyme,0P,CuCl2.There may be two possible reasons for 
this recovery, l)Uric acid is acting as an antioxidant by 
scavenging the OH radical and 2) Uric acid prevents the 
chelation of Cu^* bound to the enzyme. Howell and 
Wyngaardcn[21] have shown that OH radical generated 
by H2O2 plus either FeS04 or UV light are scavenged by 
urate. Earlier studies have shown that uric acid inhibits 
L-DOPA-Cu(lI)mediated DNA cleavage and quenches 
OH radical production[22]. 
Our results are supported by these findings where uric 
acid provides a preventive mechanism against such 
damage. The quenching of Cu,Zn SOD with 1,10 
phenanthroiine in the presence and absence of CUCI2/ 
uric acid is shown by fluorescence emission spectra (Fig 
l).Ashift in the Xmjxand decrease in the intensity of 
fluorescence indicate for the possible interaction between 
Cu * of enzyme and OP. The SDS-Polyacrylamide gel 
electrophoretic pattern of above reaction mixture is 
shown in Fig-2,the recovery of enzyme activity in the 
presence of uric acid is confirmed by the intensity of the 
band (Lane a). 
.,m 
a b e d 
Lane a :Cu,Zn SOD + ImMlJOphenanthroline +CUCI2 ^ 
0.5mM Uric Acid 
Lane b : Cu.Zn SOD + ImM 1,10 phenanthroiine + ImM 
CuCI, 
Lane c : Cu.Zn SOD + ImM 1,10 phenanthroiine 
Lane d : Cu.Zn SOD alone in l.5mM Potassium phosphate 
buffer pH 6.8. 
Fig 1: F l u o r e s c e n c e s p e c t r a of i n t e r a c t i o n of 
Cu ,Zn SOD with 1,10 p h e n a n t h r o i i n e 
200.0 
(EM) 
^ • 
0.000 = • — • - • • — -
4 0 0 600 800 
C u ( l 
f o r m 
A. Cu,Zn SOD alone in (.5 mM potassium phosphate 
buffer pH 6.8 
B. Cu,ZnSOD+lmM 1,10 phenanthroiine 
C. Cu.Zn SOD +lmMl,10phcnanthro!inc + ImM 
CUCI2 
D. Cu.Zn SOD +lmMl,IOphcnanthroline + ImM 
CuCl2+0.5mM uric acid 
1) but a l s o i n t e r a c t wi th c o p p e r in b o u n d 
such as the c o p p e r of C i i .Zn 
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SOD.Although these results are preliminary 
but the work is in progress where certain 
known dietary fiavonoids with the metal 
"Chelating propert ies have been selected for 
the interaction with Cu.Zn SOD. These 
studies will demonstra te the pro-oxidant 
properties of polyphenol ic fiavonoids, which 
are generally considered to be antioxidants 
and ant icarcinogens. 
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